¥xÆW¥¼¤W¥«ªÑ²¼ °]¸gºô 

¥¼¤W¥«  

¥¼¤W¥«ªÑ²¼¦æ±¡,¿³ÂdªÑ²¼¶R½æ,¥¼¤W¥«ÂdªÑ²¼¬d¸ß,§Ö³t´x´¤¥¼¤W¥«ªÑ²¼¶R½æ¯ß°Ê

Åwªï¨Ó¨ì¥²´Iºô ¤â¾÷ª© ¥[¤J·|­û µn¤J ­º­¶
¥¼¤W¥«ÂdªÑ²¼¦æ±¡¬d¸ß,¥¼¤W¥«ªÑ²¼¶R½æ¹L¤á,¿³ÂdªÑ²¼¦æ±¡¬d¸ß¡ã§K¥I¶O±M½u¡G0800-035-178
°Q½×°Ï>ªYÄ£¥ÍÂå
¥«³õ­º¨£·sÃÄ ±ÂÅv½Í¤¤     µoªí·s¸ÜÃD ¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Ghung120110149413  µoªí®É¶¡:2020/6/24 ¤U¤È 02:11:23
¥«³õ­º¨£·sÃÄ(¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸) Àø®Ä¤ÀªR p=0.009

6634 ªYÄ£

ªÑ¥»: 3.832»õ

¥D­n·~°È:

¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo

¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤)

¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤)

Ä~Äò©¹¤U¬Ý...!

=============================================================================

²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ)

¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢

²£«~Àu¶Õ:

1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ«

2.¥«³õ­º¨£·sÃÄ(First-in-class)

3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x

4.µL¦w¥þ©Ê°ÝÃD

¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C

Ävª§¤O:

1.¦h­«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢

2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A­°§C¨x¯×

3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x

¬ãµo¶¥¬q:

1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á

2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ

Àø®Ä¤ÀªR¡G

1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n

2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009)

=============================================================================

²£«~02¡GSNP-630

¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢

²£«~Àu¶Õ:

1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE)

2.¥«³õ­º¨£·sÃÄ(First-in-class)

3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x

4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~

¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C

Ävª§¤O:

1.¦h­«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢

2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A­°§C¨x¯×

3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡

4.µL¦w¥þ©Ê°ÝÃD

¬ãµo¶¥¬q:

1.Á{§É«e

2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C

3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C

Àø®Ä¤ÀªR¡G

1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05

=============================================================================

²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯)

¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯)

²£«~Àu¶Õ:

1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê

2.¸Ñ¨M­¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs)

3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q

¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ

Ävª§¤O:

1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«

2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^

3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O

¬ãµo¶¥¬q:

1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç

2.¤w¥Ó½ÐUSFDA¼Ï&#32445;Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D

3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç

=============================================================================

²£«~04¡GSNP-830/ SNP-840

¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B­««×¯kµh)

²£«~Àu¶Õ:

1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è

2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q

¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ

Ävª§¤O:

1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è

2.½Æ¤è¤w¥Ñ¬ü°êFDA­n¨D­°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä

3.¦³¨Ï¥Î±M§Q¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y

4.¥i¼W¥[¤AñQÓi×ô¾¯¶q

¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A­°§C¦¨Å}°Æ§@¥Î

5.¤GªÌ¾Ü¤@±ÂÅv

6.¥i¼W¥[¥«¦û²v

¬ãµo¶¥¬q:

1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç

SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ý­n¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç

µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ

=============================================================================

*****************************************************************************

SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G

1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005

1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005

=============================================================================

*****************************************************************************

¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G

1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv

2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv

3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿­±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv

=============================================================================

*****************************************************************************

¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@­p¹º

§Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó

¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ù­È±o´Á«Ý¡A¦³¾÷·|¬O ¤U¤@­Ó ¦X¤@ ÄƪÑ

-----------------------------------------------------------------------------

¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×)

·|­û¡Gdk10140377  µoªí®É¶¡:2024/10/11 ¤W¤È 11:01:27²Ä 4016 ½g¦^À³
¬Ý¨Ó¤j®a³£¸õ²î¡A®¥³ß¤U²î¡C

µe¤j»æªº¹Ú¨S¤F¡A¾ã¤Ñ°Ñ®i¡C¹³§Ú­Ìªº·~°È¤@¼Ë¡A²n¦º®³¤u¥qªº¿ú¥hª±

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/10/1 ¤W¤È 10:37:35²Ä 4015 ½g¦^À³
¤S¬O¤£°Ê¦p¤sªº¤é±`
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2024/9/8 ¤W¤È 10:53:28²Ä 4014 ½g¦^À³
¦Û±q¤Wªi¥X²M«á¡A«Ü¤[¨S¦^¨Ó¡A«e°}¤l¬Ý¨ì810½¥Ãö¸`¹êÅç±o¨ìµ²ªG¨Ó¬Ý¬Ý¡A¥«³õ¬Ý¨ÓÁÙ¬O»{¦P60¦h¤¸ªº»ù®æ¡AÁÙ¦b²î¤Wªºª©¤Í¥[ªo¡A§ÚÁÙ¬O»{¦PªYÄ£ªºÃīܦn¡A¥u¬O§Ú¤£Ä@ªá10¦~µ¥¡A¤j®a¥[ªo
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GCrest10153652  µoªí®É¶¡:2024/9/7 ¤U¤È 01:43:40²Ä 4013 ½g¦^À³
§ë¸ê¤£°µ¥\½Ò·íµM¬Oµ¥¦º¡A¦ý¥\½Ò¨Ó·½¤]±o­n¨¥¤§¦³ª«¡C

¦³¤H­n§â©U§£©^¬°¦c¯å¨º¤]¬O­Ó¤H½tªk¡A§ë¸ê¬ÕÁ«¥»´N¬O­Ó¤H¦Û­t¡C

·|¦b¦¹ª©¦ÛµM¤â¤W¤]¦³ªÑ²¼¡A¦ÛµM¤]§Æ±æªÑ»ù¦³¦nªí²{¡A

¦ý©êºp¡A´N¬O¬Ý¤£¤U¥h³oºØºô¸ô¬n­·¡C

¥Î¤@°ïÁÀ¨¥¥]»q¤@¨Ç¹ê¸Ü¡A¥H¬°³o¼Ë´N¯àÅܦ¨¯uªº¶Ü¡H

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GÂæÃz10149029  µoªí®É¶¡:2024/9/7 ¤W¤È 11:10:30²Ä 4012 ½g¦^À³
¦³¦b¿³Âd¶R¹LÃĵØÃÄ,¥_·¥¬Pªº´Nª¾¹D§Ú¦b»¡¬Æ»ò¤F!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GÂæÃz10149029  µoªí®É¶¡:2024/9/7 ¤W¤È 10:38:19²Ä 4011 ½g¦^À³
­PR¤j:±z´£¨Ñªº¸ê°T¹ï§ÚÀ°§U«Ü¤j½Ð°í«ù¤U¥h

¸Ó»{¯u®É´N»{¯u,¤£¸Ó»{¯u®É±z´N§O·í¯u,»{¯u±z´N¿é¤F!

.....................................

2021¦~§Ú¶}©l¶R÷~°¥¡A·í®É¤]¬O¤@°ï»Ä¥Á¦b÷~°¥ªO¤Wooxx

§Úµ¥¤F3¦~¦h³Ìªñ¤~µo°Ê¡A«Ü©úÅã¥L­Ì¬OÁȤ£¨ì÷~°¥ªº¿ú

¬Û¦Pªº³õ´º¥u·|¦bªO¤W¤£Â_¦a¥X²{¡A¥u¬OªÑ²¼¤£¦P

§ë¸ê¬O¦Û¤vªº¨Æ,°µ¦n¥\½Ò.¤U¦nÂ÷¤â.³Ñ¤Uªº´N¬Oµ¥«Ý

(ªÑ²¼90%ªº®É¶¡¬O©U§£®É¶¡,¤×¨ä¬O¿³ÂdªÑ)

.....................................

¨C­Ó¶RªÑ²¼ªº³£»¡¬O¨Ó§ë¸êªº

³s­Ó3~5¦~³£µ¥¤£°_¡A½Í¬Æ»ò§ë¸ê

¶RªÑ²¼¤£°µ¥\½Ò¡A¨S¦³«H¥õ¡A¤£µ¹®É¶¡....±zÁÙ¬O¦^¤õ¬P§a!¦a²y¬O«Ü¦MÀIªº

.........................

¥»¤HªYÄ£¤w¶R2¦~¦h¥Ø«e¤pÁ«¤¤

@¥²´Iºôª©¥D½Ð§R°£¥»¤H«e¤@½gµo¤å,ÁÂÁÂ!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G°]°È¦Û¥Ñ¤H10132540  µoªí®É¶¡:2024/9/7 ¤W¤È 08:57:05²Ä 4010 ½g¦^À³
to ROGER5889

¥L±j¥Ñ¥L±j¡A²M­·©Ø¤s±^¡A¥L¾î¥ô¥L¾î¡A©ú¤ë·Ó¤j¦¿¡C

ºô¥Á§Î§Î¦â¦â¡A§A¶Kªº¸ê°T¡A¦³¤Hµø¬°ÁT¤g¡A¦ý¤]¦³¤Hµø¬°¬Ãó¯¡C¦³¤H«ü±±±a­·¦V¡B­JB¥X³f¡A¥ç¦³¤H¬Ý¥X¯u¹D²z¡C

¨ä¹ê¡A¤£»Ý¦]¬°¬Y¤@¤èªº«ü±±©ÎÆg´­´NÀH¤§°_»R¡A¦Ó¼vÅT¤ß¹Ò¡C§ë¸êªº¬ÕÁ«¡Aºô¥Á®Ú¥»¤£µh¤£¾i¡C

§ë¸ê´N¬O¨«¦Û¤vªº¸ô¡A¦³®É­Ô¬O«Ü©t¿Wªº¡C

ÃĵØÃĦb¿³Âd®É¡A¨C¤@¦¸µoªíÁ{§É¼Æ¾Ú¡A´N¦³¯S©wªº´CÅé°w¹ï¨ä¼Æ¾Ú´£¥X½èºÃ¡AÁÙ·|±Mªù¥X¤@½g»y½Õ¥Rº¡«ü±±ªº¤å³¹¡C

§Ú¬Û«H³o´CÅé¬O¦³¥Øªº³o¼Ë°µªº¡A¤£ºÞ©Ò¥Ñ¦ó¨Ó¡A¦ýÅ¥±q³o´CÅé¦Ó½æÄw½Xªº¤H¡A²{¦bªÖ©w«á®¬²ö¤Î¡C

·sÃĪѦ³«Ü°ªªº§ë¸êªùÂe¡A°£¤FÃöª`¤½¥qªºÁ{§É¼Æ¾Ú¥~¡AÁٻݭn¤j¶qªº¾\Ū²£·~°T®§¤Î¬ÛÃö´Á¥Z¡A¤~¦³¤@ÂI¯à¤O§PÂ_

ºô¸ôªº®ø®§¯u¹ê©Ê¡A¤@¯ë§ë¸ê¤H«Ü¦h¬O³s¤½¶}»¡©ú®Ñ¡A¡B°]³ø³£¤£¬Ýªº¤H¡A¥u¯à³Q´CÅé²oµÛ¨«¡C

»¡¨ìÄw½X¡AÃĵØÃĦb¿³Âd®É¡A¦³¬Y¦ì¤jªÑªF160¤W¤U®É¡A«ùÄò½æ¤F¤­¤d±i¡A½æ¤F¤»­Ó¤ë¤~½æ¥ú¡A§Ú¬Û«H·í®É¥L¬O½ß¿úªº¡C

¤¤¸Î¦b¿³Âd®É¡Aµo©ú¤H¦ó¤j¤@ªº¥|¤d±i§Þ³NªÑ¡A¦b 50-60 ¤@¸ô½æ¥ú¡A±¾µP«á¸³¨Æªø±i­ì©À¤]´¿¥Ó³ø½æªÑ¡A¦ý³Ì«á¨ú±o

¬ü°êÃÄÃҮɤ´¤@¸ôöt¨ì¤T¦Ê¤W¤U¡C§ë¸ê¦nª±ªº¬O¡A¤ß¹Ò¤£¦Pµ¦²¤¤£¦P¡A©Ò¥H¦P¤@Àɦ³¤HÁȦ³¤H½ß¡C

¨ä¹ê¤¤¸Î tmb-355 ¦]¬°¬O IV ªºªºÃö«Y¡A¤@«×¬O­n³Q¤½¥q§ô¤§°ª»Õªº¡A«á¨Ó¬O«á½u¥ÎÃįÊÃĪºÃö«Y US-FDA ¥D°Ê­n¨D

¨ÃÀ°¦£tmb-355¤W¥«¡C¦pªG¨S¦³ US-FDA «á­±ªºÀ°¦£¡A·í®Éªº§ë¸ê¤H¥i¯à·|­±Á{ºG¯PªÑ»ù­×¥¿¡C©Ò¥H¡A¯à¤£¯àÁȨì¿ú¡A

°£¤F°µ¨¬¥\½Ò»P­@¤ß¡A½t¥÷¤]«Ü­«­n¡C

¤¤¸Î¨úÃÄÃÒ«á§Ú´N½æ¥ú«ùªÑ¤F¡C§Ú»{¬° IV ¤ÎÃÄ«~¥«³õªº©w¦ì¡A­n½æªº¦n¤£®e©ö¡A¦ý«D±`·PÁ¤¤¸ÎÅý§Ú®Ê¤É¦³´ß¤@±Ú¡A

¤]§Æ±æ¤j®a³£¯àÂǥѧë¸ê§ïÅܥͩRªº­y¸ñ¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GCrest10153652  µoªí®É¶¡:2024/9/6 ¤U¤È 01:47:31²Ä 4009 ½g¦^À³
¨S­Jê°Tªº¸Ü¡A«ç»ò©È³Q°v©O¡H

¬O»¡­Jº¤]¤£¤î¨º¤@±ø¡C

¤µ¦~5/9¤~»¡¹L¤@¦¸¦A¨£¡A©ó20¤Ñ«á¯}¥\¡A¤£ª¾¹D³o¦¸¯à¼µ¦h¤[¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/9/6 ¤U¤È 12:44:38²Ä 4008 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/5/9 ¤U¤È 05:02:15²Ä 3729 ½g¦^À³

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/4/3 ¤U¤È 09:00:02²Ä 3682 ½g¦^À³

...ÄCÀY¦Y¤Ó¦h¡A°Æ§@¥Î¬OÀY©ü²´ªá@...

------------------------------------------------------------------------------------

§Ú¤£·R²q´ú½Ö¶R½æªÑ²¼¡A»F¦]¦P¾Ç·|ÄCÀY¤jªº¿ù»~µo¨¥(§â¼W¥[74.5±i»¡¦¨´î¤Ö)¡A¦]§Ú¨S¦b¦P¾Ç·|µù¥U¡A¤è¦b³o¶K¤å¼á²M¡C

---------------------------------------------------------------------------------------------------

±q«¥¼á²M¦P¾Ç·|ÄCÀY¤jªº¿ù»~¶K¤å«á¡AC¥S°v¤W§Ú¡A±z³ßÅw³oª©´N¯dµ¹±zµo´§!

§Ú°h¥X¶K¤åÅo!«ô«ô

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GCrest10153652  µoªí®É¶¡:2024/9/6 ¤U¤È 12:34:29²Ä 4007 ½g¦^À³
·íµM§ë¸êªº¿ú¬O¦Û¤vªº¡A¬ÕÁ«¦Û­t¤Ñ¸g¦a¸q¡C

¦ý¦bºô¸ô¤W´²¨B¤£¹ê°T®§¡A¨º¬O¹Hªk¡F¸Õ¹Ï¥H¤£¹ê°T®§±a­·¦V¡A¨º¬OµL¨}¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/9/6 ¤U¤È 12:06:38²Ä 4006 ½g¦^À³
¥xÆWµL¨x¬r¼Ï¯Ã¸ÕÅçpivotal trial/4~12g¤w§¹¦¨-->«ö¦~³ø114Q4 NDA(¥Ó½ÐÃÄÃÒ)<--->µ¥¸ò¥xÆWTFDA°Q½×½T»{¥Ó½ÐÃÄÃÒ!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/9/6 ¤W¤È 09:31:30²Ä 4005 ½g¦^À³
­ü~~¿ú¬O¦Û¤wªº¡A§O¤H³£¬Oµ¹¥X·N¨£¡A·íµM¤j®a½ß¤@®w¤l·Q§ä¾Ô¥Ç«Ü²z¸Ñ

¤]³\¬O¦n·N¤À¨É¡B¤]³\¬O´c·N¥X³f¡B¤]³\¬O¤jªÑªF¦w±Æ

¤Ï¥¿¥Ø«e65ªºªÑ»ù¡A§Ú·Q¨S¤H¬OÁÈ¿úªº

¤@°ïºô¬õ¤£¤]¬O³o¼Ë¡Aªü¦U¤O(ÁÙ¬O¤°»ò°­³Õ¤h)¡C¤j³°¤@°ïºô¬õ¤°»ò³£¤£À´·Ó½Z°á¤ñ§Ú¤Q¦~ÁȪºÁÙ¦h¡C

§è»·¤F~¤Ï¥¿¥Ø«e´N¬O½ß¨ì¦P¨Æ¯º¨ì¤£¦æ

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G´MÄ_10151381  µoªí®É¶¡:2024/9/5 ¤U¤È 04:48:41²Ä 4004 ½g¦^À³
¨ä¹êR¤j¬O­Ó«D±`´Îªºªø´Á§ë¸ê¤H¡A¯à°÷ªø´Á¤£Â_ªº»`¶°§ë¸ê¼Ðªºªº¬ÛÃö¸ê°T´£¨Ñµ¹§ë¸êªB¤Í¡A¦b¥Í§Þ»â°ì¬Û«H¤]¤Q¤À±M·~¡C

¥u¤£¹L¤j³¡¤À§ë¸ê¤H³£§Æ±æ§ë¸ê¯à¦bµu®É¶¡¤ºÀò±o¦^³ø¡A¦ý°¾°¾¥Í§ÞÃþªÑ¤£¾A¦X³oÃþ¾Þ§@¡C

¦]¬°¤j®a¹ïªYÄ£¹L«×´Á«Ý¡A®É¶¡¤@¤[³£¥¢¥h­@¤ß¤F¡A§ó¦óªp¬O¦bªÑ¥«ªº¦hÀY´Á¶¡¡A¬Ý¨ì¹j¾À¾F©~²ü¥]º¡º¡¡A´N§ó­@¤£¦í©Ê¤l¤F¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GCrest10153652  µoªí®É¶¡:2024/9/5 ¤U¤È 02:05:41²Ä 4003 ½g¦^À³
¤Ó³Y²§¡I¡I¡I

³Ì·RÃöª`¤ÎÁr´úªYÄ£¤½¥qªÑ²¼¬y¦VªºR¤j¡A©~µM¨S´£¨ì¤C¤ë¶¡¤jªÑªF¨Î®m¤Î°ª¶¥¥DºÞ¦ó¨ó²zªºªÑ²¼¼Æ¶qÅܤơI

²ö«D¡H¡H

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/9/4 ¤U¤È 07:38:57²Ä 4002 ½g¦^À³
Ãĵؤ]¬O³Qª©¤Wªº»¡ªk¬~¤F¥X¥h

­ü¡A´«¨ìªYÄ£¤Ï¦Ó¿é¤@¿Ç¤l

¤£¦p¦sªÑ¹ê¦bÂI

===============================

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G°]°È¦Û¥Ñ¤H10132540  µoªí®É¶¡:2024/9/4 ¤W¤È 10:44:55²Ä 4001 ½g¦^À³
to ROGER5889:

US-FDA 505B2 Á{§É¯à®i¶}·N¸q«D¤Z¬O«ü 810 ¥h°£ APAP ¨x¬r©Ê¦w¥þ©Êªì¨BÀò±o»{¥i¡C

¤@¯ëÃĪ«Àø®Ä³q±`·|¦³¦]¤H¦Ó²§ªº¸¨®t«ÜÃø«OÃÒ 100% ³£¦³®Ä¡A¦ý APAP ªº°Æ§@¥Î¨ä¨x¬r©Ê¬O¦³¥i¯à·|­P©Rªº¡C©Ò¥H¡A§Ú­Ó¤Hı±o¡A810 ¥h°£ APAP ¨x¬r©Êªº®ÄªG¡A¶·¦³ 100% ¤HºØ³£¦³®Äªº½×­z©ÎÃÒ©ú¥h»¡ªA US-FDA ¦P·NÁ{§É¡C

¤é«e SNP-810 °ª¾¯¶qªºÁ{§É¼Æ¾Ú¡A12g ©Ò²£¥Íªº¦³¬r¥NÁª«Â÷¨x¬r©Ê¼Ð·Ç¤´¦³¤@¤j¬q¶ZÂ÷®ÄªGÅãµÛ¡A³oÀ³¸Ó¬O«Ü¦³»¡ªA¤Oªº¼Æ¾Ú¡A«Ü¦³¾÷·|Åý US-FDA ÂIÀY¦P·NÁ{§É¡C

·sÃĪѻEµJÁ{§É¼Æ¾Ú´N¦n¡A¨ä¥L¤£¶·ªá¤Ó¦h¤ß«ä¡C

ÃĵØÃĦb¿³Âd®É¡A¬y¨¥¬Æ¦h¡AÁÙ¦³¤H¦b¥²´Iºô¶}±MªO¨Ó¶}½|¤½¥q°ª¼h¡A¦ý²{¤µªÑ»ù»¡©ú¤F¤@¤Á¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GCrest10153652  µoªí®É¶¡:2024/9/4 ¤W¤È 09:23:24²Ä 4000 ½g¦^À³
½×«æ­þ¤ñ±o¤WR¤j¡A¥þºô³Ì¿n·¥À°ªYÄ£§ä¥X¸ô«Å¶Çªº´NÄݱz¤F¡ã±z¨S¦bªYÄ£±¾­Ó¤°»ò¦ì¤l¯uªº¬OªYÄ£ªº·l¥¢¡C

¬Ý±z¨C¤Ñ§ä´Á¥Z§ä±o³o»ò»{¯u¡A¦WºÙ§è¨ì­Ó¤°»ò¿}¤]¯àµo¤@°ï¤å³¹¡A§ó§O»¡¬ã¨s¦U­Ó¥DºÞªÑ²¼¬y¦V¡A¦Aµoªí¤@°ï¦ü¬O¦Ó«Dªº¨¥½×±a­·¦V¡C

µo¨¥¤£¥Î­t³d¡A§¹¥þ¤£¥Î¨DÃÒ¤]¥i¥HÁ¿±o¸ò¯uªº¤@¼Ë¡A³oºØ§V¤O¨S¦³¤H¤ñ±o¹L±z°Ú¡I

§Ú¬Ý¤£¥Î¥þºô¡A¥þ¥xÆWªÑ¥«¨S¦³¤ñR¤j§ó¿n·¥ªº¤F¡I

¦p¦¹¥Î¤ß¡A¥u§Æ±æ¦¶¸³¬Ý±o¨£¡A§O¶d­t¤FR¤jªº§V¤O

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/9/4 ¤W¤È 07:31:49²Ä 3999 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/24 ¤U¤È 05:12:20²Ä 1918 ½g¦^À³

±q¸ê¥»ÃB/ªÑªF¤H¼Æ:ªYÄ£(6.9»õ/ 2271¤H) :Ä_ÄÖ(8.5»õ/ 29736¤H):°ê¹©(14.2»õ/ 18372¤H):¦X¤@(38.8»õ/ 45737¤H)

¥Ø«e©úÅã¤H®ð¤£¨¬¡A­«§Q´N¦b½G¥ÐµL¤H¯Ñ¡A¯Ñ¶}¦³¤Hª§(¤H¨ú§Ú±ó)!

---------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/8/14 ¤U¤È 06:16:26²Ä 3941 ½g¦^À³

ªYÄ£¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ!!!(§Æ±æ°ª®p·|¦³ÁôÂê©2«¬¿}§¿¯f¼Æ¾Ú¤½¶})

-------------------------------------------------------------------------------------------

¤W¦¸揬¯ä«á¦n¤[¤£¨£¡A¥b©]Ãöª`§Ú¶K¤å¡A¨¯­W±z¤F!(2¦~¨ÓªÑªF¤Ö86¤H¡A¨º»ò§Ú¸Ó­±¾À¤F)

[§Æ±æ]¦³¼Æ¾Ú¤½¶}¡Aµ¥°ª®p·|«á´Nª¾¹D¡A±z«æ¬Æ?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GCrest10153652  µoªí®É¶¡:2024/9/4 ¤W¤È 12:01:53²Ä 3998 ½g¦^À³
³o®a¤½¥q²{¦b¬Ý¨ÓÁÙ¯u¬Oº¡¦MÀIªº¡A­n¾aR¤j¦b³oµoªí¦UºØ¸I¨ìÃ䪺ªF§è¦è´ê¬°¤½¥q©Ô©ï¨­»ù¡A¬OÀ³¸Ó¸u½ÐR¤j¨ì¤½¥q¾á¥ôÅU°Ý¡A·Q¥²¯à¬°³o¨Ç®É¤éªº°±Â\§ä¨ì¬ð¯}¤f¡C

R¤j¦b³o¥²´Iºôªº¯Ñ¯Ð¤Î§V¤O¤j®a¦³¥Ø¦@¸@¡AÀ³¸Ó­n§â¸ê°T¾ã²z¦¨¥U´£¨Ñµ¹¤½¥qªº°ª¼h­Ì°Ñ¦Ò¡A¤£µM®ö¶O¤F³o¨ÇÄ_¶Q¸ê®Æ¦h¥i±¤©O¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GCrest10153652  µoªí®É¶¡:2024/9/3 ¤U¤È 11:41:07²Ä 3997 ½g¦^À³
R¤j¤°»ò¤£·|¡A®·­·®»¼vÁÙ¯u¬OÆZ±jªº°Ú¡I

³o¼Ë³£¯àÙT¥X¡uÁôÂüƾڡv¡ã

ªYÄ£ªÑ»ù¯u¬O­n¾a±z°Ú¡I

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G´MÄ_10151381  µoªí®É¶¡:2024/9/3 ¤U¤È 03:44:08²Ä 3996 ½g¦^À³
³o´N¬O­Ó¤H¤§«e´£¨ìªº¡AªYÄ£¬°¤°»ò¤£¥Î¢Ý¢â¢Ñ·m¥«¥e¥h¹G­¢°ê»Ú¤j¼tñ±ÂÅv¡H

¡×¡×¡×¡×¡×¡×

¡Ö¡Ö·íµM¦pªG¤¤¶¡ ©ÎªÌ¦]¬°¬O§Ú­Ì­n¥h°µ ·|¹ï©ó¤j¼tªº¦æ¾P©Î¥«³õ²£¥Í[«Â¯Ù]ªº¸Ü ¥L­Ì¤]¥i¯à±ÂÅv.....

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/9/3 ¤W¤È 07:12:26²Ä 3995 ½g¦^À³
6/6ªk»¡·|¼v­µÀÉ httpd://www.sinewpharma.com/Upload/download/20240606-video.MP4

44:15¬í°_:....·íµM¦pªG¤¤¶¡ ©ÎªÌ¦]¬°¬O§Ú­Ì­n¥h°µ ·|¹ï©ó¤j¼tªº¦æ¾P©Î¥«³õ²£¥Í[«Â¯Ù]ªº¸Ü ¥L­Ì¤]¥i¯à±ÂÅv.....

¼v­µÀɬO6/29¤W¶Ç¥­¥x! 6/9ªº»¡ªk«D¬B¤H¤ú¼z.

---------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/9 ¤W¤È 09:16:38²Ä 3790 ½g¦^À³

¤jÃļt¡u¤U¤£¤F¥x¡v§óÁ}Ãø¦a¤@¤Ñ¡AÅý¶D³^«ß®v¾ß¨ìºj¡A¯à´Á«Ý¤£µo¥Í¤j¨Æ???

¶D³^«ß®v/®ø¶OªÌ/¾ÇªÌ/µû½×®a/ªk©x¦b½æ³õ¬[¤W¬Ý¨£SAFETYNADOL(µL¨x¬r)¡A¹j¾ÀªºTylenol(¦³¨x¬r)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/9/2 ¤U¤È 06:56:47²Ä 3994 ½g¦^À³
A:¤fªA¦w¼¢¾¯A+ Naldebain (¤fªA) B:¤fªA¦w¼¢¾¯B+ SafeTynadol (¤fªA) C: Naldebain (¤fªA)+ SafeTynadol (¤fªA)

¦¸­n«ü¼Ð¡G¡E¶}©l¨Ï¥Î¸ÕÅçÃĪ««á70¤p®É¤§¨x«ü¼Æµ²ªGÅã¥Ü¤T¸ÕÅç²Õ[¥¼¹F]²Î­p¤WªºÅãµÛ®t²§¡A¥B§¡¥¼¥X²{¨x¬r©Ê

¡E¶}©l¨Ï¥Î¸ÕÅçÃĪ««á°Æ§@¥Îµ²ªGÅã¥Ü¤T¸ÕÅç²Õ[¥¼¹F]²Î­p¤WªºÅãµÛ®t²§¡C

------------------------------------------------------------------------------

5/27¤½§i4~12g SNP-810¨x«ü¼Æ(ALT/AST)[¥¿±`]¨S¥X²{¨x¬r©Ê/°Æ§@¥Î¦P4g´¶®³¯k-->¥i¹w¨£B:¤fªA¦w¼¢¾¯B+SafeTynadol¨x«ü¼Æ[¥¿±`]µL¨x¬r©Ê/°Æ§@¥Î¦P4g´¶®³¯k

¦pªG«ü¼Ð[¹F]²Î­p¤WªºÅãµÛ®t²§¬O¦n¨ÆÁÙ¬OÃa¨Æ?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/9/2 ¤U¤È 05:02:07²Ä 3993 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/4/18 ¤U¤È 06:48:45²Ä 3693 ½g¦^À³

¦¶³Í¥Áªí¥Ü¡AµL¨x¬r©Ê¤îµhÃÄSNP-810¡]¦w®õ®³¯k¡^©ó2020¦~¡B2021¦~¤À§O»P2®a°ê»Ú¯ÅÃļtñ­q¦X§@¨óij¡AµL©`´Á¶¡¨ä¤¤¤@®a¦X§@¼t°Ó½T»{¸ÕÅçµ²ªG¤£¦p¹w´Á¡A¥H­P¦X§@¤¤¤î¡C

------------------------------------------------------------------------------------

¦X§@¤¤¤î(«D²×¤î)

«á¨Ó­×§ï±ø¥ó«á¦p¹w´Á? ©Ò¥H¥ÛXX¤j·§¬O¥¼¯à¤Î¦­µo²{Åܼƾá³d¥h¾¡C

FDA­n¨D°Êª«¼Ò«¬¹êÅç¬O¦b«OÅ@Á{§É[¨ü¸ÕªÌªº¦w¥þ]¡A·Q­nÀò±oÃÄÃÒ¡AFDA¬Ý±o¬O[¤HÅéÁ{§É]¼Æ¾Ú!!!

ªp¥B¦³¤HÅ骽±µÃÒ©úµL¨x¬r«á¡A¤j¼t°£«D¶Ì¤F¡A¤~©T°õ°Êª«¼Æ¾Ú¨M©w!!!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/9/2 ¤U¤È 04:52:13²Ä 3992 ½g¦^À³
©Ò¥H¤~»¡¾Ç¾Ç°ê³»¡Aª£¤@ªiÅý¤j®a¤U¨®

µUµk¤S¨Ó¤F¡A¤°»ò610+810ÅýAI¥D¤Oª£¤@¤U «¢

¦ý¨ä¹ê¦³¤]§C½Õªº¤½¥q¡A«á¨Ó¦³¦n¤U³õªº¥ý¨Ò¡C¥u§Æ±æªYÄ£¬O³oºØ¡A¦ý¤Ï¥¿¤â¤W¦³²¼ªº¤H§Ú¬Ý¤]¤£¦h¡A³s­Jp¤]¨S¦³¡A³o¬Ý¦n¬°¤°»ò¤£À£®a¨­

===============

¥«³õ¥D¤Oªº¶åı¬O±Ó¾Uªº¡A¥D¤O¤£¶i³õ¦Û¦³¥Lªº¹D²z¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G´MÄ_10151381  µoªí®É¶¡:2024/9/2 ¤U¤È 04:06:35²Ä 3991 ½g¦^À³
ªñ´X¦~¨Ó¡A·í¥«³õ½Í½×¨ì¥Í§ÞÃþªÑ³Ì¨üÃöª`ªº±ÂÅv®×¡]©Î¦³¾÷·|±ÂÅv¡^¡A§Aµ´¹ï·j´M¤£¨ìÈЪYÄ£ÈШâ­Ó¦r¡A¬°¤°»ò¡H

·íªYÄ£¦b2021~2022¦~»P°ê»Ú¤jÃļtªº±ÂÅv®×®øÁn°Î¸ñ«á¡A­Ó¤H´N»{¬°ªYÄ£¤w¿ù¥¢³Ì¨Î±ÂÅv¾÷·|¡A±q­J±Ð±Â´¿´£¨ì°ê»Ú¤jÃļt¶RªYÄ£ªÑ²¼¤@¨Æ¡A¤Î³o¦¸ªºÁ{§É¸ÕÅç¨Ã«D°ê»Ú¤jÃļtªº­n¨D¡A¤j·§´N¥i¥HÅ¥¥XºÝ­Ù¡C

¥«³õ¥D¤Oªº¶åı¬O±Ó¾Uªº¡A¥D¤O¤£¶i³õ¦Û¦³¥Lªº¹D²z¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/9/2 ¤U¤È 02:12:50²Ä 3990 ½g¦^À³
8/27

¡E¶}©l¨Ï¥Î¸ÕÅçÃĪ««á°Æ§@¥Îµ²ªGÅã¥Ü¤T¸ÕÅç²Õ¥¼¹F²Î­p¤WªºÅãµÛ®t²§¡C

¡E³N«á4¤Ñ¯f¤Hº¡·N«×µ²ªGÅã¥Ü¤T¸ÕÅç²Õ¥¼¹F²Î­p¤WªºÅãµÛ®t²§¡C

¤£´N¼gªº«Ü²M·¡¡C§Ú¦Û¤w»{¬°°Õ~

§ë¸ê¤H¤]¨S¤ÏÀ³¡A¤j¤á¤]¤£¶i³õª£¡A´N·d¯ºªº¬O²{¦bÁÙ¯}70¡C¨ä¹ê¬Ý°Q½×ªºµ{«×´Nª¾¹D¬O¥s¦n¤£¥s®y¡A¨S¦³¤j¤á©Ô´N¬O¦º¤ô¤@Åy

=================================================

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/9/2 ¤U¤È 01:53:39²Ä 3989 ½g¦^À³
2024/09/02--ªYÄ£¥ÍÂå°ª¨x¦w¥þ©Ê¤îµh·sÃÄSNP-810¦X¨Ö±j®Ä¤îµh·s½Æ¤è [¹F]I/II´ÁÁ{§É¸ÕÅç[¥D][¦¸]­n«ü¼Ðwww.sinewpharma.com/news-detail31.htm

¤½¥q¤µ¤Ñ²æ¿Ç¤l©ñ§¾¡A8/27¤£»¡©ú¥Õ!(²q´ú¦³¤H¥´¥h°Ý¦¶¸³¹F¼Ð§_???)

------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/8/27 ¤U¤È 09:31:59²Ä 3959 ½g¦^À³

1.¥D­n«ü¼Ð»P¦¸­n«ü¼Ð§¡[¹F¼Ð].............)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/9/2 ¤W¤È 10:49:23²Ä 3988 ½g¦^À³

¤£´N¬O¤j·§²v¬O¶¶ÃĪº¤fªA?®É¶¡®t(¤Ï¥¿²{¦b¤½§i¤F, ¦A°Ý¤@¦¸´N¥i¥H´¦ÅS¤F§a~~~)

²Ä¤@¥Ø¼Ð»ù===>¶¶ÃÄ¡A­nº²Â_¥|¤Ñ

²Ä¤G¥Ø¼Ð==>¤U¥«

¾Ç¾Ç¥x·L

======================================

°Ý5.

SNP-810 ¦X¨ÖªºÃĪ«²{¦bÁÙ¤£¾A¦X´¦ÅS?

------------------------------------------------------------------------------------

°w¾¯§ï¤fªA§Ú¯à¸Ñ¡A¦X¨ÖªºÃĪ«²{¦bÁÙ¤£¾A¦X´¦ÅS? §ÚµL¸Ñ! ¦³¤H¯à¤À¨É§_?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/9/2 ¤W¤È 08:56:34²Ä 3987 ½g¦^À³
°£¤FÀù¯g¯kµh«ü¤Þ[¤fªA]Àu¥ý¡A2017¦~¬ü°êÆbÃö¸`¨ó·|¬ã°Q·|--¤]¬O«Øij±Ä¥Î[¤fªA]¦h¼Ò¦¡Âíµh!

¥þÃö¸`¸m´«³N¤¤ªº¤fªA¦h¼Ò¦¡Âíµhwww.sciencedirect.com/science/article/abs/pii/S0883540317304023

µ²½×

«Øij±Ä¥Î[¤fªA]¦h¼Ò¦¡Âíµh¡Aµ²¦X¾~¤ùÃþ©M«D¾~¤ùÃþÂíµhÃÄ¡B¿ï¾Ü©Ê©M«D¿ï¾Ü©Ê§Üµoª¢ÃÄ¡B¹ï¤AñQ®ò°ò×ô©M¥[¤Ú¼Q¤BÃþÃĪ«¡A§@¬°ÆbÃö¸`©Î½¥Ãö¸`¸m´«³N±wªÌ¹w¨¾©Ê¯kµhºÞ²z¤èªkªº¤@³¡¤À¡C´î¤Öªü¤ùÃþÃĪ«ªº®ø¯Ó©M³Ì¤j­­«×¦a´î¤Ö°Æ§@¥Î¬O¥D­nµ²ªG¡A¹w¨¾ºC©Ê¯kµh¥i¥H¹ïªø´Áµ²ªG²£¥Í¿n·¥¼vÅT¡C

------------------------------------------------------------------------------------------------

MMA¦h¼Ò¦¡¯kµh±±¨î¬O©Ò¦³±µ¨ü¤â³Nªº±wªÌ³N«á±±¨î¯kµhªº­«­n¤èªk»PÁͶÕ(¤fªA­º¿ï)¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/31 ¤W¤È 11:54:23²Ä 3986 ½g¦^À³
www.genetinfo.com/investment/featured/item/80405.html?start=2

°Ý5.

SNP-810 ¦X¨ÖªºÃĪ«²{¦bÁÙ¤£¾A¦X´¦ÅS?

------------------------------------------------------------------------------------

°w¾¯§ï¤fªA§Ú¯à¸Ñ¡A¦X¨ÖªºÃĪ«²{¦bÁÙ¤£¾A¦X´¦ÅS? §ÚµL¸Ñ! ¦³¤H¯à¤À¨É§_?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/31 ¤W¤È 11:34:48²Ä 3985 ½g¦^À³
[°w¾¯]§ï[¤fªA]·mWHO³Ì°ª¯Å§O¤îµh²Ä1¶¶¦ì¥«³õ!

°ê¤º¥~µ¹Ãij~®|ªº²Ä1Àu¥ý³£¬O[¤fªA]

--------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2023/11/1 ¤U¤È 07:47:43²Ä 3500 ½g¦^À³

SNP-810 ­º¦¸¥Î©ó¯f¤H¤§Á{§É¸ÕÅç¡A¾ãÅé¶}µo¥Øªº¬°ÅçÃÒ¡G

www.lotus.org.tw/publication-article/562

WHO½w¸Ñ[Àù¯g¯kµh]«ü¤Þ¡A´£¥X¤T­Ó¯kµh±±¨îªº¥ÎÃÄ­ì«h¡]3B­ì«h¡^

²Ä1­Ó¢Ð¡G¡u¨Ì·Ó®É¶¡¡]By the clock¡^¡v¡AÂå®v¤@©w­nª¾¹DÃĪ«ªº¦³®Ä§@¥Î®É¶¡¡A¦b«e¤@¾¯¶qÃĮĮø¥¢«e¬ù¤@¤p®É´N¶·µ¹¤U¤@¾¯¶q¡A±±¨î¨ì¨S¦³¯kµh¡A¦Ó¤£¬Oµ¥µh°_¨Ó¤~¦YÃÄ¡A¥H§K½w¤£ÀÙ«æ¡C

²Ä2­Ó¢Ð¬O¡u¨Ì·Ó¶¥±è¡]By the ladder¡^¡v¡G¨Ì·Ó¥@¬É½Ã¥Í²Õ´¡]WHO¡^ªº¤T¶¥¬q¡A±qª÷¦r¶ð©³¼h²Ä¤@¶¥¡u«DÃþ©T¾J®øª¢¤îµhÃÄ¡v¡A¨ì¤¤¶¡²Ä¤G¶¥¡u®z¾~¤ùÃþ¡v¡A¥]¬A¥i«Ý¦]¡]codeine¡^¡B¯S©Ôº¿Äu¡]tramadol¡^¡A³Ì«á¬O³»ºÝ²Ä¤T¶¥¡u±j®Ä¾~¤ùÃþ¡v¡A¥]¬A¶Ü°Ø©M¡u§h©Z¥§¤îµh¶K¤ù

²Ä3­Ó¢Ð¬O¡u¸g¥Ñ¤fªA¡]By the mouth¡^¡v¡Gª`®g°w¾¯¬O¤£±o¤w¤~¥Îªº¤èªk¡C°ê¥~µ¹Ãij~®|ªºÀu¥ý¦¸§Ç¬O¤fªA¡B¨zªù¶ë¾¯¡B¥Ö¤Uª`®g¡BÀR¯ß©Î¦Ù¦×ª`®g¡A°ê¤º«h¤£µM¡A¤fªA¤§«á´N¬Oª`®g¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/31 ¤W¤È 09:58:22²Ä 3984 ½g¦^À³
5/27 &8/27:¹w­p©óÅU°Ý¤½¥q§¹¦¨[³Ì²×³ø§i]«áµo­«°T¤½§i!

µ¥ªYÄ£¦¬¨ìCRO³Ì²×³ø§i¡A¾ã²z¤@¤Uµ¹2®a°ê»Ú¤jÃļt...

Go Go ªYÄ£ Go Stronger Let¡¦go

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/31 ¤W¤È 09:08:38²Ä 3983 ½g¦^À³
·|­û¡G°]°È¦Û¥Ñ¤H10132540 µoªí®É¶¡:2024/8/14 ¤U¤È 05:29:31²Ä 3938 ½g¦^À³

SNP-810 ¥Ø«eªºÃöÁä¡A­Ó¤Hı±o¬O¦b US-FDA µL¨x¬rÁ{§É¦w¥þ©ÊªººA«×¡A­Y US-FDA ¦P·N°õ¦æµL¨x¬rÁ{§É¡A¨ä·N¸q«D¤Z¡C

---------------------------------------------------------------------------------------------------

FDA¦Ê¤À¦Ê³q¹L¦P·NªYÄ£°õ¦æµL¨x¬rÁ{§É(ÃöÁä¦b¨ü¸Õ¤H¼Æ»P®É¶¡)

²z¥Ñ:1.FDA­n¨D°Êª«¼Ò«¬¹êÅç¬O¦b«OÅ@Á{§É[¨ü¸ÕªÌ]ªº¦w¥þ¡A¦Ó5/30¤½§iªº¤HÅéÁ{§É¼Æ¾Ú¡Aªí©ú¦w¥þµL¸·!

2.¡mFDA¡n¤£¦A±j¨î¤HÅéÁ{§É¸ÕÅç«e»Ý¶i¦æ°Êª«¸ÕÅç¡I

www.genetinfo.com/international-news/item/66096.html

2022.12.23¬ü°ê°ê·|³q¹L¡uFDA ²{¥N¤Æªk®×2.0¡v¥H´î¤Ö°Êª«¸ÕÅç¡A¥i§Q¥Î´À¥N¤èªk¥[³tÃĪ«¶}µo

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/31 ¤W¤È 08:33:58²Ä 3982 ½g¦^À³
¦¶¸³»´´y²H¼g±a¹L.....¬Æ¦Ü·|­n¨Dªk³W³æ¦ì À³¸Ó§â¨º¨Ç·|¶Ë¨xªº«~¶µµ¹¥L®³±¼

2018¦~¥Nªí®ø¶OªÌ§Q¯qªº²Õ´¦­¼g«Hµ¹°ê·|!

-----------------------------------------------------------------------------------------------

ROGER588910148151 µoªí®É¶¡:2024/6/30 ¤U¤È 06:58:03²Ä 3867 ½g¦^À³

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/2/3 ¤W¤È 10:56:59²Ä 662 ½g¦^À³

J&J»PGSKªº°ª¼h¬OÄø³J?¥H«e¹C»¡°ê·|ij­ûªý¼¸FDA¡A²{¦b¤£ª¾¹D¤Ï¹L¨Ó§Q¥Î³o±ø¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï­²ªk®×¡n?

-------------------------------------------------------------------------------------------------

...2018 ¦~1 ¤ë¼gµ¹°ê·|»â¾É¤Hªº¤@«Ê«H¤¤¡A¤@­Ó¥Nªí®ø¶OªÌ§Q¯qªº²Õ´¤½¶}´£¥X¤F³o¼Ëªº¾á¼~¡G«D³B¤èÃĤ½¥q¥i¯à·|­­¨î¸û¦Ñ¦ý¦P¼Ë¦³®Äªº«D³B¤èÃĪº¨ÑÀ³¡A±q¦Ó­¢¨Ï®ø¶OªÌÁʶR¸û·s¡B¸û¶Q¥BÀò±o[¿W®a¸gÀçÅv]ªºÃĪ«

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/30 ¤W¤È 10:35:24²Ä 3981 ½g¦^À³
1.¦b 27 ¦W¤J²Õ±wªÌ¤¤¡A¦³ 2 ¦W¥X²{³¡¤À½w¸Ñ¡]7.4%¡^¡C¦b¦¹ AAP ªº I ´Á¸ÕÅ礤Æ[¹î¨ìªº¬Û¹ï¸û§Cªº½w¸Ñ²v¥i¯à¬O¥Ñ©ó

µLªk±N AAP ¾¯¶q¤É¯Å¦Ü¨¬°÷ªº¤ô¥­¡]20 g/m 2¶¤¦C¤¤ªº 1/3 ±wªÌ(33%)¥X²{³¡¤À½w¸Ñ¡^

¸û§C¾¯¶q7.4%³¡¤À½w¸Ñ °ª¾¯¶q1/3±wªÌ(33%)¥X²{³¡¤À½w¸Ñ

¸û§C¾¯¶q7.4%³¡¤À½w¸Ñ °ª¾¯¶q1/3±wªÌ(33%)¥X²{³¡¤À½w¸Ñ

2.

Kobrinsky µ¥¤H©ó 2005 ¦~µoªí¤F AAP ¥Î©óªvÀøÀù¯gªº³Ì²×Á{§É®×¨Ò¡C

¤@¦W30­Ó¤ë¤jªº«Ä¤l³Q¶EÂ_¥X±w¦³ [±ß´Á]¨x¥À²Ó­M½F¡C¸Ó±wªÌ³Ìªì±µ¨üªüÅð¯ÀªvÀø¡A¦ý¤£©¯ªº¬O¯f±¡¥X²{¤F¶i®i¡C§@¬°¤G½uªvÀø¡A±wªÌ±µ¨ü90 mg/m 2¶¶¹`¡B1.5 mg/m 2ªø¬K·sÆP©M600 mg/m 2 5-¬t§¿áGÔr¡CµM¦Ó¡A¸Ó±wªÌªº¸~½F³QÃÒ©ú¹ï³oºØÀøªk [µL®Ä]¡C

³Ì«á¡A±wªÌ±µ¨ü30 g/m 2 AAP ¦X¨Ö©µ¿ðNAC ·m±Ï©M¦P®É90 mg/m 2¶¶¹`ªvÀø¡C

³Ì«á¡A±wªÌ±µ¨ü30 g/m 2 AAP ¦X¨Ö©µ¿ðNAC ·m±Ï©M¦P®É90 mg/m 2¶¶¹`ªvÀø¡C

³Ì«á¡A±wªÌ±µ¨ü30 g/m 2 AAP ¦X¨Ö©µ¿ðNAC ·m±Ï©M¦P®É90 mg/m 2¶¶¹`ªvÀø¡C

ºI¦Ü¥»¤åµoªí®É¡A¸Ó±wªÌ¤w±µ¨ü¤â³N 8 ¦~¡A¡A¥¼±w¯f¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/30 ¤W¤È 10:20:52²Ä 3980 ½g¦^À³
¥¼¨Ó¤è¦V¡Ð°ª¾¯¶qµL¨x¬rSNP-810§@¬°§ÜÀùªvÀøÃĪ«!!!
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/30 ¤W¤È 10:16:22²Ä 3979 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/2/1 ¤W¤È 08:44:57²Ä 3644 ½g¦^À³

°ª¾¯¶q(40g)¹ï¤AñQ®ò°ò×ôªvÀø [Àù¯g¥½´Á] ±wªÌ­Ý¨ã¤îµh®ÄªG!

------------------------------------------------------------

°ª¾¯¶q¹ï¤AñQ®ò°ò×ôªvÀøÀù¯g¥½´Á±wªÌ­Ý¨ã¤îµh®ÄªG!

2024.1.31-www.mdpi.com/2673-4389/4/1/7

--------------------------------------------------------------------------------------------

°ª¾¯¶q(40g)¹ï¤AñQ®ò°ò×ô[ªvÀø][Àù¯g¥½´Á][Àù¯g¥½´Á][Àù¯g¥½´Á]±wªÌ­Ý¨ã [¤îµh] ®ÄªG!

19 ¦W±ß´ÁÀù¯g±wªÌ¶i¦æ¤F°ª¾¯¶q¹ï¤AñQ®ò°ò×ôÁp¦XNAC±Ï´©ªº¸ÕÅç(8/19=42%)

¤K¦WºC©Ê¯kµh¯g­Ô¸s±wªÌ±µ¨ü°ª¾¯¶q AAPªvÀø±ß´ÁÀù¯g®É¥i¹F¨ì [12-24]¤p®Éªº§¹¥þÂíµh(ÃĤO²¤Àu¾~¤ùÃþ[ªø®Ä«¬]¤îµhÃÄ?).

SNP-810µL¨x¬r¥«³õ? (­JP»¡¹L¦Y¾ãÅø¨S¨Æ)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/30 ¤W¤È 09:35:16²Ä 3978 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2021/1/31 ¤U¤È 08:09:40²Ä 649 ½g¦^À³

·í¥«³õ[µL]¨x¬rSNP-810¥i¥H¨ú¥N[¦³]¨x¬rAPAP«á¡A¾Ö¦³SNP-810ªºÃļt¡A¤£·Q­n¯Þ»K¦V¥~Ås¤ä«ùFDA¤U¬[APAP¦nºÙÅQ¤îµhÃÄ¥«³õ???©³¤UFDA¸ê®Æ¤@¼Ë¼Ö¼Öªø...

-----------------------------------------------------------------------------------------------

www.sinewpharma.com/Upload/download/20240606-video.MP4

ťť¦¶¸³ªº»¡ªk:

2024.6.6ªk»¡·|26:00~.....¬Æ¦Ü·|­n¨Dªk³W³æ¦ì À³¸Ó§â¨º¨Ç·|¶Ë¨xªº«~¶µµ¹¥L®³±¼

.....¬Æ¦Ü·|­n¨Dªk³W³æ¦ì À³¸Ó§â¨º¨Ç·|¶Ë¨xªº«~¶µµ¹¥L®³±¼

.....¬Æ¦Ü·|­n¨Dªk³W³æ¦ì À³¸Ó§â¨º¨Ç·|¶Ë¨xªº«~¶µµ¹¥L®³±¼

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/29 ¤U¤È 06:04:06²Ä 3977 ½g¦^À³
¥ÌÅS¾J+¤T´â½©¿}¡u1+1>2¡vªºAPAP¥h¬r¨¾¬r¾÷¨î!

¥ÌÅS¾JmKATP³q¹D--½Õ¸`MPTP»¤¾É¬OAPAP»¤¾Éªº¨x·l¶Ëªº®Ö¤ß(²Ó­M¦º¤`³~®|ªºÃöÁäIJµo¦]¯À)

¥ÌÅS¾JmKATP³q¹D½Õ¸`²É½uÅ齤¹q¦ì¡B©I§l(¤T´â½©¿}»¤¾É²É½uÅé©I§l¼W±j»P½¤¹q¦ì¼W¥[)

2021.11.18-²É½uÅé¹[³q¹D½Õ¸`¾¯ªº´À¥N¼Ð¹vwww.mdpi.com/1420-3049/27/1/299

²É½uÅé¹[³q¹D±±¨î¹[¬y¤J²É½uÅé°ò½è¡A±q¦Ó½Õ¸`²É½uÅ齤¹q¦ì¡BÅé¿n¡B©I§l©M¬¡©Ê®ñ (ROS) ªº¦X¦¨¡C

mitoK(²É½uÅé¹[³q¹D)ªº¬¡©Ê½Õ¸`²É½uÅéROSªº¦X¦¨©M²É½uÅé°ò½èCa 2+ªºÄá¨ú¡A±q¦Óª½±µ½Õ¸`²É½uÅé³q³z©ÊÂà´«¤Õ¡]mPTP¡^ªº¶}©ñ¡A³o¬O²Ó­M¦º¤`³~®|ªºÃöÁäIJµo¦]¯À

²É½uÅé¹[³q¹D±±¨î¹[¬y¤J²É½uÅé°ò½è¡A±q¦Ó½Õ¸`²É½uÅ齤¹q¦ì¡BÅé¿n¡B[©I§l] ©M¬¡©Ê®ñ (ROS) ªº¦X¦¨¡C

----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/8/29 ¤W¤È 06:00:02²Ä 3970 ½g¦^À³

2017.10.20-¹ï¤AñQ®ò°ò×ô¬r©Ê¡G¹ï¾÷¨î©M¥¼¨Ó«e´ºªº·s¨£¸Ñeuropepmc.org/article/PMC/5885144

..³Ì²×ªº MPTP(²É½uÅé³q³z©ÊÂà´«¤Õ)»¤¾É¬O APAP »¤¾Éªº¨x·l¶Ëªº®Ö¤ß

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/29 ¤U¤È 05:01:26²Ä 3976 ½g¦^À³
1.2023.12.15-²É½uÅé«~½è±±¨î¡G¨ä¦b¥NÁÂ¥\¯à»Ùê¬ÛÃö¯×ªÕ¨x¯f (MASLD) ¤¤ªº§@¥Î

www.ncbi.nlm.nih.gov/pmc/articles/PMC10786205/

¦b MASH ±wªÌ¤¤¡A[²É½uÅé³Ì¤j©I§l¶q¸û§C][²É½uÅé³Ì¤j©I§l¶q¸û§C][²É½uÅé³Ì¤j©I§l¶q¸û§C]...¦]¦¹¡A²É½uÅé»P

MASLDªºµo¯f¾÷¨î©M¶i®i¦³Ãö¡C

Á`¤§¡A²É½uÅé¥\¯à»Ùê¦b MASLD ªºµo¯f¾÷¨î¤¤§êºtÃöÁ䨤¦â¡C¬ã¨s¤H­û¡BÁ{§ÉÂå¥Í©MÃĪ«¶}µo°Óªº¦@¦P§V¤O¹ï©ó¹w¨¾©M

ªvÀø³oºØ¯e¯f¦ÜÃö­«­n¡C±N·s¿oªº²É½uÅé¹v¦V¤èªkÂà¤Æ¬°¦³®Ä¥B¦w¥þªºÀøªk±N´î»´¥þ²y MASLD ±wªÌªº¯e¯f­t¾á¨Ã´£°ª¥Í¬¡

«~½è¡C

2. 2023.12.20-Mtfp1®ø¿Ä¼W[±j²É½uÅé©I§l]¨Ã¹w¨¾¨x¯×ªÕÅÜ©Ê

www.nature.com/articles/s41467-023-44143-9

---------------------------------------------------------------------------------------

¤T´â½©¿}»¤¾Éªº[²É½uÅé©I§l¼W±j]¿W¥ß©ó²É½uÅé Ca +2³æ¦VÂà¹B³J¥Õ¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/29 ¤U¤È 04:52:31²Ä 3975 ½g¦^À³
¿Õ¨©º¸¼ú100¶g¦~¬ö©À¡C 1931¦~¿Õ¨©º¸¥Í²z¾Ç©ÎÂå¾Ç¼ú±o¥D¥Ëº¸³ù www.sohu.com/a/372301122_799846

Warburg°²³]¡A¥\¯à¥¢½Õªº²É½uÅé¥i¯à¬O¸~½F²Ó­M¤¤¿}¸Ñ²v¸û°ªªº­ì¦]¡A¤]¬OÀù¯gµo®iªº¥D­n­ì¦]¡C

¥¿±`²Ó­Mªº¯à¶q¨Ó·½¬O²É½uÅ骺¦³®ñ©I§l!

www.ncbi.nlm.nih.gov/pmc/articles/PMC7848014/

§Ú­Ìªí©ú¡A¤T´â½©¿}³z¹L¼W¥[²É½uÅé¸ó½¤¹q¦ì©M[©I§l§@¥Î]....¨Ó¼W¥[²É½uÅé¥Íª«¯à

¤T´â½©¿}»¤¾Éªº²É½uÅé[©I§l¼W±j]¿W¥ß©ó²É½uÅé Ca +2³æ¦VÂà¹B³J¥Õ¡C

¤T´â½©¿}»¤¾Éªº²É½uÅé[©I§l¼W±j]¿W¥ß©ó²É½uÅé Ca +2³æ¦VÂà¹B³J¥Õ

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/5/1 ¤U¤È 08:06:14²Ä 3717 ½g¦^À³

²É½uÅé²¾´ÓÀøªk!

¥Ëº¸³ù(¥L¬O©M·R¦]´µ©Z¦P®É¥N¥B¦P¼Ë³»¦yªº¬ì¾Ç®a¡A¹ïÀù²Ó­Mªº¥NÁ¦³³z¹ýªº¬ã¨s¡A¨Ã¦b 1931 ¦~±o¨ì¿Õ¨©º¸¼ú)»{¬°¡A¥¿

±`²Ó­Mªº¯à¶q¨Ó·½¬O²É½uÅ骺¦³®ñ©I§l¡A²£ª«¬O¤G®ñ¤ÆºÒ©M¤ô¡F¦Ó¸~½F²Ó­M¥Íªøªº¯à¶q¨Ó·½¬O¡AÂǥѸ²µå¿}¦b²Ó­M½è¤ºµo»Ã

¦¨ªº¨Å»Ä..

---------------------------------------------------------------------------

4. 2021.1.18-¤T´â½©¿}¨ë¿E Caco-2 ²Ó­M¤¤ªº²É½uÅé¥Íª«¯à

§Ú­Ì­º¦¸ÃÒ©ú¤T´â½©¿}«æ¼@¼W¥[²É½uÅé¥Íª«¯à¡A¨ä¯S¼x¬O¯Ó®ñ¶q©M¸ó½¤¹q¦ì¼W¥[...

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/8/29 ¤W¤È 09:36:39²Ä 3974 ½g¦^À³
¨º´N­n¬Ý¤fªAªø®Ä¤£¦¨Å}¤î¼@µhªº°Æ§@¥Î/»ù¿ú/¤è«K©Ê
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/29 ¤W¤È 08:49:35²Ä 3973 ½g¦^À³
¦h¼Ò¦¡Âíµh¤¤³Ì±`¨£ªºÃĪ«²Õ¦X¬O¾~¤ùÃþÃĪ«»P¹ï¤AñQ®ò°ò×ô¡]¦û²Õ¦Xªº 14.4%¡^¡B¾~¤ùÃþÃĪ«»P«DÃþ©T¾J§Üµoª¢ÃÄ¡]10.2%¡^¡F¾~¤ùÃþÃĪ«¥[«DÃþ©T¾J§Üµoª¢ÃÄ©M¹ï¤AñQ®ò°ò×ô¡]7.2%¡^¡F¾~¤ùÃþÃĪ«¥[¹ï¤AñQ®ò°ò×ô¡B¥[¤Ú¼Q¤BÃþÃĪ«©M COX-2 §í¨î¾¯ (5.7%)¡A¥H¤Î¾~¤ùÃþÃĪ«¥[¥[¤Ú¼Q¤BÃþÃĪ«©M¹ï¤AñQ®ò°ò×ô (5.1%)¡C

------------------------------------------------------------------------------------------------

¤W­±ªº½Æ¤è:¹ï¤AñQ®ò°ò×ô¾¯¶q­­¨î325mg--->§ï¬°SNP-810¾¯¶q650mg/1000mg¡A¤îµh®ÄªG¥i¯à§óÅãµÛ§ó«ù¤[¡A¦³µL¥«³õ§l¤Þ¤O?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/29 ¤W¤È 08:41:00²Ä 3972 ½g¦^À³
2005.6¤ë--NASH¡G¤@ºØ²É½uÅé¯e¯f

www.journal-of-hepatology.eu/article/S0168-8278(05)00170-4/fulltext

§Ú­Ì»{¬° NASH ¦b¬YºØµ{«×¤W¥i¥H³Qµø¬°¤@ºØ²É½uÅé¯e¯f¡A¦]¬° [²É½uÅé¥\¯à»Ùê]¯A¤Î¾É­P NASH ªº©Ò¦³³sÄò¨BÆJ¡C

-----------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/5/1 ¤U¤È 08:06:14²Ä 3717 ½g¦^À³

²É½uÅé²¾´ÓÀøªk!

3.2022.10.22-²É½uÅé²¾´Ó¡GªvÀøªÎ­D¡B¿}§¿¯f©M«D°sºë©Ê¯×ªÕ¨xªº¾÷·|©M¬D¾Ô(NAFLD ³Q»{¬°¬O¤@ºØ²É½uÅé¯e¯f)

translational-medicine.biomedcentral.com/articles/10.1186/s12967-022-03693-0

...µo²{ªí©ú²É½uÅé¹v¦VÃĪ«¥i¯à¹ï NAFLD ±wªÌ²£¥Í­«­n¼vÅT....

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/8/29 ¤W¤È 08:39:36²Ä 3971 ½g¦^À³
¬Ý¨ÓSNP-810®ÄªG©M¤£¦¨Å}¤î¼@µh®t¤£¦h¡A¦ý¤£«ù¤[¡C¦ý¤]»¡¤F¥»¨Ó´N¥´ªº¤£¬O«ù¤[¾Ô¡A¨ü¤£¤F¦h¦Y¦h¦¸´N¦n¡A¤Ï¥¿¦Y¤£¦º??

¦ý¥«³õ¤ÏÀ³¤£¨Î@@

N2.¦¸­n«ü¼Ð: ªì¦¸¨Ï¥Î±Ï´©ÃÄ«~¤§ [®É¶¡] (¶VºC¥Nªí¤îµh®ÄªG¶V¦n)µ²ªGÅã¥Ü¦X¨Ö¨Ï¥ÎSNP-810¤Î¤£¦¨Å}¤î¼@µhÃIJժ즸¨Ï¥Î®É¶¡¬°1236.86+/-411.15¤ÀÄÁ¡A²Î­pÅãµÛºC©ó³æ¿W¨Ï¥ÎSNP-810²Õ¤§563.38+/-387.34¤ÀÄÁ(p<0.05)¡A¤]ÅãµÛºC©ó³æ¿W¨Ï¥Î¤£¦¨Å}¤î¼@µhÃIJդ§554.18+/-642.15¤ÀÄÁ(p<0.05)-->¦³®É¶¡¡A¨S¦³¤T¸ÕÅç²Õ¨Ï¥Î±Ï´©ÃÄ«~ªº®ø¯Ó(¦¸¼Æ/¾¯¶q)®t²§?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/29 ¤W¤È 06:00:02²Ä 3970 ½g¦^À³
2017.10.20-¹ï¤AñQ®ò°ò×ô¬r©Ê¡G¹ï¾÷¨î©M¥¼¨Ó«e´ºªº·s¨£¸Ñeuropepmc.org/article/PMC/5885144

...³ÌªñªºÃÒ¾Úªí©ú±¡ªp¥i¯à¨Ã«D¦p¦¹¡A¦]¬°§Y¨Ï¦bªvÀø¾¯¶qªºAPAP¤U¤]·|²£¥Í APAP ³J¥Õ¥[¦Xª«;¨Æ¹ê¤W¡A³J¥Õ½è¥[¦Xª«¬O¦b GSH ÅãµÛ¯ÓºÉ¤§«e§Î¦¨ªº¡C³Ìªì»{¬°²Ó­M¤¤³J¥Õ½è¥[¦Xª«ªº§Î¦¨¹ï©ó²Ó­M¦º¤`¦ÜÃö­«­n¡A¦ý²{¦b¬Ý¨Ó[²É½uÅé³J¥Õ½è¤Wªº³J¥Õ½è¥[¦Xª«§Î¦¨»P¬r©Ê³Ì¬ÛÃö][²É½uÅé³J¥Õ½è¤Wªº³J¥Õ½è¥[¦Xª«§Î¦¨»P¬r©Ê³Ì¬ÛÃö]

³Ì²×ªº MPTP(²É½uÅé³q³z©ÊÂà´«¤Õ)»¤¾É¬O APAP »¤¾Éªº¨x·l¶Ëªº®Ö¤ß

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2023/5/22 ¤U¤È 09:28:53²Ä 3204 ½g¦^À³

...¥ÌÅS¾J¼W¥[¤FCPT1 ©M UCP1 ªºªí¹F¡C²³©Ò©Pª¾¡ACPT1 ©M UCP1 ·|¼W¥[[²É½uÅ鬡©Ê] .....

--------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/19 ¤W¤È 09:13:56²Ä 3842 ½g¦^À³

¥ÌÅS¾J(¶t/Áâ§l¦¬«O¯d)+¤T´â½©¿}(T1R3¿E°Ê¶tÁâ)¡u¤@¥[¤@¤j©ó¤G¡vªº®ÄÀ³!¥ÌÅS¾J¬¡¤ÆmKATP³q¹D(²É½uÅéATP¹[³q¹D)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/29 ¤W¤È 05:42:28²Ä 3969 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/5/1 ¤U¤È 10:03:42²Ä 3718 ½g¦^À³

§Ú­Ì­º¦¸ÃÒ©ú¤T´â½©¿}«æ¼@¼W¥[²É½uÅé¥Íª«¯à¡A¨ä¯S¼x¬O¯Ó®ñ¶q©M¸ó½¤¹q¦ì[¼W¥[]

---------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2023/11/13 ¤U¤È 04:05:17²Ä 3527 ½g¦^À³

³Ì·s®ø°£¯×ºwLD¿n²Ö¬ã¨s

2023.7.13- Nature:¨xŦ¦Û¾½³z¹L²Ó­M¥~¯×½è¤Àªc§ïµ½«D°sºë©Ê¯×ªÕ©Ê¨xª¢

www.nature.com/articles/s41467-023-39404-6

-----------------------------------------------------------------------------------------

±qSNP-810³Ìªñ¤½¥¬ªºÁ{§É¼Æ¾Ú¡A¥i¥H´Á«ÝSNP-610¦bMASHªººt¥X!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/29 ¤W¤È 05:33:24²Ä 3968 ½g¦^À³
SNP-810ªº[¥h¬r]/[¨¾¬r]¾÷¨î? [¦Û¾½]²M°£³J¥Õ½è¥[¦Xª«©M¨ü·l²É½uÅé(¥h¬r)/§í¨îcyp2e1¥NÁ²£¥ÍNAPQI(¨¾¬r)

8¤ë¥¿¦n¦³2½g¬ã¨s:

1.2024.8¤ë -¹ï¤AñQ®ò°ò×ô¨x¬r©Êªº¤¤¤ß¾÷¨î¡G³J¥Õ½è¥[¦Xª«©M®ñ¤ÆÀ£¤O¤Þ°_ªº [²É½uÅé¥\¯à»Ùê]

dmd.aspetjournals.org/content/52/8/712

2.2024.8.14-°w¹ï¹ï¤AñQ®ò°ò×ô¤Þ°_ªº¨x·l¶Ëªº [¦Û¾½]§@¥Î¡G³Ì·s¶i®i www.mdpi.com/2673-4389/4/3/27

APAP³z¹L²Ó­M¦â¯À P450 2E1 (CYP2E1) ¥NÁ²£¥Í NAPQI¡A§Î¦¨ APAP ¥[¦Xª«¡A¨Ã³z¹L[¥¼ª¾¾÷¨îªx¯À¤Æ]¡C

ÃÒ¾Úªí©ú¦Û¾½¦b²M°£¨xŦ APAP ¥[¦Xª«©M¨ü·l²É½uÅé¤è­±µo´§µÛ¦ÜÃö­«­nªº§@¥Î¡A¦Ó³o¨Ç¬O APAP ¨x¬r©ÊªºÃöÁä¦]¯À¡C

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/5 ¤W¤È 09:09:54²Ä 3765 ½g¦^À³

SNP610»PSNP-810ªº(¥ÌÅS¾J+¤T´â½©¿})¤À¤l¯ÅÁp¤ÏÀ³:

²Ó­M¤À¸Ñ³J¥Õ½èªº¨â®M¨t²Î¡Gªx¯À(2004¦~¿Õ¨©º¸¤Æ¾Ç¼ú/Cyp2e1)»P²Ó­M¦Û¾½(2016¿Õ¨©º¸¥Í²zÂå¾Ç¼ú/¤T´â½©¿}-T1R3

¡i2016¿Õ¨©º¸¥Í²zÂå¾Ç¼ú¡j¤é¥»²Ó­M¥Íª«¾Ç®a¤j¶¨¨}¨å±Ð±Â-µo²{¦Û¾½§@¥Î¾÷¨î(²Ó­M¤j±½°£À°§U¤HÅé¦Û§Ú­×´_)

¦Û¾½§@¥Î¯à²¾°£¦s¬¡®É¶¡¸ûªøªº³J¥Õ½è¡A¬O [°ß¤@] ¯à¯}Ãa¾ã­Ó­M¾¹¦p²É½uÅé¡B¹L®ñ¤ÆÅé¡B¤Î¤º½èºôªº§@¥Î¡C

----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2023/8/26 ¤U¤È 07:31:12²Ä 3424 ½g¦^À³

¼ö©I©IªºNature¤l¥Z½×¤å.

USP14 ¦b LPO ©Mª¢¯g¤¤ªº¥\¯à¨ú¨M©ó CYP2E1

1.2004¦~¿Õ¨©º¸¤Æ¾Ç¼ú(³J¥Õ½èªº¤À¸Ñ¾÷¾¹):¬ã¨s¦b²Ó­M¤¤¦p¦ó¹ï¤@¨Ç¤£»Ý­nªº³J¥Õ½è¥[¤W¤@ºØºÙ¬°[ªx¯À]ªº¦hÐ`肽¼ÐÅÒ¡A

½Õ¸`³J¥Õ½èªº¦s¦b¡F¥L­Ìªº¬ã¨s¦b¤Æ¾Çª¾ÃѤW¦³­«­nªº¬ð¯}¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G°]°È¦Û¥Ñ¤H10132540  µoªí®É¶¡:2024/8/28 ¤W¤È 08:12:08²Ä 3967 ½g¦^À³
Naldebain (¯Çµh¸Ñ) ¬O¡y¶Ü°Ø¡zµ¥¯Åªº¤£¦¨Å}ªºÃÄ«~¡A°Æ§@¥Î»·§C©ó¶Ü°Ø¡A³o¬O³B¤èºàÃÄ¡CNaldebain §ï¦¨¤fªA¡A¥i¥HÁקKªø®Ä°w¾¯·í¦³°Æ§@¥Î»Ýªø¹F¤C¤Ñªº§xÂZ¡A¥B¤fªA¤]¤è«K¡A¦ýNaldebain ¦]ªk³WªºÃö«Y¦b¬ü°ê¤´¥¼µÛ¤â¨úÃÒªº¶¥¬q¡C

APAP ªº¤îµh®ÄªG¬O¾¯¶q¥¿¬ÛÃö¡Asnp-810 ½Æ¤è³B¤èºàÁ{§Éªº­«ÂI¡A¦b¥Î¦b¹ê»Ú¯f¤H¨­¤W¦³®ÄªG¥BÀu©ó³æ¤è¡A¥Nªí¥[¤F¤£¶Ë¨xªº½á§Î¾¯¤£¼vÅT APAP ¤îµhÀø®Ä¡A¥Ñ©ó¨S¦³¨x¬r©Ê¡A¤é«á 810 ¾¯¶q¬O¥i¥H©¹¤W¥[ªº¡C

¶Ç²ÎªºÀn¤ùÃþ¦³°ª«×¦¨Å}¤Î§í¨î©I§l§@¥Î¾É­P¦º¤`¡A­Y­n·f¥H¥Ø«e¶Ç²ÎªºÀn¤ùÃþ¤îµhÃĪº²Õ¦Xªº¸Ü¡A¨ä²Õ¦XªºÀn¤ùÃþ¤îµhÃĬO¥i¤Ö¾¯¶q¡A¥H­°§C¦¨Å}ªº¾÷²v¡A³o¼Ëªº½Æ¤è²Õ¦X¥u­n°µÂ²³æªºÁ{§É´N¥i¥H¤W¥«¡C­«ÂI¬O¡A·í APAP µL¨x¬r©Êªº°ÝÃD«á¡A¨ä½Æ¤è²Õ¦X¬O¦Ê¦ÊºØªº¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/28 ¤W¤È 06:04:20²Ä 3966 ½g¦^À³
FDA©ó2011.1.131¤ë13¤éµo¥¬...¯S§O°w¹ï¤AñQÓi×ô»P¾~¤ùÃþ¦¨¤À¡]¦pcodeine¡Bhydrocodone¡Boxycodone¡^¤§½Æ¤èÃÄ«~¡C¬°¦³®Ä­°§C¤AñQÓi×ôÃÄ«~¹L¶q¨Ï¥Î¾É­PÄY­«¨xŦ¶Ë®`©Î¹L±Ó¤ÏÀ³¤§­·ÀI¡A¬ü°êFDA­n¨D¸Óµ¥ÃÄ«~¡A±N¤AñQÓi×ô¦¨¤À¤§³Ì¤j³æ¦ì¾¯¶q­°§C¬°325mg 325mg 325mg¡A¦P®É©óÃÄ«~¥é³æ¥H¡u¥[®Øĵ»y¡v»¡©ú¸ÓÃÄ«~¥i¯à¤Þ°_ÄY­«¨xŦ¶Ë®`¤§­·ÀI¡F¡uĵ»y¡v¥[¥Z¦³Ãö¸ÓÃÄ«~¥i¯à¤Þ°_¹L±Ó¤ÏÀ³¤§¤º®e¡C

½Æ¤èÃĪ«:SNP-810(650mg 650mg 650mg ¨S¦³¨x¬r©Ê)+¤£¦¨Å}¤î¼@µhÃÄ!!!

---------------------------------------------------------------------------------------------

¦h¼Ò¦¡Âíµh¤¤³Ì±`¨£ªºÃĪ«²Õ¦X¬O¾~¤ùÃþÃĪ«»P¹ï¤AñQ®ò°ò×ô¡]¦û²Õ¦Xªº 14.4%¡^¡B¾~¤ùÃþÃĪ«»P«DÃþ©T¾J§Üµoª¢ÃÄ¡]10.2%¡^¡F¾~¤ùÃþÃĪ«¥[«DÃþ©T¾J§Üµoª¢ÃÄ©M¹ï¤AñQ®ò°ò×ô¡]7.2%¡^¡F¾~¤ùÃþÃĪ«¥[¹ï¤AñQ®ò°ò×ô¡B¥[¤Ú¼Q¤BÃþÃĪ«©M COX-2 §í¨î¾¯ (5.7%)¡A¥H¤Î¾~¤ùÃþÃĪ«¥[¥[¤Ú¼Q¤BÃþÃĪ«©M¹ï¤AñQ®ò°ò×ô (5.1%)¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/28 ¤W¤È 05:47:29²Ä 3965 ½g¦^À³
2024.5.2-MMA¦h¼Ò¦¡Âíµh [­°§C] ¤F¦í°|ªÓÃö¸`¸m´«³N¤¤ [ªü¤ùÃþÃĪ«] ªº¨Ï¥Î

www.clinicalpainadvisor.com/news/multimodal-pain-management-lowers-opioid-use-in-inpatient-shoulder-arthroplasty/

¦h¼Ò¦¡Âíµh¤¤³Ì±`¨£ªºÃĪ«²Õ¦X¬O¾~¤ùÃþÃĪ«»P¹ï¤AñQ®ò°ò×ô¡]¦û²Õ¦Xªº 14.4%¡^¡B¾~¤ùÃþÃĪ«»P«DÃþ©T¾J§Üµoª¢ÃÄ¡]10.2%¡^¡F¾~¤ùÃþÃĪ«¥[«DÃþ©T¾J§Üµoª¢ÃÄ©M¹ï¤AñQ®ò°ò×ô¡]7.2%¡^¡F¾~¤ùÃþÃĪ«¥[¹ï¤AñQ®ò°ò×ô¡B¥[¤Ú¼Q¤BÃþÃĪ«©M COX-2 §í¨î¾¯ (5.7%)¡A¥H¤Î¾~¤ùÃþÃĪ«¥[¥[¤Ú¼Q¤BÃþÃĪ«©M¹ï¤AñQ®ò°ò×ô (5.1%)¡C

---------------------------------------------------------------------------------------------

½Æ¤èÃĪ«[SNP-810+¤£¦¨Å}¤î¼@µhÃÄ]¦³§óÀuªº¤îµh®ÄªG¥B¨S¦³¨x¬r©Ê--°w¹ï¤W­z¥«³õ!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/28 ¤W¤È 05:23:08²Ä 3964 ½g¦^À³
2023.1.29-°©¬ì¤â³N«áMMA³N«á¯kµh±±¨î www.ncbi.nlm.nih.gov/books/NBK572072/

¦h¼Ò¦¡¯kµh±±¨î¬O©Ò¦³±µ¨ü¤â³N©Î¦UºØ¨ä¥L¤â³Nªº±wªÌ³N«á±±¨î¯kµhªº­«­n¤è¦¡¡C³o¦b°©¬ì¤â³N¤¤¤×¨ä­«­n...

´î»´¬Y¨ÇÃĪ«Ãþ§Oªº°Æ§@¥Î¡A¨Ã´î¤Ö³N«áªü¤ùÃþÃĪ«ªº¨Ï¥Î¡C

Á{§É·N¸q

¦h¼Ò¦¡Âíµh¬O³\¦hÂå¾Ç»â°ì½w¸Ñ¯kµhªº¥¼¨Ó¡C°©¬ì¤â³N»â°ì¤@ª½³B©ó³oºØ·s¤u¨ãÁ{§É¨Ï¥Î©M³N«á¯kµh½w¸Ñ³Ð·sªº«eªu¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/28 ¤W¤È 05:15:09²Ä 3963 ½g¦^À³
SNP-810[¦X¨Ö]¤£¦¨Å}¤î¼@µhÃÄ(¦h¼Ò¦¡¤îµh)¡A»P¤U­±¤TÁ`°©¬ìªº®t§O:[°w¾¯]§ï¬°[¤fªA]¡C

³Ì·sªº¤îµhÆ[©À¬°MMA¡u¦h¼Ò¦¡¤îµh¡v¤]ºÙ¬°¡§¥­¿ÅÂíµh¡¨:°w¹ï¨­Å骺¯kµh¸ô®|¨Ï¥Î¤£¦PºØÃþªº¤îµhÃÄ¡A´î»´³æ¤@¤îµhÃĪ«ªº¾¯¶q¥H¤Î°Æ§@¥Î¡A¨Ã¥H¸û¤Öªº¶Ü°ØÃþÃĪ«¹F¨ì§ó¦nªº¤îµh®ÄªG¡C(­°§C¾~¤ùÃþÃĪ«ªº­·ÀI)

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/8/27 ¤U¤È 07:29:11²Ä 3957 ½g¦^À³

­Ó¤HÆ[ÂI:1.C²Õ©úÅãÀu©óA²Õ»PB²Õªº¾÷²v«Ü°ª

----------------------------------------------------------------------------

®Ú¾Ú³o½g¤åÄm:

2022.4.15--link.springer.com/article/10.1007/s40122-022-00383-z

¬Ñ¤G»Ä¦a¨º¥¬°Ø½wÄÀ¦h¼Ò¦¡Âíµh¥Î©ó¤WªÏ³Ð¶Ë¤â³N³ò³N´Á¯kµhºÞ²z¡G¤@¶µ¦^ÅU©Ê¤ñ¸û¬ã¨s(ºaÁ`§ó¥¿¬°¤T­xÁ`Âå°|°ê¨¾Âå¾Ç¤¤¤ß°©¬ì)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/27 ¤U¤È 10:52:48²Ä 3962 ½g¦^À³
1.2024.5.27-(OTC«D³B¤èµL¨x¬r¦w¥þ©Ê¹F¼Ð)---­«ÂI¦bµL¨x¬r(¦w¥þ)!

2.2024.8.27(³B¤è¤îµhÀø®Ä¹F¼Ð)´«½¥¤â³N¯f¤H¤§³N«á[¯kµh±±¨î]Á{§É¸ÕÅç¨ú±o¸ÕÅç¤ÀªRµ²ªG---­«ÂI¦bÃĪ«¤îµh®ÄªG(Àø®Ä)!

½Æ¤èÃĪ«[SNP-810+¤£¦¨Å}¤î¼@µhÃÄ]¦³§óÀuªº¤îµh®ÄªG¥B¨S¦³¨x¬r©Ê¡C

±z¥i¯à·d²V¤F!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/27 ¤U¤È 10:44:48²Ä 3961 ½g¦^À³
1.Á{§É¸ÕÅç:SNP-810[¦X¨Ö]¤£¦¨Å}¤î¼@µhÃĥΩ󴫽¥¤â³N¯f¤H¤§³N«á¯kµh±±¨îÁ{§É¸ÕÅç¨ú±o¸ÕÅç¤ÀªRµ²ªG--¥D­n«ü¼Ð¤îµh®ÄªG

¹F¼Ð!

2.¦¸­n«ü¼Ð¡G¡E¶}©l¨Ï¥Î¸ÕÅçÃĪ««á70¤p®É¤§¨x«ü¼Æµ²ªGÅã¥Ü¤T¸ÕÅç²Õ[¥¼¹F]²Î­p¤WªºÅãµÛ®t²§¡A¥B§¡¥¼¥X²{¨x¬r©Ê---¹F¼Ð(¦³

²Î­p¤WªºÅãµÛ®t²§¬OÃa¨Æ)

FDA¬°¦ó­­¨î½Æ¤èÃÄAPAP¤£¯à¶W¹L325mg¡A´N¬O¨x¬r©Ê!

3.³o¬OP2¸ÕÅç!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G´MÄ_10151381  µoªí®É¶¡:2024/8/27 ¤U¤È 10:15:41²Ä 3960 ½g¦^À³
¦pªG§Ú¬O°ê»Ú¤jÃļt¡G

1.±q¸ÕÅçµ²ªG¨Ó¬Ý³æ¿W¨Ï¥ÎSNP-810²Õ©M³æ¿W¨Ï¥Î¤£¦¨Å}¤î¼@µhÃIJմX¥G¨S¦³®t²§¡A¥ú¬O³oÂI§Ú´N«o¨B¤F¡I

2.»P¨äªá¤jµ§±ÂÅvª÷¨ú±o©M¥Ø«e¤£¦¨Å}¼@µhÃIJմX¥G¨S¦³®t²§ªºÃÄ¡A¤£¦p¦A§ä´À¥N¤è®×¡C

3.µhı¬O¥DÆ[ªº¡A36¤HªºÁ{§É¸ÕÅç¡A®£©È¤£¯à¥Nªí¤°»ò¡C

­«ÂI¬O¡A¤TºØ¤è¦¡³£¤£¶Ë¨x¡I¤£¶Ë¨x¡A³o­ì¥»¤£¬OSNP-810ªº³Ì¤jÀu¶Õ¶Ü¡H²{¦b©O¡H

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/27 ¤U¤È 09:31:59²Ä 3959 ½g¦^À³
1.¥D­n«ü¼Ð»P¦¸­n«ü¼Ð§¡¹F¼Ð(°£¥~¦¸­n«ü¼Ð:³N«á4¤Ñ¯f¤Hº¡·N«×µ²ªGÅã¥Ü¤T¸ÕÅç²Õ¥¼¹F²Î­p¤WªºÅãµÛ®t²§)

2.¦¸­n«ü¼Ð: ªì¦¸¨Ï¥Î±Ï´©ÃÄ«~¤§ [®É¶¡] (¶VºC¥Nªí¤îµh®ÄªG¶V¦n)µ²ªGÅã¥Ü¦X¨Ö¨Ï¥ÎSNP-810¤Î¤£¦¨Å}¤î¼@µhÃIJժ즸¨Ï¥Î®É¶¡¬°1236.86+/-411.15¤ÀÄÁ¡A²Î­pÅãµÛºC©ó³æ¿W¨Ï¥ÎSNP-810²Õ¤§563.38+/-387.34¤ÀÄÁ(p<0.05)¡A¤]ÅãµÛºC©ó³æ¿W¨Ï¥Î¤£¦¨Å}¤î¼@µhÃIJդ§554.18+/-642.15¤ÀÄÁ(p<0.05)-->¦³®É¶¡¡A¨S¦³¤T¸ÕÅç²Õ¨Ï¥Î±Ï´©ÃÄ«~ªº®ø¯Ó(¦¸¼Æ/¾¯¶q)®t²§?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G´MÄ_10151381  µoªí®É¶¡:2024/8/27 ¤U¤È 08:47:26²Ä 3958 ½g¦^À³
±qÁ{§É¸ÕÅç¤ÀªRµ²ªG¨Ó¬Ý¡ASNP-810(¦w®õ®³¯k)¦ü¥G¨S¦³¥O¤HÅåÆvªº¦a¤è¡A¬Ý¨Ó±ÂÅv¤§¸ô¤£¤Ó¥i¦æ¡A³Ì¨Î¸Ñ¤èÁÙ¬O¦b¢Ý¢â¢Ñ·m¥«¥e¡C
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/27 ¤U¤È 07:29:11²Ä 3957 ½g¦^À³
­Ó¤HÆ[ÂI:1.C²Õ©úÅãÀu©óA²Õ»PB²Õªº¾÷²v«Ü°ª

----------------------------------------------------------------------------

®Ú¾Ú³o½g¤åÄm:

¬Ñ¤G»Ä¦a¨º¥¬°Ø¡]¶¶ÃÄ°w¾¯¡^

2022.4.15--link.springer.com/article/10.1007/s40122-022-00383-z

¬Ñ¤G»Ä¦a¨º¥¬°Ø½wÄÀ¦h¼Ò¦¡Âíµh¥Î©ó¤WªÏ³Ð¶Ë¤â³N³ò³N´Á¯kµhºÞ²z¡G¤@¶µ¦^ÅU©Ê¤ñ¸û¬ã¨s(ºaÁ`

±`³WÂíµh¡]CA¡^²Õ©M¥q¤Ú¯S¦a¨º¥¬°Ø¡]DS¡^²Õ....¬Ñ¤G»Ä¦a¨º¥¬°Ø¡]¶¶ÃÄ°w¾¯¡^

©Ò¦³±wªÌ§¡±µ¨ü¹ï¤AñQ®ò°ò×ô 500 mg ¤fªA¡A¨C¤é 3 ¦¸¡A¶ë¨Ó©õ¥¬ 200 mg ¨C¤é¨â¦¸....

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/27 ¤U¤È 07:02:14²Ä 3956 ½g¦^À³
1.2024.5.27-(OTC«D³B¤èµL¨x¬r¦w¥þ©Ê¹F¼Ð)

ªYÄ£¨ú±oµL¨x¬r¤îµh·sÃÄSNP-810(¦w®õ®³¯k)¹F²{¦æ»¡©ú®Ñ«Øij¨Ï¥Î¾¯¶q¤T­¿(12§J)¤§µL¨x¬r©ÊÁ{§É¸ÕÅç¤ÀªRµ²ªG

2.2024.8.27(³B¤è¤îµhÀø®Ä¹F¼Ð)SNP-810¦X¨Ö¤£¦¨Å}¤î¼@µhÃĥΩ󴫽¥¤â³N¯f¤H¤§³N«á¯kµh±±¨îÁ{§É¸ÕÅç¨ú±o¸ÕÅç¤ÀªRµ²ªG

-------------------------------------------------------------------------------------------------

À³¸Ó¥i¥H©ãª`¤jÃļt[­n][¤£­n]¤F?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/27 ¤U¤È 06:53:45²Ä 3955 ½g¦^À³
2024.8.27-¤½§i:SNP-810¦X¨Ö¤£¦¨Å}¤î¼@µhÃĥΩ󴫽¥¤â³N¯f¤H¤§³N«á¯kµh±±¨îÁ{§É¸ÕÅç¨ú±o¸ÕÅç¤ÀªRµ²ªG

¤îµh®ÄªG¹F¼Ð¹w®Æ¤¤¤§¨Æ--¦ý§Úı±o¸û¤j¨ü¯qªÌ¥i¯à¬O¶¶ÃÄ(°w¾¯§ï¦¨¤fªA¾¯«¬)

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/11 ¤W¤È 07:23:43²Ä 3799 ½g¦^À³

A:¤fªA¦w¼¢¾¯A+ Naldebain (¤fªA) B:¤fªA¦w¼¢¾¯B+ SafeTynadol (¤fªA) C: Naldebain (¤fªA)+ SafeTynadol (¤fªA)

------------------------------------------------------------------------------------------

¤£­t³d¥ô¦a­Ó¤HÆ[ÂI:1.C²Õ©úÅãÀu©óA²Õ»PB²Õªº¾÷²v«Ü°ª(¦ýÂùª¼¸ÕÅç³]­p¡A¸Ñª¼«e¨S¤H»¡±o·Ç)¡C

2.Áö»¡SNP-810¾¯¶q¬O650mg(¶W¹LFDA³B¤èAPAP325mg³W©w)¡A¦ý§Úı±o¸û¤j¨ü¯qªÌ¥i¯à¬O¶¶ÃÄ(°w¾¯§ï

¦¨¤fªA¾¯«¬)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/26 ¤U¤È 10:05:25²Ä 3954 ½g¦^À³
2023--历¥v©Êªº错误¡A¦Ê亿级ªº¥«场¡A谁来买单¡H

°h热镇µh药¥·热®§µh(APAP)ªº传记¬G¨Æ

finance.sina.cn/stock/med/2023-09-07/detail-imzkvnvs3836452.d.html?from=wap

ªñ¤é笔ªÌ·N¥~读¤F国¥~ªº¤@½g对¤A酰®ò°ò×ôªº发现¥v¡A¦Ü¤µ¤ß¦³§E±ª¡C¨­为医药¤H¡A¬ã发¨î药ªºªì°J¬O让±wªÌ¨ü¯q¡C¥X¤_¥»¤ß笔ªÌ写¦¹¤å¥H¤À¨É给¦U¦ì读ªÌªB¤Í¡C笔ªÌ¬Ý来¡A历¥vªº错误¤£该让ÆÓ¶dªº婴¥®¤I¥Î¤@¥Íªº°·±d来买单¡C¤F¸Ñ¥·热®§µhªº发现¥v¡A©Î许会§A对¥¦¦³§ó²`¨èªº¤F¸Ñ¡A从¦Ó§ï变§A¥H©¹对¥¦ªº认ª¾¡A§Æ±æ为时¤£±ß¡I

-------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2020/12/22 ¤U¤È 08:25:07²Ä 408 ½g¦^À³

¬ü°êÃĪ«±M®a»¡:®õ¿Õ¡]Tylenol,APAP)¬O¡§¨´¤µ¬°¤î³Ì¦MÀIªºÃĪ«!

¤@¥¹¥X²{§ó¦w¥þÃĪ«SNP-810¡AFDA¤£µL¥i¯à±N¥u§t[¤AñQÓi×ô]¦¨¤ÀªºÃĪ«±j¨î¤U¥«¡A ³o­Ó¼s¤j¥«³õ·|Åܦ¨¦³¦h¤j???

---------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2020/12/22 ¤U¤È 07:53:02²Ä 406 ½g¦^À³

¦pªG¨S¦³¸Ñ¬r¾¯¡A¹ï¤A酰®ò°ò×ô(APAP)¥i¯à¦­´N³Q§¹¥þ¸T¤î¤F!---³o¬OÂå¾Ç±M®aWilliam M. Lee, M.D»¡ªº!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/24 ¤W¤È 11:24:57²Ä 3953 ½g¦^À³
¯f²z¨ó¦P§@¥Î¡A§Y¨Ï¬O©Ò¿×ªº[¦w¥þ¾¯¶q]APAPªvÀø¦³¥i¯à¤Þµo¨x·l¶Ë!

¹ï¤AñQ®ò°ò×ô¦b¦³ÃҾڱư£¥¦¤§«e¡A¥¦¤´µM¬O2021~2022¦~¥þ²yÃzµo¡§¤£©ú¨àµ£¨xª¢¡¨ªº¶ûºÃ¹ï¶H¡C

2024.6.20-°ê»Ú«æ©Ê¤p¨à¨xª¢Ãzµo¡G¹ï¤AñQ®ò°ò×ô¬O¯Ê¥¢ªºÀô¸`¶Ü¡H

onlinelibrary.wiley.com/doi/10.1002/ped4.12438

...¦b¥H¦â¦C³Â¯lÃzµo´Á¶¡¶i¦æ¤F¤@¶µ­È±oª`·Nªº¤HÅé¬ã¨s....ªvÀø¾¯¶q¹ï¤AñQ®ò°ò×ôªº¦í°|¨àµ£ªº¹ï¤AñQ®ò°ò×ô³J¥Õ¥[¦Xª«¤ô¥­¡]¨x¬r©Ê¼Ð»xª«¡^....2% ªº¨àµ£Å餺ÃĪ«¿@«×¹L°ª¡]Åã¥Ü¹ï¤AñQ®ò°ò×ô¤Þ°_ªº¨x·l¶Ë¡^¡X¦Ò¼{¨ì©Ò¦³±µ¨üªº¾¯¶q³£¦bªvÀø½d³ò¤º¡A³o­Ó¼Æ¦r¥i¤£¤p....

¦b¤@¶µ°w¹ï¦]«æ©Ê¯f¬r©Ê¨xª¢¦í°|ªº±wªÌªº¬ã¨s¤¤¡A¹ï¤AñQ®ò°ò×ôªºªvÀø¾¯¶q»P«æ©Ê¯f¬r©Ê¨xª¢ÄY­«µ{«×ªº´À¥N¼Ð»xª«ªº§ó¤jÅܤƦ³Ãö¡C³o¨Ç¬ã¨s±j½Õ¤F³o¼Ë¤@­Ó¨Æ¹ê¡G§Y¨Ï¨S¦³©úÅ㪺¯gª¬¡A¨xŦ¤´µM¥i¯à¦³¼ç¦bªº·l¶Ë¡C

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/5/31 ¤U¤È 07:49:05²Ä 3746 ½g¦^À³

2021~2022¦~¥þ²yÃzµo¡§¤£©ú¨àµ£¨xª¢¡¨¬Ì±¡¡AÄa®×¾÷²v°ª!

¤£¹L¤@¥¹½T»{º×­º´N¬O¦³¨x¬rAPAP¡AµL¨x¬rSNP-810???(¬ü°ê109¨Ò¨àµ£¡A5­Ó¦º¤`¯f¨Ò 10%«Ý¨xŦ²¾´Ó)

2024.2.19-¼³¼ö®§µh¬O¤£©ú­ì¦]­«¯g«æ©Ê¨xª¢«÷¹Ï¤¤¯Ê¤Öªº¤@¶ô¶Ü¡H

www.journalofinfection.com/article/S0163-4453(24)00061-6/fulltext

---------------------------------------------------------------------------------------------

APAP¥i¯à¬O2021~2022¦~¥þ²yÃzµo¡§¤£©ú¨àµ£¨xª¢¡¨¬Ì±¡ªº¥D­n¶ûºÃ¹ï¶H!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/19 ¤W¤È 11:10:54²Ä 3952 ½g¦^À³
2024.4.15--2«¬¿}§¿¯fªºªvÀø¼Ò¦¡¬O®É­ÔÂàÅܤF www.mdpi.com/1422-0067/25/10/5488

2 «¬¿}§¿¯fªºªvÀø¾ú¨ÓµÛ­«©ó§ïµ½¦å¿}¿@«×¡B«P¶i¹B°Ê©M´îªÎ¡A¦Ó¤£¬O±Mªù¥H¹ê²{ 2 «¬¿}§¿¯fªº½w¸Ñ¬°¥Ø¼Ð¡CµM¦Ó¡A¥¿¦p¤W­±¼sªx°Q½×ªº¨º¼Ë¡A2 «¬¿}§¿¯f¤£À³¦A³Qµø¬°¤@ºØºC©Ê¡BÃøªv©Ê¡B¶i¦æ©Ê¯e¯f¡C³oºØ½d¦¡ÂàÅܬO°ò©ó¯f²z¥Í²z¾Ç¨£¸Ñ¡A¨Ã±o¨ì¤@¨t¦CÁ{§É¬ã¨s©MÆ[¹îªºÃÒ¹ê¡A³o¨Ç¬ã¨s©MÆ[¹îÄÄ©ú¤F¾É­P2 «¬¿}§¿¯fªº­«­n¡]·s¡^¾÷¨î¡G­Ó¤H¯×ªÕìH­È°²»¡ªí©ú¡A

¦]¦¹¡A¨xŦ©M¯ØŦ¤º¹L¦h¯×ªÕªº²Ö¿n¦ü¥G¬O¾É­P²Ä 2 «¬¿}§¿¯fªº¥D­n¼ç¦b¾÷¨î¡C¶V¨Ó¶V¦hªºÃÒ¾Úªí©ú....

¦­´Á¹w¨¾/´î¤Ö¨xŦ©M¯ØŦ²§¦ì¯×ªÕ°ï¿n¥i¯à¦¨¬°²Ä¤G«¬¿}§¿¯fºÞ²zªº¥D­nªvÀø¥Ø¼Ð¡C

------------------------------------------------------------------------------------------------

°ê»Ú¤jÃļt¤U­Ó°l³v¼Ðªº:´î¤Ö¯ØŦ¯×ªÕÃĪ«ªvÀøT2D!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/19 ¤W¤È 10:47:28²Ä 3951 ½g¦^À³
2023.8.31-Åé­««ü¼Æ¡u¥¿±`¡v¤H¸sªº²Ä 2 «¬¿}§¿¯f¯f¦]¡GÀËÅç­Ó¤H¯×ªÕìH­È°²»¡

www.ncbi.nlm.nih.gov/pmc/articles/PMC10472166/

­Ó¤H¯×ªÕìH­È°²»¡°²³]¡AµL½×Åé­««ü¼Æ¦p¦ó¡A²Ä2«¬¿}§¿¯f±wªÌ³£±Nªí²{¥X¬Û¦Pªº¯f²z¥Í²z¾÷¨î¡A¨Ã¥B¥i¯à¦b´î­««á«ì´_¨ì«D¿}§¿¯f¦å¿}±±¨î¡C³o¬O«D±`­«­nªº¡A¦]¬°¥¦ªí©ú³oºØ±`¨£¯e¯f¤£¨ã¦³¨Ì¿àÅé­«ªº²§½è©Ê­P¯f¾÷¨î¡C

[«DªÎ­D]±Ú¸s¯à¶qÄá¨ú¥¿±`¤Æ«á 2 «¬¿}§¿¯f°fÂà (ReTUNE) ¬ã¨sªº¥Øªº¬O©ú½T´ú¸Õ­Ó¤H¯×ªÕìH­È°²³]¡C³o­Ó°²³]¥ý«eªº¹w´ú¬O¡ABMI ¥¿±`©Î±µªñ¥¿±`ªº¤H¥i¥H³z¹L´î­«¨Ó¹ê²{ T2D ½w¸Ñ¡A¨Ã¥B³o±N³z¹L¬Û¦Pªº¼ç¦b¯f²z¥Í²zÅܤƨӹê²{

-------------------------------------------------------------------------------------------------

[«DªÎ­D]2«¬¿}§¿¯fªÌ¡A¤]¯à³z¹L´î­«¨Ó¹ê²{ T2D ½w¸Ñ!

­Ó¤H¯×ªÕìH­È°²»¡¸ÑÄÀ¤F T2D ¤¤»PÅé­«¬ÛÃöªº©úÅ㲧½è©Ê¥H¤Î¥NÁ¦w¥þ®w¤¤¯×ªÕÀx¦s¯à¤Oªº­ÓÅé®t²§¡C¥Õ¸Ü´N¬O¥~ªí¬Ý°_¨Ó¤£ªÎ¡A¦ý¨x¯ØŦ¤ÓªÎ!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/19 ¤W¤È 08:24:15²Ä 3950 ½g¦^À³
2024.2.6-DiRECT ¬ã¨sÅã¥Ü¡A´î­«¥i¨Ï²Ä 2 «¬¿}§¿¯f½w¸Ñ¦Ü¤Ö 5 ¦~

www.diabetes.org.uk/about-us/news-and-views/weight-loss-can-put-type-2-diabetes-remission-least-five-years-reveal-latest-findings

¤H­Ì³q±`·|Åé­«¤Ï¼u¨Ã¤£¦A½w¸Ñ¡C

·sªº¬ã¨sµ²ªGªí©ú¡A¦³¨Ç¤H¥i¥H¦b¤­¦~¤º«O«ù½w¸Ñª¬ºA¡A¦ý§Ú­Ì¤]µo²{³o¹ï¤j¦h¼Æ¤H¨Ó»¡¬O¤£¥i¯àªº¡C³\¦h´î±¼ªºÅé­«¤S«ì´_¤F¡C

------------------------------------------------------------------------------------------------

¬JµMºû«ùªø´Á´î­«Ãø¡A¨º¯à±N¯×ªÕ²¾¥X¨xŦ»P¯ØŦªºÃĪ«???(ªYÄ£ªº¯×ªÕ¯ØÃĪ«)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/19 ¤W¤È 08:02:27²Ä 3949 ½g¦^À³
Roy Taylor±Ð±ÂªºÂù´`Àô°²»¡:2«¬¿}§¿¯f¹ê»Ú¤W¬O¥Ñ¨xŦ©M¯ØŦ¤º¹L¦hªº¯×ªÕ¤Þ°_ªº¡C

¡u¹ï©ó²Ä 2 «¬¿}§¿¯f±wªÌ¨Ó»¡¡A¦n®ø®§¬O¡A§Ú­Ìªº¬ã¨sªí©ú¡A§Y¨Ï±z±w¦³³oºØ¯e¯f 10 ¦~¡A±z¥i¯à¯à°÷³z¹L±N©Ò¦³­«­nªº·L¶q¯×ªÕ²¾¥X [¯ØŦ] ¨Ó°fÂà¯f±¡¡C¥Ø«e¡A³o¥u¯à³z¹L¤j´T´îªÎ¨Ó¹ê²{¡v

2016 ¦~µoªíªº Counterbalance ¬ã¨sªí©ú¡A¤j¦h¼Æ¤Hªº 2 «¬¿}§¿¯f¦bªø¹F 10 ¦~¤º³£¬O¥i°fªº¡A¦Ó¥B¥u­nÅé­«¤£¤Ï¼u¡A¥¿±`ªº·s³¯¥NÁ´N·|ªø´Á«ùÄò¡C

-------------------------------------------------------------------------------------------

2«¬¿}§¿¯f´N¬Oªø´Á¹L¶qªº[¯ØŦ]¯×ªÕ®û¼í¶Ë®`¯Ø®q£]细­Mªº¤@ºØ¥i°f©Ê¥NÁ²§±`¯e¯f¡C

1.¤j´T´îªÎ-->´î¤Ö¨xŦ©M¯ØŦªº¯×ªÕ(¯Ø®q£]细­M­«·s±Ò°Ê)--GLP-1¿}§¿¯fÃĪ«.

2.±N¯×ªÕ²¾¥X[¯ØŦ]¨Ó°fÂà¯f±¡(¯Ø®q£]细­M­«·s±Ò°Ê)--ªYÄ£ªºªvÀø[¯×ªÕ¯Ø]ÃĪ«

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/18 ¤U¤È 01:59:16²Ä 3948 ½g¦^À³
´îªÎ¯«ÃĤU¤@¨B¸Ó¦ó¥h¦ó±q?

°í«ù¨Ï¥ÎGLP-1¨üÅé¿E°Ê¾¯ÃĪ«¥i¯à¨Ã¤£®e©ö¡C¦]¬°¨ä¤¤¦³¨Ç¤H·|¥X²{äú¤ß¡B¹Ã¦R¡B¸¡Âm©M«K¯µµ¥°Æ§@¥Î¡C¦h¶µÁ{§É¸ÕÅçÅã¥Ü¡A¨Ï¥Î¥q¬ü®æ¾|肽ªº°Ñ»PªÌ¤¤¦³ªñ75%´¿¸g¾ú¤F­G¸z¹D¤£¾A¡A·íµM¡A¨ä¤¤¤j¦h¼Æ°Æ§@¥Î¬O»´«×¦Ü¤¤«×ªº....

1.2024.4.22-ª¾¦W´îªÎÃÄ­±Á{°Æ§@¥Î¡B¯f¤H­t¾á»P°±ÃÄ­·ÀI¡A¤U¤@¨B¸Ó¦ó¥h¦ó±q?

®Ú¾Ú¤@¥÷¬ã¨sÅã¥Ü¡A¬ü°ê±q2021¦~¶}©lªAÃĪº¯f¤H¤¤¡A°ª¹F2/3¦b1¦~¤º°±ÃÄ....

2.¡§ú£ªÎ¯«药¡¨¥q¬ü®æ鲁肽¦}«D¤@ª½¦³®Ä¡A当°±药时会发¥Í¤°¤\¡H

news.bioon.com/article/20e58220254f.html

....°±ÃĤ@¦~«á¡A³\¦h¤H´î±¼ªºÅé­«·|¦^´_¬ù¤T¤À¤§¤G¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/8/18 ¤W¤È 10:14:06²Ä 3947 ½g¦^À³
udn.com/news/story/6904/8165921?from=udn-catehotnews_ch2

¦b²ö¨Ì¯Á¤Ò´N¥ô«e¤£¤[¡A³Â¦{ºî¦XÂå°|ªº«¢¥»¯à±q鮟鱇³½¨­¤W¿ï´Þ¥X¤É¿}¯À«eÅX³J¥Õ¡]preproglucagon¡^°ò¦]¡A¨ä¤¤¥]§t¤É¿}¯À¤Î¤@¬q¥\¯à¤£¸Ôªº§Ç¦C¡]§YGLP-1¡^¡CGLP-1©M¸²µå¿}¨Ì¿à©Ê«P¯Ø®q¯À肽¡]GIP¡^¦³³¡¥÷§Ç¦C¤@¼Ë¡FGIP¬O·í®É©Òª¾°ß¤@ªº¸zªc¯À¡AÁö¯à«P¶i¯Ø®q¯À¤Àªc¡A¦ý¥Î¨ÓªvÀø²Ä¤G«¬¿}§¿¯f±wªÌ©l²×¨S¦³¦¨®Ä¡CGLP-1©MGIP¦³´X¤À¬Û¦ü¤S©M¤É¿}¯À¦ü¥G¦³Ãö¡A·|¤£·|¥t¦³¥\®Ä¡H²ö¨Ì¯Á¤Ò©M«¢¥»¯à­^¶¯©Ò¨£²¤¦P¡A³£¨M©w¶i¤@¨B¬ã¨sGLP-1¡C

GLP-1¬O¥Ñ37­ÓÓi°ò»Ä²Õ¦¨¡A²ö¨Ì¯Á¤Ò°ò©ó¤§«e¹ï¤É¿}¯Àªº¤F¸Ñ¡A§PÂ_GLP-1­Y¦³§@¥Î¡AÀ³¸Ó¬O7-37³o¬q§Ç¦C¡C¦o¯Ó¶O¤ß¤O°µ¥X¹ïÀ³ªº§ÜÅ餧«á¡A©M«¢¥»¯à¶i¦æ¦X§@¡AªGµM¦b¹êÅ繫ªº¸z¤ºµo²{GLP-1ªº7-37¤ù¬q¡A¥Nªí¥¦À³¸Ó¤]¬O¤@ºØ¸zªc¯À¡C¦A¨Ó´N­n½T»{GLP-1¡]7-37¡^¬O§_¯uªº·|«P¶i¯Ø®q¯À¤Àªc¡H³o¶µ¹êÅç¥Ñ²ö¨Ì¯Á¤Ò­t³d¦X¦¨GLP-1¡A«¢¥»¯àªº¹Î¶¤¦A±N¤§ª`®g¨ì¹êÅ繫Å餺¡Aµ²ªG¤£¦ýÃÒ¹ê¤F³o¤@ÂI¡AÁÙÅå³ßµo²{¥u­n«Ü¤Öªº¾¯¶q´N°÷¤F¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/16 ¤W¤È 11:29:12²Ä 3946 ½g¦^À³
¤W¤ëµoªí¦b¡m¨x¯f¾Ç¡nÂø»x¤Wªº¬ã¨s¦õÃÒ¤FªYÄ£SNP-6ªºÀø®Ä¾÷¨î!!!

¤T´â½©¿}¥i¯à¾É­P [T²Ó­M¨üÅé] ªºªÅ¶¡¶ZÂ÷§ó¤j¡A±q¦Ó¤¤Â_°T¸¹¶Ç¿é¡A§í¨îCD4+ CD8+ T ²Ó­M¼W´Þ!

2024.7.24-§Ü­ìÅX°Êªº CD8 + T ²Ó­M§J¶©ÂX¼W¬O¤HÃþ©M¤p¹« MASH ªº¤@­ÓÅãµÛ¯S¼x

journals.lww.com/hep/fulltext/9900/ag_driven_cd8__t_cell_clonal_expansion_is_a.978.aspx

Á`¤§¡A³o¨Ç¼Æ¾Ú´£¨ÑªºÃÒ¾Úªí©ú¡A¬¡¤Æªº T ²Ó­M³z¹L MASH ¤¤T²Ó­M¨üÅé (TCR) ªº°Ñ»P¡A¦b¨xŦ¤¤¶i¦æ§J¶©©ÊÂX¼W©M²Ö¿n¡C

§Ú­ÌÃÒ©ú¡A§J¶©ÂX¼Wªº CD8 + T ²Ó­M¦b±w¦³ MASH ªº¤HÃþ©M¤p¹«ªº¨xŦ¤¤²Ö¿n¡C³o¨Çµo²{ªí©ú§Ü­ì¬¡¤ÆCD8+ T ²Ó­M¦b MASH µo¯f¾÷¨î¤¤ªº¼ç¦b§@¥Î¡C

---------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/14 ¤U¤È 10:36:57²Ä 3914 ½g¦^À³

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/5 ¤U¤È 05:46:20²Ä 3884 ½g¦^À³

­^°ê¦P¦æ¥h¦~µoªíªº[¤T´â½©¿}]¾÷¨îÀ°¤FªYÄ£¤j¦£!!!

°ª¿@«×ªº¤T´â½©¿}¥i¯à¾É­PPLC-£^1»P(¬¡¤Æªº¡^T²Ó­M¨üÅ骺ªÅ¶¡¶ZÂ÷§ó¤j¡A±q¦Ó¤¤Â_°T¸¹¶Ç¿é¡A[§í¨îCD4+ CD8+ T ²Ó­M¼W´Þ]

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/15 ¤W¤È 10:46:24²Ä 3945 ½g¦^À³
2023.4.12-health.ltn.com.tw/article/breakingnews/4268482

Ãö©ó¿}§¿¯fÂ_®Ú©M°fÂà³o¦^¨Æ¡A¦pªGÄY®æ¨Ó»¡¡A¬O [¤£¥i¯à] µo¥Íªº¡C·í½ñ¤J¿}§¿¯fªº¨º¤@¨è¡A°ò¦]´N¤w¸g§ïÅÜ¡A±N¤j´T´£¤É¿}§¿¯f¿ò¶Ç¾÷²v¡A«áÄò¥u¯à³z¹L¶¼­¹¨Ó¡u±±¨î¡v¡C

------------------------------------------------------------------------------------

¤W­±ªº»{ª¾¤w¹L®É¡ARoy Taylor ±Ð±Â±´°Q²Ä 2 «¬¿}§¿¯fªº¯f¦]-¥Lªºµo²{ÃÒ©ú¤F T2D ªº[¥i°f]©Ê

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/15 ¤W¤È 10:39:16²Ä 3944 ½g¦^À³
¶}³Ð©Ê¬ì¾Ç¬ð¯}µo²{²Ä2«¬¿}§¿¯f¥i¥H°fÂà!!!

2023.10.30-Roy Taylor ±Ð±Â±´°Q²Ä 2 «¬¿}§¿¯fªº¯f¦]

from.ncl.ac.uk/discovering-cause-of-type-2-diabetes-roy-taylor

Roy Taylor ±Ð±Âªº¶}³Ð©Êµo²{¤w³Q NHS(­^°ê°ê®aÂåÀøªA°ÈÅé¨t)±µ¨ü¡A³o¤£¶È·N¨ýµÛ¬ì¾Ç¬ð¯}¡A¤]¼Ð»xµÛ§Ú­Ì»{ª¾©MªvÀø 2 «¬¿}§¿¯f (T2D) ¤è¦¡ªºÂàÅÜ¡C¥Lªºµo²{ÃÒ©ú¤F T2D ªº¥i°f©Ê¡A¤w¦¨¬°¦¨¤d¤W¸U¤Hªº§Æ±æ¿O¶ð¡A¨Ï±wªÌ¯à°÷§ïÅܦۤvªº¥Í¬¡¡C

----------------------------------------------------------------------------------------------

³z¹L´î¤Ö¯ØŦ¯×ªÕ°fÂà²Ä 2 «¬¿}§¿¯f(¬ã¨s¤H­ûªí©ú¡A³z¹L´îªÎ´î¤Ö¤£¨ì¤@§Jªº¯×ªÕ¥i¥H°fÂà¿}§¿¯f)

www.ncl.ac.uk/press/articles/archive/2015/12/pancreasstudy/

¥@¬É¿}§¿¯f¤j·|¤Wµoªí¡C¬ã¨s­û®õ°Ç±Ð±Â(Professor Roy Taylor)¦b¤j·|¤W»¡¡G¡u²Ä¤G«¬¿}§¿¯f±wªÌ´î­«¤§«á¡A¥i¥H´î¤Ö¯ØŦªº¦h¾l¯×ªÕ¡A«P¨Ï¯ØŦ¥\¯à«ì´_¥¿±`¡C¦]¦¹¡A¦pªG§A°Ý§Ú¡A¯f¤H»Ý­n´î¤Ö´X¤½¤ç¤~¯à§ïµ½¿}§¿¯f¡Aµª®×´N¬O1¤½§J¡C¤£¹L¡A³o1¤½§J¥²¶·¬O¨Ó¦Û¯ØŦªº¯×ªÕ¡C¡v

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/15 ¤W¤È 08:00:43²Ä 3943 ½g¦^À³
2024.4.4- [¯ØŦ¯×ªÕ] ÅܤƪºÃIJz¾Ç´ºÆ[ link.springer.com/article/10.1007/s40265-024-02022-7

¹ï´î¤Ö¯ØŦ¤º¯×ªÕ¨I¿nªºÃĪ«ªº±´¯Á¤w¦³¥|¤À¤§¤@­Ó¥@¬öªº¾ú¥v¡CÁöµM©|¥¼§å­ã¥Î©óªvÀø¯ØŦ¯×ªÕÅܪº¯S©wÃĪ«¡A¦ýÃĪ«ªº­«·s§Q¥Î¦b´î»´³Ì±`¨£ªº¯ØŦ¯e¯fªº­t¾á¤è­±Åã¥Ü¥X§Æ±æ¡C³o½g¥D­n¤å³¹·§­z¤F¨´¤µ¬°¤î¤w¬ã¨sªº 12 ÃþÃĪ«¡A¦®¦b´î¤Ö¯ØŦ¤º¯×ªÕ¨I¿n¡C

·½¦Û¤º³¡¯ØŦ¯×ªÕªº¯ØŦ¯e¯f (PANDORA) °²»¡±N¯ØŦ¾Çªº¦h¾Ç¬ì»â°ì´£¤É¨ì¤F¤@­Ó·sªº¤ô¥­¡A

±N¯ØŦªº¯×ªÕÅܤƽT©w¬°§ïÅÜ¿}§¿¯f¡B¯ØŦª¢©M¯ØŦÀù¦ÛµM¯fµ{ªº°ò¥»¥Ø¼Ð

±N¯ØŦªº¯×ªÕÅܤƽT©w¬°§ïÅÜ¿}§¿¯f¡B¯ØŦª¢©M¯ØŦÀù¦ÛµM¯fµ{ªº°ò¥»¥Ø¼Ð

±N¯ØŦªº¯×ªÕÅܤƽT©w¬°§ïÅÜ¿}§¿¯f¡B¯ØŦª¢©M¯ØŦÀù¦ÛµM¯fµ{ªº°ò¥»¥Ø¼Ð

------------------------------------------------------------------------------------------

¼ï¦·©Ô°²»¡»{¬°¯ØŦªº[¯×ªÕÅܤÆ] ¬O©Ò¦³¯ØŦ[«D¿ò¶Ç©Ê]¯e¯fªº¦@¦PÅX°Ê¤O¡C

[©s¼wº¸ÀH¾÷¤Æ]Ãþ¦ü©ó¦ÛµMªº¡uÀH¾÷¹ï·Ó¸ÕÅç¡v--¦]ªGÃö«Y¬OÅKÃÒ¦p¤s!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/14 ¤U¤È 08:01:50²Ä 3942 ½g¦^À³
ªYÄ£ªºªvÀø¯×ªÕ[¯Ø]´N¬O¶W«e±ÙÂ_¡uÀù¤ý¡v¯ØŦÀù!!!

¯Ø¯×ªÕ--2«¬¿}§¿¯f»P¡uÀù¤ý¡v¯ØŦÀù-[¦]ªG][¦]ªG][¦]ªG]Ãö«Y¬OÅKÃÒ¦p¤sµL¥iÅG»é!

-------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/10 ¤U¤È 07:28:56²Ä 3901 ½g¦^À³

¦b©s¼wº¸ÀH¾÷¤Æ©M«e¤©Ê¶¤¦C¬ã¨s¤¤¡A¯ØŦ¤º¯×ªÕ·|¼W¥[¯ØŦÀùªº­·ÀI¡C³o¬°¯×½è»P¯ØŦÀù¯g¤§¶¡ªº¦]ªGÃö«Y´£¨Ñ¤F¦³»¡ªA¤Oªº¤HÃþÃÒ¾Ú¡A[ÃÒ¹ê¤F¼ï¦·©Ô°²»¡ªº¹w´ú]¡C

---------------------------------------------------------------------------------------------------

¯ØŦ­P©Rªº¯×ªÕ--2«¬¿}§¿¯f»P¡uÀù¤ý¡v¯ØŦÀù

[©s¼wº¸ÀH¾÷¤Æ]³Q»{¬°Ãþ¦ü©ó¡u¦ÛµMªºÀH¾÷¹ï·Ó¸ÕÅç¡v---¦]ªGÃö«Y¬OÅKÃÒ¦p¤sµL¥iÅG»é!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/14 ¤U¤È 06:16:26²Ä 3941 ½g¦^À³
ªYÄ£¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ!!!(§Æ±æ°ª®p·|¦³ÁôÂê©2«¬¿}§¿¯f¼Æ¾Ú¤½¶})

³z¹L´î¤Ö¯ØŦ¯×ªÕ°fÂà²Ä 2 «¬¿}§¿¯f(¬ã¨s¤H­ûªí©ú¡A³z¹L´îªÎ´î¤Ö¤£¨ì¤@§Jªº¯×ªÕ¥i¥H°fÂà¿}§¿¯f)

-------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/10 ¤U¤È 04:31:01²Ä 3898 ½g¦^À³

www.sinewpharma.com/Upload/download/20240606-video.MP4

40¤À:¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ

-----------------------------------------------------------------------------------------

³z¹L´î¤Ö¯ØŦ¯×ªÕ°fÂà²Ä 2 «¬¿}§¿¯f(¬ã¨s¤H­ûªí©ú¡A³z¹L´îªÎ´î¤Ö¤£¨ì¤@§Jªº¯×ªÕ¥i¥H°fÂà¿}§¿¯f)

www.ncl.ac.uk/press/articles/archive/2015/12/pancreasstudy/

¥@¬É¿}§¿¯f¤j·|¤Wµoªí¡C¬ã¨s­û®õ°Ç±Ð±Â(Professor Roy Taylor)¦b¤j·|¤W»¡¡G¡u²Ä¤G«¬¿}§¿¯f±wªÌ´î­«¤§«á¡A¥i¥H´î¤Ö¯ØŦªº¦h¾l¯×ªÕ¡A«P¨Ï¯ØŦ¥\¯à«ì´_¥¿±`¡C¦]¦¹¡A¦pªG§A°Ý§Ú¡A¯f¤H»Ý­n´î¤Ö´X¤½¤ç¤~¯à§ïµ½¿}§¿¯f¡Aµª®×´N¬O1¤½§J¡C¤£¹L¡A³o1¤½§J¥²¶·¬O¨Ó¦Û¯ØŦªº¯×ªÕ¡C¡v

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/14 ¤U¤È 06:03:44²Ä 3940 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/18 ¤U¤È 11:23:36²Ä 3841 ½g¦^À³

www.sinewpharma.com/Upload/202312/news_2023122509345208.pdf

Type 2 diabetes or pre-diabetes

Present, n=18

Not present, n=17

----------------------------------------------------------------------------

SNP-610©Û¦¬±wªÌ:Type 2 diabetes or pre-diabetes

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/14 ¤U¤È 05:59:08²Ä 3939 ½g¦^À³
2024.6.6-ªk»¡·|¼v­µÀÉ www.sinewpharma.com/Upload/download/20240606-video.MP4

37¤À40¬í~¦¶¸³»¡¤fÀY³ø§i[2­Ó]ÃD¥Ø!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G°]°È¦Û¥Ñ¤H10132540  µoªí®É¶¡:2024/8/14 ¤U¤È 05:29:31²Ä 3938 ½g¦^À³
²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

[oral insulin] => ³o­ÓÀ³¸Ó¬O³o¶¡·|ij«Ç¥t¤@³ø§i¤H Miriam Kidron ( Oramed Pharmaceuticals )ªº¥DÃD¡C

----------------------------------------------------------------------------------------------------

SNP-810 ¦bOTC¬O¤@­Ó¥iÃöª`ªºÂI¡A¦ý¦]µL¨x¬r©Ê¦Ó¶}©Ýªº APAP ¤¤¡B°ª¾¯¶qÁp¦X¤îµh¥ÎÃÄÁ{§É¤]­È±o´Á«Ý¡C

SNP-810 ¥Ø«eªºÃöÁä¡A­Ó¤Hı±o¬O¦b US-FDA µL¨x¬rÁ{§É¦w¥þ©ÊªººA«×¡A­Y US-FDA ¦P·N°õ¦æµL¨x¬rÁ{§É¡A¨ä·N¸q«D¤Z¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/13 ¤U¤È 10:01:58²Ä 3937 ½g¦^À³
2023.6.20¦L«×ªº¤@¶µÀH¾÷Á{§É¸ÕÅç--«DÀç¾i©Ê²¢¨ý¾¯¤T´â½©¿}¹ï¦L«× 2 «¬¿}§¿¯f¦¨¤H¤ßŦ¥NÁ¦MÀI¦]¤lªº¼vÅT

diabetesjournals.org/diabetes/article/72/Supplement_1/615-P/150427/615-P-Effect-of-Nonnutritive-Sweetener-Sucralose

µ²ªG¡G¹ï§¹¦¨¬ã¨sªº 115 ¦W°Ñ»PªÌ¡]¹ï·Ó²Õ¡An=42 ©M¤z¹w²Õ¡An=73¡^ªº¼Æ¾Ú¶i¦æ¤F¤ÀªR¡C»P¹ï·Ó²Õ¬Û¤ñ¡A¤¶¤J²Õªº¸y³ò¡]p = 0.02¡^¡B¯×½è²Ö¿n²£ª«¡]p = 0.02¡^©M¤ºÅ¦ªÎ­D«ü¼Æ¡]p = 0.02¡^ [ÅãµÛ] ´î¤Ö

µ²½×¡G¬ã¨sªí©ú¡A¥Î NNS´À¥N²K¥[¿}(¤T´â½©¿})¥i¥H¨Ï¦¨¤H2 «¬¿}§¿¯fªºªÎ­D«ü¼Æµo¥Í[¦³§Q]ªºÅܤơC

µ¥ªYÄ£9¤ë°ª®p·|¤½¥¬ªº[¥ÌÅS¾J+¤T´â½©¿}]ªº2 «¬¿}§¿¯fÁ{§É¼Æ¾Ú¡A¦A¨ÓÀ˵ø¡C

------------------------------------------------------------------------------------------------

²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

[oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f???

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/13 ¤U¤È 02:15:13²Ä 3936 ½g¦^À³
catiescause.org/blog/

2023 ¦~ 6 ¤ë 5 ¤é

³Í­Û¥v±K´µ (Karen Smith)¬O Catie¡¦s Cause ªº³Ð©l¤H¡A³o¬O¤@­Ó«DÀç§Q·Oµ½¾÷ºc¡A­P¤O©ó´£°ª¤H­Ì¹ï¦w¥þ¨Ï¥Î«D³B¤è¤îµhÃĪº»{ÃÑ¡C¦b¦oªº¤k¨à³Í¸¦¦]¹L«×¨Ï¥Î®õ¿Õ¦Ó¾É­P¨x°IºÜ¥h¥@«á¡A³Í­Û³Ð¥ß¤F³o­Ó²Õ´¡A¦®¦b´¦¥Ü®e©öÀò±o³o¨ÇÃĪ«©Ò±a¨Óªº·N¥~©M¦³·Nªº°Æ§@¥Î¡C

³Í­Û¸ÑÄÀ»¡¡G¡u¬ã¨sªí©ú¡A¦³¥|­Ó¥D­n¸sÅé¨ü¨ì¹ï¤AñQ®ò°ò×ô¤¤¬rªº¼vÅT¡C¦~»´¤HªÖ©w¬O¤@­Ó«Ü¤jªº¸sÅé¡A³q±`¬O¦]¬°¥L­Ì¿W¦Û¤@¤H¡A¨Ã¥B¨S¦³·NÃѨìÃĪ«ªº¦MÀI¡C¦³¨Ç¤H¥L­Ì¤¤ªº¤@¨Ç¤H½T¹ê¶}©lÀݥΥ¦¡A¦Ó¥B¥L­Ì¤ÓÀWÁc¦a¨Ï¥Î¥¦¡A¥i´dªº¬O¡A¤j¬ù50% ªº¦º¤`¬O¦Û±þ³y¦¨ªº¡A©Ò¥HÅãµM¬O¦³·Nªº¡A¦ý¨ä¤¤50% ¬OµL·Nªº¡C

¡u¥t¤@¸s¤H¬O¥®¨à¡A¦]¬°·í¥L­Ìªº«Ä¤lÀYµh®É¡A¤÷¥À©¹©¹·|Åå·W¥¢±¹¡A¥L­Ì·|¹L«×¥ÎÃÄ¡C²Ä¤T­Ó¨ü¼vÅTªº¸sÅé¬O¦Ñ¦~¤H¡A¦]¬°¥L­ÌÃø¥H¾\Ūĵ§i¼ÐÅÒ©Î¥¿¦bªA¥Î¤j¶q¨ä¥LÃĪ«¡A¥L­ÌªºÃĪ«¨xŦ¥i¯à¤w¸g¨ü¨ì·l®`¡C

¡u³Ì«á¤@²Õ¬O¨º¨ÇÀò±oÂåÀø«O°·ªº¾÷·|¦³­­ªº¤H¡C³o¥D­n¬O¦]¬°¥L­Ì¨S¦³¤Hĵ§i¥L­Ì¦pªG¹L«×¨Ï¥Î³oºØÃĪ«·|µo¥Í¤°»ò¡C¥L­Ì¶É¦V©ó¥hÃĩЦӤ£¬O¥h¬ÝÂå¥ÍµM«á®³°_¬[¤l¤Wªº¥ô¦óªF¦è¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/13 ¤W¤È 09:22:28²Ä 3935 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/9 ¤W¤È 09:16:38²Ä 3790 ½g¦^À³

¤jÃļt¡u¤U¤£¤F¥x¡v§óÁ}Ãø¦a¤@¤Ñ¡AÅý¶D³^«ß®v¾ß¨ìºj¡A¯à´Á«Ý¤£µo¥Í¤j¨Æ???

¶D³^«ß®v/®ø¶OªÌ/¾ÇªÌ/µû½×®a/ªk©x¦b½æ³õ¬[¤W¬Ý¨£SAFETYNADOL(µL¨x¬r)¡A¹j¾ÀªºTylenol(¦³¨x¬r)

---------------------------------------------------------------------------------------------

2020¦~ªºTylenol¤¤¬r·N¥~!

catiescause.org/blog/

³Í¸¦ªº¬G¨Æ

³Í¸¦¬O§Úªº¤k¨à¡A¦o¬O¤@­Ó¥Rº¡¬¡¤Oªº 20 ·³¤k«Ä¡A¹ï¥Í¬¡¥Rº¡¼ö±¡¡A¬O¤@¦ì¦h¤~¦hÃÀªºÃÀ³N®a©M°¨³N¹B°Ê­û¡A¬O¦P²z¤ß©M§V¤O¤u§@ªº¤Æ¨­¡C¦³®É§Ú±o°±¤U¨Ó«ä¦Ò¡A³oºØ¨Æ«ç»ò·|µo¥Í¦b¦o¨­¤W¡Aµo¥Í¦b§Ú­Ì¨­¤W¡H³Í¸¦¹LµÛ¥R¹êªº¥Í¬¡¡CµM¦Ó¡A¦oªº®Èµ{µo¥Í¤F·N·Q¤£¨ìªºÂà§é¡A¦o¤£©¯¦º©ó«æ©Ê¨x°IºÜ¡A³o¬O®õ¿Õ¤¤¬r³y¦¨ªº·´·À©Ê«áªG¡C¦o±q¥¼·Q¨ì³o¥ó¨Æ·|¹Ü¨«¦oªº¥Í©R¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/10 ¤U¤È 09:31:17²Ä 3934 ½g¦^À³
bmcgastroenterol.biomedcentral.com/articles/10.1186/1471-230X-11-20

¹Ï1:¨x¬r©ÊAPAP 4gªvÀø¾¯¶q²£¥ÍªºAAP-Cys ¿@«×¹Ïªí

VS.

12gµL¨x¬rSNP-810ªºAAP-Cysªº¹Ïªí-2024.6.6-ªk»¡·|¼v­µÀÉ 23¤À39¬í

¤d¨¥¸U»y¤£­Y¹Ïªí²M´·!!!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/10 ¤U¤È 09:15:14²Ä 3933 ½g¦^À³
4g¦³¨x¬rAPAPªvÀø¾¯¶q²£¥ÍªºAAP-Cys³q±`§C©ó0.5 nmol/mL ªº¿@«×!

12gµL¨x¬rSNP-810ªºAAP-Cysªº¿@«×?--->¼Æ¾Ú:2024.6.6-ªk»¡·|¼v­µÀÉ 23¤À39¬í

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/1 ¤U¤È 01:00:55²Ä 3748 ½g¦^À³

µL¨x¬rSNP-810(12g) VS. ¦³¨x¬rAPAP(4g)ªº[¾î¦V¤ñ¸û]:

....¨x¬r©Ê¤§¥NÁª«AAP-Cys adducts¿@«×¤ÎAAP-Cys¿@«×©ó©Ò¦³¾¯¶q²Õ§¡¥¼¹F¨x¬r©Ê¼Ð·Ç-->¦p¯à¤½¥¬¼Æ¾Ú§ó¦n!

¦]¬°APAP-CYS¬OAPAP¼ÉÅSªº¯S²§©Ê¥Íª«¼Ð°O¡C APAP-CYS ¿@«×>1.1 nmol/ml¤w³Q«Øij§@¬° ALT >1000 IU/L ±wªÌ¹ï¤A

ñQ®ò°ò×ô¹L¶q¾É­P¨x·l¶Ëªº¼Ð°O¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/10 ¤W¤È 10:28:20²Ä 3932 ½g¦^À³
2019¦~¤@¶µÀH¾÷¹ï·Ó¸ÕÅç¡A­¹¥Î¤T´â½©¿}ªº¤HªºÅé­«ÁÍ©ó¤U­°¡A¨Ã¥B©úÅã§C©ó­¹¥Î¥ô¦ó¨ä¥L²¢¨ý¾¯ªº¤H¡C

www.sciencedirect.com/science/article/pii/S0002916522031860?via%3Dihub

µ²½×

»Pªü´µ¤Ú²¢¡BrebA ©M¤T´â½©¿}¬Û¤ñ¡A½©¿}©M¿}ºë®ø¯Ó¶qÅãµÛ¼W¥[Åé­«¡A¦Ó»P¿}ºë¡Bªü´µ¤Ú²¢©M rebA ®ø¯Ó¶q¬Û¤ñ¡A¤T´â½©¿}ªºÅé­«ÅܤƧe­t¤è¦V¥B¸û§C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/10 ¤W¤È 10:21:01²Ä 3931 ½g¦^À³
¤é¥»(²Ä¤@²Õ)2013--²¢¨ý±Ó·P¨üÅé¦b 3T3-L1 ²Ó­M¯×ªÕ¤À¤Æªº·s½Õ¸`¥\¯à

------------------------------------------------------------------------

¬ü°ê¦P¦æ¬ã¨s(²Ä2²Õ)

www.ncbi.nlm.nih.gov/pmc/articles/PMC3820882/

³o¶µ¬ã¨s³Ñ¤Uªº³Ì¦³½ìªº°ÝÃD¬O [¯×ªÕ²Õ´]¤¤²¢¨ý¨üÅ骺¥Í²z§@¥Î¡]¦pªG¦³ªº¸Ü¡^¡C¾¨ºÞ§Ú­Ì¬O[²Ä¤G­Ó]´y­z¥¦­Ìªº¤p²Õ¡A¦ý¹ï©ó³o¨Ç¨üÅ骺¥\¯à©|¥¼¹F¦¨¦@ÃÑ....Á`¦Ó¨¥¤§¡A³o¨Ç¼Æ¾Ú´¦¥Ü¤F¤H¤u²¢¨ý¾¯¦b¯×ªÕ¥Íª«¾Ç¤¤ªº·s§@¥Î¡A¨Ãªí©ú²¢¨ý¨üÅé¥i¯à¥Nªí¤ñ¥Ø«e»{Ãѧó¼sªx¡B§ó½ÆÂøªº¨üÅé¸s¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/10 ¤W¤È 09:47:08²Ä 3930 ½g¦^À³
©ú¥§Ä¬¹F¤j¾Ç¬ã¨sªí©ú¤T´â½©¿}¯×ªÕÅé¿n´ú¶q¤§¶¡¨S¦³ÅãµÛÃöÁp¡C

¤é¥»¬ã¨sÁÙ¯à§Ü¯×ªÕ§Î¦¨

1.2014--¯ØŦ £] ²Ó­M¤¤ªí¹Fªº²¢¨ý·P¨ü¨ü¾¹¡G²¢¨ý¤À¤l¥R·í°¾¦V¿E°Ê¾¯

www.e-enm.org/journal/view.php?doi=10.3803/EnM.2014.29.1.12

¦UºØ²¢¨ý¤À¤l¬O§_¦b£]²Ó­M¥H¥~ªº²Ó­M¤¤§êºt°¾¦V¿E°Ê¾¯¡H³o¬O¤@­Ó¦³½ìªº°ÝÃD¡A§Ú­Ì¤w¸g¦³¤F¤@¨Çµª®×¡C....

¤T´â½©¿}¦b [¯×ªÕ²Ó­M] ¤¤ªº§@¥Î»P¦b [£]²Ó­M]¤¤ªº§@¥Î [©úÅ㤣¦P]¡CŲ©ó°¾¦V¿E°Ê§@¥Î¥H²Ó­M«¬¯S²§©Ê¤è¦¡µo¥Í...²¢

¨ý¤À¤l¤]¦b¯×ªÕ²Ó­M¤¤§êºt°¾¦V¿E°Ê¾¯¡C

2.2013--²¢¨ý±Ó·P¨üÅé¦b 3T3-L1 ²Ó­M¯×ªÕ¤À¤Æªº·s½Õ¸`¥\¯à (¤T´â½©¿}§Ü¯×ªÕ§Î¦¨)

journals.plos.org/plosone/article?id=10.1371/journal.pone.0054500

¦b¥»¬ã¨s¤¤¡A§Ú­ÌÃÒ©ú¤F²¢¨ý¶Ç·P¨üÅé¦b¤À¤Æ¯×ªÕ²Ó­M¤¤ªºªí¹F¡A¨ä¦b3T3-L1²Ó­Mªº¯×ªÕ§Î¦¨¤À¤Æ¤¤µo´§­t½Õ¸`§@¥Î¡A±q

¦Ó¬°²¢¨ý¶Ç·P¨üÅ骺 [·s«¬«D¨ýı¥\¯à]´£¨Ñ¤FÃÒ¾Ú...

³oºØ¿W¯Sªº²¢¨ý·PÀ³¨üÅé¥i¯à¦¨¬°ªvÀøªÎ­D¬ÛÃö¯e¯f¡]¦p²Ä 2 «¬¿}§¿¯f©M¥NÁ¯g­Ô¸s¡^ªº¼Ð¹v¡C

³oºØ¿W¯Sªº²¢¨ý·PÀ³¨üÅé¥i¯à¦¨¬°ªvÀøªÎ­D¬ÛÃö¯e¯f¡]¦p²Ä 2 «¬¿}§¿¯f©M¥NÁ¯g­Ô¸s¡^ªº¼Ð¹v¡C

³oºØ¿W¯Sªº²¢¨ý·PÀ³¨üÅé¥i¯à¦¨¬°ªvÀøªÎ­D¬ÛÃö¯e¯f¡]¦p²Ä 2 «¬¿}§¿¯f©M¥NÁ¯g­Ô¸s¡^ªº¼Ð¹v¡C

-----------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/10 ¤U¤È 04:12:14²Ä 3896 ½g¦^À³

2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

[oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f???

2«¬¿}§¿¯f©MNAFLD ±wªÌªº[ALT¤U­°]»P [¨xŦ¯×ªÕ´î¤Ö] ¦³Ãö....(SNP-610­°§C29.5 U/L)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/10 ¤W¤È 09:32:49²Ä 3929 ½g¦^À³
©ú¥§Ä¬¹F¤j¾Ç2023.7.13-µoªí¦b¡m°ê»ÚªÎ­DÂø»x¡n¬ã¨sªí©ú:ªø´ÁÄá¨ú¤H³y²¢¨ý¾¯»PÅé¯×ªÕ²Õ´Åé¿n¼W¥[¦³Ãö

www.nature.com/articles/s41366-023-01336-y

ªø´Á­¹¥Îªü´µ¤Ú²¢¡B¿}ºë©M´îªÎ¶¼®Æ»P¸¡³¡¯×ªÕÀx¦s©M¦Ù¦×¤º¯×ªÕ¼W¥[¦³Ãö¡CµM¦Ó¡A¬ã¨sµo²{[¤T´â½©¿}]»P³o¨Ç¯×ªÕÅé¿n´ú¶q¤§¶¡¨S¦³ÅãµÛÃöÁp¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/6 ¤W¤È 08:04:04²Ä 3928 ½g¦^À³
§Ú²´¤U3®a:ªYÄ£ /¶¶ÃÄ/§K¬Ì¥\§{(³o®a«ÜÃø¶R¨ì²¼)¡AÀ³¸Ó¬O¥xÆW²Ä1®a±ÂÅv«e10¤jÃļtªº¼öªù¡C

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/7/7 ¤U¤È 02:00:43²Ä 2200 ½g¦^À³

µ²½×:¥iª`·N±i¤l¤å³Õ¤h¦¨¥ßªº§K¬Ì¥\§{(¸òÀH¤j¤û¨«¿ù¤£¤F)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/6 ¤W¤È 07:49:51²Ä 3927 ½g¦^À³
3¦~«e°ß¤@»P2®a«e10¤jÃļtñ­q¦³Àv¦X§@¨óijªº·sÃĤ½¥q

·|¤£·|¦¨¬°²Ä1®a±ÂÅv«e10¤jÃļtªº·sÃĤ½¥q¡A«ø¥Ø¥H«Ý!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/8/6 ¤W¤È 07:30:55²Ä 3926 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/9 ¤U¤È 05:06:23²Ä 3890 ½g¦^À³

¡§1¦~5­¿ªÌ¦p¹L¦¿¤§ÃV¡B5¦~1­¿ªÌ«o¹é­Y¨°¬P¡¨(®©¤£¥X? ¦^·Q¤@¤U°ê¹©¿ÄÂ_¤W300.....)

§Ú¬J¬ÝªÅ´N¤£°µ¦h¤]¤£°µªÅ¡A°O¤£²M¬O¨º¦~¼o¤F¿Ä¸ê¨é¸ê®æ¡C

­P´I¤§¹D¡A§Ö´N¬OºC¡AºC´N¬O§Ö¡AµLÄߪi°Ê¡A[°í«ù¦Û§Ú§PÂ_]

-----------------------------------------------------------------------------------------------

¥xªÑ¥v¸Ö¯Å±Y¶^¡A¹L¦¿¤§ÃV¤µµS¦b?

[ºC´N¬O§Ö]ªºªYÄ£­P´I¬ü¹Ú¯à¦¨¯u?

2024.6.6-ªk»¡·|¼v­µÀÉ www.sinewpharma.com/Upload/download/20240606-video.MP4

¯u¹ê.°È¹ê.¥­¹ê

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/7/25 ¤W¤È 08:18:46²Ä 3925 ½g¦^À³
ÆWÆW©ñ¤G¤Ñ¡Aj¤½¥q¨S©ñ¤~¹ï¡A¥[³t°Q½×¦¬ÁÊ·sÃĮסC§C¼Ð¤~¬O±ÂÅv
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/20 ¤U¤È 11:53:27²Ä 3924 ½g¦^À³
§R°£¨x·l¶Ëĵ§i¡A¥«¦û²v¤j¼W!

FDAªº¶Â®Ø¨x·l¶Ëĵ§i¯à¥[µù·íµM¤]¯à§R°£--->FDA ¦³°Ê¾÷§å­ã³Ð·s©M¦³®ÄªºÃĪ«¡A¯S§O¬O·í³o¨ÇÃĪ«¸Ñ¨M¤F¥¼º¡¨¬ªº»Ý¨D©Î¥Nªí¬Û¹ï©ó¨ä¥LªvÀø´À¥N«~ªº­«¤j¶i¨B®É¡C

[¬Û¦PªºÃĪ«¾÷Âà]:[¦w¥ß¥Í©Z]§R°£¨x·l¶Ëĵ§i¡A¥«¦û²v¤j¼W! VS.[ªi¥Í©Z]¤£¯à§R°£¨x·l¶Ëĵ§i¡A¥«¦û²v¤j´î!

§R°£¨x·l¶Ëĵ§i«á¾P°â¤j¼Wªº2¤äÃĪ«(ambrisentan ¦w¥ß¥Í©Z»P¥ï¥§§JÄõChantix)¡A²Ä3¤ä´â´á¥­µ¥FDA¦P·N§R°£¶Â®Øĵ§i¦ô­p¾P°âÃB¤]·|¤j¼W¡C

1.FDA ÃĪ«¦w¥þ³q°T¡GLetairis¡]ambrisentan ¦w¥ß¥Í©Z¡^¤ù¾¯¤¤§R°£¨x·l¶Ëĵ§i(¦w¥ß¥Í©Zªº§Q¥Î²v¤j´T¼W¥[¡Aªi¥Í©Zªº§Q¥Î²v¤U­°¡^

www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-liver-injury-warning-be-removed-letairis-ambrisentan-tablets

2.2024.7.18--­ã¤J»P¦w¥þ¡ÐFDA ÃĪ«¼f§åÃøÃD

jamanetwork.com/journals/jamanetworkopen/fullarticle/2821345

FDA ¦³°Ê¾÷§å­ã³Ð·s©M¦³®ÄªºÃĪ«¡A¯S§O¬O·í³o¨ÇÃĪ«¸Ñ¨M¤F¥¼º¡¨¬ªº»Ý¨D©Î¥Nªí¬Û¹ï©ó¨ä¥LªvÀø´À¥N«~ªº­«¤j¶i¨B®É¡C¥t¤@¤è­±¡AFDA »Ý­n­°§C­·ÀI¡A¥H«KÁ`ªº¨Ó»¡¡A¨Ï¥Î¨ã¦³¼ç¦b¦w¥þ°ÝÃDªº­Ó§OÃĪ«¬O¦³¥²­nªº¡C

...§@ªÌµo²{¡AÀHµÛ®É¶¡ªº±À²¾¡A¨ú®ø¹ï¦w¥ß¥Í©ZªººÊ´ú­n¨D¹ï¾ã­ÓERA ÃĪ«Ãþ§O¥«³õ¥÷ÃB²£¥Í¤F­«¤j¼vÅT

¡]¦w¥ß¥Í©Zªº§Q¥Î²v¤j´T¼W¥[¡Aªi¥Í©Zªº§Q¥Î²v¤U­°¡^¡A¦P¼Ë¡]¦b¸û¤pµ{«×¤W¡^¼vÅT¤F¹ï¦w¥ß¥Í©ZªººÊ´ú¡C

§ÙµÒÃĪ«¥ï¥§§JÄõ¡]Chantix¡F½÷·ç¡^ªº±¡ªp¦³©Ò¤£¦P¡C 2006 ¦~Àò±o§å­ã«á¡A¤H­Ì³Ìªì¼ö±¡°ªº¦¡A¨Ã±o¨ì¤F¼sªxÃöª`¡C¨ì 2008 ¦~¡A¦³Ãö¶}©lªA¥Î¥ï¥§§JÄõ«á¥X²{¦Û±þ©ÀÀY©M¥ø¹Ï¦Û±þªº³ø§i¾É­P FDA ¦¬¨ì¤F´X¥÷¦w¥þ¿Ô¸ß³qª¾¡A¨Ã³Ì²×µo¥X¤F¶Â®Øĵ§i¡CÀH«á¥ï¥§§JÄõªº¨Ï¥Î«æ¼@´î¤Ö¡A³B¤è²v«ùÄò¤U­°¡Aª½¨ìÀH«á¹ï¥ï¥§§JÄõªº¦w¥þ©Êµû¦ô¨Ã¥¼ÃÒ¹ê¦Û±þ­·ÀI¼W¥[¡AFDA ©ó2016 ¦~12 ¤ë¨ú®ø¤F¶Â®Øĵ§i¡C²v¤j´T¼W¥[

FDA ¥¿¦b­«·sµû¦ô¥Ø«e´â´á¥­ REMS ­n¨Dªº­·ÀI©M¯q³B....»P[¦w¥ß¥Í©Z]ªº±¡ªp¤@¼Ë¡A§Ú­Ì§Æ±æ´ú¸Õ­n¨DªºÅܤƱN¾É­P TRS ±wªÌ¤j¶q¨Ï¥Î´â´á¥­¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/18 ¤W¤È 09:02:02²Ä 3923 ½g¦^À³
SNP-810»PSNP-610[¥ÌÅS¾J­°®ò]¾÷¨î!

2021.5.18--¹ï¤AñQ®ò°ò×ô¤¤¬r¤Þ°_ªº°ª®ò¦å¯g

www.tandfonline.com/doi/full/10.1080/15563650.2021.1933512

¹ï¤AñQ®ò°ò×ô¤Þ°_ªº[¨x¬r©Ê]¥i¾É­P[°ª®ò¦å¯g]¡A¦ý©|¤£²M·¡®ò¿@«×¤É°ª¬O§_¹w¥ÜµÛ¸£¯fÅÜ¡C

...Á`¦@¯Ç¤J 102 ¦ì±wªÌ¡A¨ä¤¤ 75 ¦ì¥X²{®ò¿@«×¤É°ª¡C´N¶E®É¡A40% (30/75) ªº±wªÌ¿@«×°ª©ó 100 µmol/L¡C

-------------------------------------------------------------------------------------------------

2018.1.10--¸z¹D¥ÌÅS¾J¹ï«æ¶E°ª®ò¦å¯g¡B®ñ¤ÆÀ£¤O©M¨x©Ê¸£¯fÅÜÄY­«µ{«×ªº¼vÅT

µ²½×:¸z¤º[¥ÌÅS¾J]¹ï©ó´î¤Ö«æ¶E«Ç CLD ±wªÌªº [°ª®ò¦å¯g]¡B®ñ¤ÆÀ£¤O©M¨x©Ê¸£¯fÅÜ»P±`³WªvÀø¤@¼Ë¦³®Ä¥B¦w¥þ¡C¦P

¼Ë¡A¥ÌÅS¾J¤ñ¶Ç²ÎªvÀø¦³§ó¦nªº­@¨ü©Ê¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/17 ¤U¤È 10:06:40²Ä 3922 ½g¦^À³
[®ò]¤ô¥­¤w³QÃÒ©ú¬O«æ©Ê¥¢¥NÀv©ÎºC©Ê¨x°IºÜ«æ©Ê±wªÌ¦º¤`²vªº¿W¥ß¹w´ú¦]¤l¡C

2022.7.21-¦å¼ß [®ò] ¤ô¥­¥i¹w´úÁ{§Éí©wªº¨xµw¤Æªù¶E±wªÌ¦]¨xŦ¬ÛÃö¨Öµo¯g¦Ó¦í°|ªº±¡ªp©M¦º¤`²v

www.journal-of-hepatology.eu/article/S0168-8278(22)02947-6/fulltext

¤èªk

§Ú­Ì¬ã¨s¤F¨Ó¦Û 3 ­Ó¿W¥ß¨xŦ³æ¦ìªº 754 ¦WÁ{§Éí©wªº¨xµw¤Æªù¶E±wªÌ¡C±N°ò½u®ò¤ô¥­®Õ¥¿¦Ü°Ñ¦Ò¹êÅç«Çªº¥¿±`¤W­­ (AMM-ULN)¡C¥D­n²×ÂI¬O¦]¨xŦ¬ÛÃö¨Öµo¯g¦Ó¦í°|¡]²Óµß·P¬V¡BÀR¯ß¦±±i¥X¦å¡B©úÅã¨x©Ê¸£¯f©Î¸¡¤ô·sµo©Î´c¤Æªº½Æ¦X²×ÂI¡^¡C¨Ï¥Î§Ö³t²Î¤@ÀH¾÷´ËªL¶i¦æ¦hÅܶqÄvª§­·ÀI¯Ü®z©Ê¤ÀªR¨Ó¹w´ú¨Öµo¯g©M¦º¤`²v¡C¨Ï¥Î¿W¥ß¤T¯Å¨xŦ¤¤¤ß 130 ¦W¨xµw¤Æ±wªÌªº«e¤©Ê¼Æ¾Ú¶i¦æ¤F¥~³¡ÅçÃÒ¡C

µ²½×

®ò¬OÁ{§Éí©wªº¨xµw¤Æªù¶E±wªÌ¦]¨xŦ¬ÛÃö¨Öµo¯g©M¦º¤`²v¦í°|ªº¿W¥ß¹w´ú¦]¤l¡A¦b¹w´ú¨Öµo¯g¤è­±¤ñ¶Ç²Î¹w«áµû¤À¿ö²{§ó¦n¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/17 ¤U¤È 09:31:23²Ä 3921 ½g¦^À³
§ó¥¿¬O:Sig.0.051 / Sig.<0.001
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/17 ¤U¤È 09:25:14²Ä 3920 ½g¦^À³
www.sinewpharma.com/Upload/202312/news_2023122709124108.pdf

SNP-6:ªÎ­D«¬(BMI>30)Sig.0.0051 / [«D] ªÎ­D«¬(BMI<30)Sig.<0.001

ÃöÁä¥i¯à¦b[¥ÌÅS¾J­°®ò]¾÷¨î:(°µ­Ó¬ö¿ý¡A¤é«áÀ˵ø¥Î)

1.2023.4.25-[®ò]¦b NAFLD ¤¤ªº§@¥Î¡G¤@­Ó¤£´M±`ªº¶ûºÃ¤H

www.ncbi.nlm.nih.gov/pmc/articles/PMC10326708/

¦h­«¾¹©x¯gª¬¥H¤Î NAFLD ±q»´«×¯×ªÕÅÜ©ÊÂàÅܬ°¯×ªÕ©Ê¨xª¢¡B¨xµw¤Æ©M¨x²Ó­MÀùªº¾÷¨î©|¤£§¹¥þ²M·¡¡C

NAFLD ¤¤§¿¯À´`Àô¬¡©Ê¨ü¨ì·l®`¡A¥i¯à¬O¥Ñ©óªíÆ[¿ò¶ÇÅܤƩM¨x²Ó­M¦Ñ¤Æ¼W¥[¾É­P°ª®ò¦å¯g¡C

°ª®ò¦å¯g¦³¼sªxªº­t­±¼vÅT¡A¾É­P¨xÅÖºû¤Æ¡B¦Ù¤Ö¯g¡B§K¬Ì¤ÏÀ³¨ü·l¡B­PÀù©Ê¼W¥[©M»{ª¾»Ùê¡C

§Ú­Ì»{¬°§¿¯À´`Àô¬¡©Ê­°§C¾É­Pªº®ò²Ö¿n·|¾É­P NAFLD ªº¯gª¬©M¶i®i¡C

­°®ò¥i¯à¬O±±¨î NAFLD ¯gª¬©M¹w¨¾¶i®iªº¤@ºØ·sªºªvÀøµ¦²¤¡C

2.2022.3.1-«D°sºë©Ê¯×ªÕ¨xªº¨x·l¶Ë»P§¿¯À´`Àô»Ã¯À¥¢½Õ¦³Ãö

www.nature.com/articles/s41598-022-06614-9

¨xŦ¬O­t³d±q¦å²G¤¤²¾°£´á¥H¦X¦¨§¿¯À¥H«K±Æ¥XÅé¥~ªº¥D­n¾¹©x¡C·í [®ò]¥¼¯à¦¨¥\¦a±q¥Íª«Å餤²M°£®É¡A[°ª®ò¦å¯g]¥i¯à

·|¾É­P±q¨xŦ¨ì¤j¸£ªº¤£¦Pµ²ªG¡C

[®ò]¬O¥i¯à°Ñ»P NAFLD ¶i®iªºÃöÁä¤À¤l¡A§ó¨ãÅé¦a»¡¡A³z¹L¨x¬Pª¬²Ó­M¬¡¤Æ°Ñ»P¨xÅÖºû¤Æµo®i¡C

3.2022.3.17-®ò²M°£¾¯¥i«ì´_....

www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2022.808497/full

¸g¹L 20 ¶gªº«Ø¼Ò«á¡AHFD ²Õªº©Ò¦³¤p¹«¤£¶È¥X²{ NASH¡AÁÙ¥X²{¦Ù¦×´î¤Ö©ÊªÎ­D¡C¾¨ºÞ³o¨Ç¤p¹«ªºÅé­«¨S¦³©úÅãÅܤơA

¦ý¥¦­Ìªí²{¥XÅé¯×¶q¼W¥[©M¦Ù¦×©úÅã´î¤Ö¡A³o»P [«DªÎ­D] NAFLDªº¯S¼x¬Û¦ü¡C

§Ú­Ìªº¼Æ¾Úªí©ú¡A¯×ªÕ©Ê¨xª¢¤Þ°_ªº[°ª®ò¦å¯g] ¥i¯à¦b¦Ù¤Ö¯gªºµo¥Í¤¤µo´§§@¥Î¡C

4.2018.1.10--¸z¹D¥ÌÅS¾J¹ï«æ¶E°ª®ò¦å¯g¡B®ñ¤ÆÀ£¤O©M¨x©Ê¸£¯fÅÜÄY­«µ{«×ªº¼vÅT

www.sciencedirect.com/science/article/abs/pii/S0735675718300329

µ²½×:¸z¤º[¥ÌÅS¾J]¹ï©ó´î¤Ö«æ¶E«Ç CLD ±wªÌªº [°ª®ò¦å¯g]¡B®ñ¤ÆÀ£¤O©M¨x©Ê¸£¯fÅÜ»P±`³WªvÀø¤@¼Ë¦³®Ä¥B¦w¥þ¡C¦P

¼Ë¡A¥ÌÅS¾J¤ñ¶Ç²ÎªvÀø¦³§ó¦nªº­@¨ü©Ê¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/15 ¤W¤È 10:34:59²Ä 3919 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/10 ¤U¤È 07:42:31²Ä 3794 ½g¦^À³

¸É¥R»¡©ú³o¬q(¤T´â½©¿}§Ö³tÅãµÛ¼W¥[²Ó­M¤ºATP¤ô¥­)....

--------------------------------------------------------------------------------------------

1.2024.2.8--ATP ³z¹L½Õ¸`³æÅéºc¶H¨Ó¨¾¤î[³J¥Õ½è»E¶°]

www.cell.com/biophysj/abstract/S0006-3495(23)01231-6

¬ã¨s¤H­ûµo²{ATP¤£¶È¥i¥H¨¾¤î·sªº³J¥Õ½è»E¶°Åé¡AÁÙ¥i¥H·»¸Ñ¥ý«e¦s¦bªº³J¥Õ½è»E¶°Åé¡A

2.2023.10.20-¤TÁC»Ä¸¢苷 (ATP) ©M³J¥Õ½è»E¶°¦b¦~ÄÖ¬ÛÃöªºµø¤O«Â¯Ù©Ê²´³¡¯e¯f¤¤ªº§@¥Î

www.ncbi.nlm.nih.gov/pmc/articles/PMC10609282/

°ª ATP ¿@«×¦s¦bªº±¡ªp¤U¡AATP §@¬°¥Íª«¤ô·»§Uªø¾¯µo´§§@¥Î¡A±q¦Ó¨¾¤î³J¥Õ½è»E¶°¨Ãºû«ù³J¥Õ½è·»¸Ñ«×¡C

µ²½×:§Ö³tÅãµÛ¼W¥[²Ó­M¤ºATP¤ô¥­-->¨¾¤î³J¥Õ½è»E¶°Åé»P·»¸Ñ³J¥Õ½è»E¶°Åé!

¤T´â½©¿}³o¾÷¨î»P¥ÌÅS¾J¥Î¦bªü¯÷®üÀq¯g¡B©¬ª÷´Ë¤ó¯g©M 2 «¬¿}§¿¯fªº§í¨î»P·»¸Ñ³J¥Õ½è»E¶°®ÄªG???

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/15 ¤W¤È 10:06:36²Ä 3918 ½g¦^À³
1. www.movementdisorders.org/MDS/Scientific-Issues-Committee-Blog/Mannitol-Treatment-for-

Parkinsons-Disease.htm

Arkadir ³Õ¤h¡A±z¯à´y­z¤@¤U±z¦b©¬ª÷´Ë¤ó¯g±wªÌ¤¤´ú¸Õ¥ÌÅS¾Jªº¸gÅç©M­p¹º¶Ü¡H

¤j½Ã¡Pªü¥d­}º¸¡]David Arkadir¡^¡AÂå¾Ç³Õ¤h¡F«¢¹FÂÄÂåÀø¤¤¤ß©M§Æ§B¨Ó¤j¾Ç¡A¥H¦â¦C­C¸ô¼»§N

¤H­Ì¤£Â_´£¥X«D±M§Qª«½è¡A¨Ò¦p¥ÌÅS¾J¡A¦³¥i¯à´î½w©¬ª÷´Ë¤ó¯gªº¶i®i¡A¬Æ¦Ü°fÂ੬ª÷´Ë¤ó¯g¡C³o¨Ç«Øij¬O°ò©ó±wªÌ©MÂå¥Íªº­Ó¤H¸gÅç¡B²z½×°²³]¡B¬y¦æ¯f¾Ç¬ã¨s¥H¤ÎÅé¥~©ÎÅ餺°Êª«¹êÅç¡C¦b§V¤O¦³¤O¦a´ú¸Õ¦¹Ãþª«½è¹ï¤HÅ骺¯u¹ê®ÄªG¤§«e¡A»Ý­n¦³¡uÁ{¬É½è¶q¡vªºÃÒ¾Ú¡C¦ý§Y¨Ï²Ö¿n¤F¨¬°÷ªºÃÒ¾Ú¡A¦b³\¦h±¡ªp¤U¡A¤@¨Ç«D±M§Qª«½è¤]¥Ã»·¤£·|³Q´ú¸Õ¡C±q¥ÌÅS¾Jªº¬G¨Æ¤¤§Ú­Ì¥i¥H¤F¸Ñ«D±M§Qª«½è¥i¯àªº©R¹B¡C

2.2021.6.23-¥ÌÅS¾J¡A¤@ºØ¿}¡AÅý§Ú­«Àò·s¥Í¡I

parkinsonsnewstoday.com/forums/forums/topic/mannitol-a-sugar-has-given-me-back-my-life/¦b³o­Óºô¯¸¤W¾\Ū¤F¦³Ãö¥ÌÅS¾Jªº¹êÅç«á¡A§Ú¨M©w¹Á¸Õ¤@¤U¡C´X¶g«á¡A§Úªº¤@¨Ç©¬ª÷´Ë¯gª¬®ø¥¢¤F¡C´N¹³§Ú¨«¸ô®É¦A¦¸¦Û°ÊÂ\°Ê¤âÁu¤@¼Ë¡C¦b¸g¾ú¤F¤Q¦~ªº©¬ª÷´Ë¼³§JÁy¤§«á¡A§Úªºªí±¡¤S¦^¨Ó¤F¡C§Úªº¦r¸ñ¦A¦¸²M´·¥i¿ë¡C §Ú»Äµhªº¨­Åé·Pı¦n¦h¤F¡C

§Ú·NÃѨì¡A¥Ñ©ó³oºØ¿}¤wÀò±o FDA §å­ã¨Ã¥B¥i¥H¦bÂdÂiÁʶR¡A¦]¦¹¤½¥q´X¥G¨S¦³°Ê¤O´ú¸Õ©M¾P°â¥ÌÅS¾J....

---------------------------------------------------------------------------------------------

µ²½×:1.¨S±M§Q«OÅ@¡AÃļt·íµM¨S¿³½ì!

2.³æÃÄ18g¾¯¶q°ª¡A­G¸z¹D¯gª¬Åý¤H©Ó¨ü¤£¤F (½Æ¤èÀ³¸Ó®ÄªG§óÅãµÛ¥B¯à§ïµ½¥ÌÅS¾J°ª¶q¾É­Pªº­G¸z¹D¯gª¬)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/15 ¤W¤È 09:43:18²Ä 3917 ½g¦^À³
2022.1.3-¤fªA¥ÌÅS¾JªvÀø©¬ª÷´Ë¤ó¯gªº¦w¥þ©Ê©M­@¨ü©Ê¡B¾¯¶q¼W¥[¡BÂùª¼¸ÕÅç

www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.716126/full

¥ÌÅS¾J¬O¤@ºØ¤ÑµM°sºë¿}¡A³Ìªñ³Q«Øij§@¬°©¬ª÷´Ë¤ó¯gªº¼ç¦b¯e¯f½w¸Ñ¾¯¡C

­G¸z¹D¯gª¬­­¨î¤F¾¯¶qªº¼W¥[¡C

©¬ª÷´Ë¤ó¯g±wªÌ¨C¤Ñ¤fªA 18 §J¥ÌÅS¾J¬O¦w¥þªº¡A¦ý¥u¦³¤T¤À¤§¤Gªº±wªÌ¯à°÷­@¨ü³o¶µ³Ì¤j¾¯¶q¡C¦b³]­p¥¼¨ÓªºÀø®Ä¸ÕÅç®ÉÀ³¦Ò¼{³o¨Çµo²{¡C

---------------------------------------------------------------------------------------------------

­G¸z¹D¯gª¬­­¨î¤F¾¯¶qªº¼W¥[--->°Æ§@¥Î¹Ã¦R©Ô¨{¤l....

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/15 ¤W¤È 09:33:00²Ä 3916 ½g¦^À³
ªYÄ£(¥ÌÅS¾J+¤T´â½©¿}+¸t¯ó×ô)»P´¶´ç¤j¾Çµoªíªº¤p¤À¤l¾÷¨î(¤]¥Î©ó2«¬¿}§¿¯f)À³¸Ó¬O¤@¼Ë¡C

¥ÌÅS¾J¥i¥H¨¾¤î¤j¸£¤¤¦³¬r³J¥Õ½èªº»E¶°¡C

1.2013-english.tau.ac.il/impact/mannitol

¯S©Ôºû¤Ò¤j¾Ç¤À¤l·L¥Íª«¾Ç©M¥Íª«§Þ³N«Y¥H¤ÎSagol ¯«¸g¬ì¾Ç¾Ç°|ªºEhud Gazit ©M Daniel Segal¥H¤Î¥L­Ìªº¦P¨Æ Ronit Shaltiel-Karyo ³Õ¤h©M³Õ¤h¥Í Moran Frenkel-Pinter µo²{¥ÌÅS¾JÁÙ¥i¥H¨¾¤î³J¥Õ½èµ²¶ô£\-¬ðIJ®Ö³J¥Õ¦b¤j¸£¤¤§Î¦¨¡Ð³o­Ó¹Lµ{¬O©¬ª÷´Ë¤ó¯gªº¯S¼x¡C

2.2019-°ò©ó¥ÌÅS¾Jªº·s«¬¤p¤À¤l¥i§í¨î¤Úª÷´Ë¤ó¯g¤¤ £\-¬ðIJ®Ö³J¥Õ¾ý¯»¼Ë³J¥Õªº»E¶°

www.ncbi.nlm.nih.gov/pmc/articles/PMC6438916/

3.2024.1.18-´¶´ç¤j¾Çªº¬ã¨s¤H­û³Ð³y¤F¤À¤l¤Æ¦Xª«¨Ó§í¨î»Pªü¯÷®üÀq¯g¡B©¬ª÷´Ë¤ó¯g©M 2 «¬¿}§¿¯f¬ÛÃöªº³J¥Õ½è»E¶°

¡u¦b²Ä 2 «¬¿}§¿¯f¤¤¡A¤j¬ù 70% ªº¯f¨Ò¯A¤Î¤@ºØºÙ¬°¯Ø®q¾ý¯»¼Ë¦h肽 (IAPP) ªº¿E¯À¡A¥¦·|¦b¯Ø¸¢¤¤¿n»E¡A¡vFortin »¡¡C ¡uªü¯÷®üÀq¯g©M©¬ª÷´Ë¤ó¯g¤À§O»P tau ³J¥Õ©M £\-¬ðIJ®Ö³J¥Õ¦b¤j¸£¯S©w°Ï°ì¿n»Eªº¹Î¶ô¦³Ãö¡C¬Y¨Ç§Î¦¡ªº¥¢´¼¯gªº¯S¼x¬O¤j¸£¤¤¦P®É¦s¦b tau ³J¥Õ©M £\-¬ðIJ®Ö³J¥Õ»E¶°¡C 2 «¬¿}§¿¯f©M¯«¸g°h¤Æ©Ê¯e¯f¤§¶¡¤]¦s¦bÃöÁp¡G³Ìªñªº¬ã¨sµo²{¯Ø¸¢©M¤j¸£¤¤¦s¦b¤£¤î¤@ºØ»E¶°³J¥Õ¡Aªí©ú³o¨Ç·î§Î³J¥Õ¨ã¦³©Ò¿×ªº¡§¥æ¤e¼½ºØ¡¨®ÄÀ³¡C

....¬ã¨s¤H­û¥i¥H±N´¶´ç¤j¾Ç¶}µoªº³o¨Ç¤Æ¦Xª«»P[¨Å¿}¡B¥ÌÅS¾J©M·L´¹ÅÖºû¯À] µ¥ÃĪ«¸üÅéµ²¦X°_¨Ó¡A³z¹L¦hºØ³~®|µ¹ÃÄ¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/14 ¤U¤È 10:42:46²Ä 3915 ½g¦^À³
®¼¦n©_¥ÌÅS¾J(¥´¶}¦å¸£«Ì»Ù + ¶t°²»¡)/¤T´â½©¿}(¤¤Â_TCR°T¸¹ + T1R3¿E°Ê¾¯)/¸t¯ó×ô(ÅãµÛ´î»´¤p¹«ªºA£]»E¶°©M[Tau]¹L«×ÁC»Ä¤Æ)¥Î¦bªü¯÷®üÀq¯gªvÀø¨ó¦P®ÄÀ³¦h¤j?

---------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2023/10/22 ¤W¤È 09:59:53²Ä 3494 ½g¦^À³

³Ìªñªº¬ã¨sªí©ú¡A²¢¨ý¨üÅ鲧¤G»EÅéT1R2+T1R3 ¦b»{ª¾¥\¯à¤¤µo´§µÛ¦ÜÃö­«­nªº§@¥Î¡A³oªí©ú²¢¨ý¨üÅé°T¸¹¶Ç¾É¥\¯à»Ùê

¥i¯à¬O¬Y¨Ç¤j¸£¯f²z¤¤»{ª¾»Ùꪺ°ò¦¡C

1.2018--T1R3ºV°£¤p¹«ªº¾Ç²ß¡B°O¾Ð©MªÀ·|¦æ¬°§ïÅÜ»P¯«¸g¤¸¥\¯à»Ù꦳Ãöwww.ncbi.nlm.nih.gov/pmc/articles/PMC5500814/

2.2015-²¢¨ý¨üÅé°T¸¹ºôµ¸¡G¹ï»{ª¾¥\¯àªº¥i¯à¼vÅTwww.ncbi.nlm.nih.gov/pmc/articles/PMC4306214/

3. 2021.11.28-DIGMBIO ªº DM3100 °w¹ïªü¯÷®üÀq¯gªº¡§¨ýı·P¨ü¾¹(¹v¦VT1K3)

...¦bÁ{§É«e¬ã¨s¤¤¡A³Á¾¢µÑ¨úª«Åã¥Ü¥X¯«¸g«OÅ@©M§Ü¥¢´¼§@¥Î¡C¥¦´î®z¤F SH-SY5Y ¤HÃþ¯«¸g¥À²Ó­M½F²Ó­M¤¤ £]-¾ý¯»¼Ë

³J¥Õ»¤¾Éªº²Ó­M¬r©Ê©M²Ó­M­ä¤`¡A¤]«ì´_¤F¤T­«°ò¦]Âà´Þ°Êª«¼Ò«¬¡]3xTg AD ¤p¹«¡^ªº»{ª¾»Ùê¡C¦b¤@¶µ¹ï 70 ¦W¦³¥DÆ[

°O¾Ð»Ùꪺ¦Ñ¦~¤H¶i¦æªº¤p«¬ÀH¾÷¹ï·Ó¸ÕÅ礤¡A¥¦§ïµ½¤Fµøı°O¾Ð¡C

DM3100­pµe©ó2021¦~5¤ë³QÁú°ê¥¢´¼¯g¬ã¨s¤¤¤ß¿ï¬°ªvÀøªºÁ{§É«e¬ã¨s¤§¤@¡C

¦P®É¡A¸Ó¤½¥q­p¹º¦b©ú¦~§¹¦¨Á{§É«e¬ã¨s«á¡A©ó2023¦~±Ò°ÊDM3100ªvÀøADªº¤@´ÁÁ{§É¸ÕÅç....

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2023/5/4 ¤W¤È 11:26:12²Ä 3154 ½g¦^À³

2023.5.4-°I°h³t«×´î½w35% §¨Óªü¯÷®üÀq¯g·sÃıN³t°e¼f!

ªüº¸¯ý®üÀq¯fªº[¶t]°²»¡!!!

¾ý¯»¼Ë³J¥ÕªºÖߩʳJ¥Õ½è¶ô³q±`¬O¾É­Pªüº¸¯ý®üÀq¯fªº¸o»íº×­º¡C¦ý®Ú¾Úµoªí¦b¬ã¨s´Á¥Z¡m²Ó­M¡n©M¡m¯«¸g¤¸¡n¤Wªº¨â¶µ¬ã¨s¡A¯u¥¿ªº¸o»íº×­º¥i¯à¬O¶t¡C

¤º½èºô©M½u²ÉÅ餧¶¡ªºCyp2e1©Î ¶t ©Î ROS ¦êÂZ¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/14 ¤U¤È 10:36:57²Ä 3914 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/5 ¤U¤È 05:46:20²Ä 3884 ½g¦^À³

­^°ê¦P¦æ¥h¦~µoªíªº[¤T´â½©¿}]¾÷¨îÀ°¤FªYÄ£¤j¦£!!!

°ª¿@«×ªº¤T´â½©¿}¥i¯à¾É­PPLC-£^1»P(¬¡¤Æªº¡^T²Ó­M¨üÅ骺ªÅ¶¡¶ZÂ÷§ó¤j¡A±q¦Ó¤¤Â_°T¸¹¶Ç¿é¡A[§í¨îCD4+ CD8+ T ²Ó­M¼W´Þ]

----------------------------------------------------------------------------------------------------

1.2020.1.8-Nature¥D¥Z-¬ã¨s´¦¥ÜCD8 T²Ó­M¦bªü¯÷®üÀq¯g¤¤ªº§@¥Îwww.nature.com/articles/s41586-019-

1895-7

.... ³æ²Ó­M RNA ©w§ÇÅã¥Ü¡A³o¨Ç²Ó­M¤¤ªºTCR°T¸¹¶Ç¾É[¼W±j]¡C­È±oª`·Nªº¬O¡A³z¹L¦b²Ä¤T²Õ¤¤¨Ï¥Î¦hºØ³æ²Ó­M TCR

©w§Çµ¦²¤¡A§Ú­Ì¦bªü¯÷®üÀq¯g±wªÌªº¸£¯áÅè²G¤¤µo²{¤F§J¶©ÂX¼Wªº CD8 + T EMRA²Ó­M¡C

2. 2023.9.22-T²Ó­M¯ÓºÜ»Pªü¯÷®üÀq¯gªº»{ª¾ª¬ºA©M¾ý¯»¼Ë³J¥Õ²Ö¿n¦³Ãöwww.nature.com/articles/s41598-

023-42708-8

¥O¤HÅå³Yªº¬O¡A§Ú­ÌÆ[¹î¨ì¾ý¯»¼Ë³J¥Õ¶§©Ê¡B»{ª¾¥¿±`ªº¨ü¸ÕªÌ¤¤¥\¯à©Ê CD4 +©M CD8 + T ²Ó­M¼W¥[¡A¦Ó¾ý¯»¼Ë³J¥Õ

¶§©Ê»´«×»{ª¾»Ùê¨ü¸ÕªÌªº¥\¯à©ÊCD4 + ©MCD8 + T ²Ó­M«h[ÅãµÛ¼W¥[]¡C­«­nªº¬O¡A·í±N T ²Ó­M¥\¯à»P MMSE ½T©wªº

»{ª¾ª¬ºA¶i¦æ¤ñ¸û®É¡A±o¤À³Ì§Cªº±wªÌªº¯ÓºÜ²Ó­M¼Æ¶q³Ì¦h¡C

­Ó¤Hµ²½×:¤T´â½©¿}¥i¯à¾É­PT²Ó­M¨üÅé(TCR)[¤¤Â_]°T¸¹¶Ç¿é¡A§í¨îCD4+ CD8+T²Ó­M¤À¤Æ»P¼W´Þªº¾÷¨î¯àªvÀøªü¯÷®üÀq¯g!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/12 ¤U¤È 02:52:09²Ä 3913 ½g¦^À³
¥ÌÅS¾JÅãµÛ¼W¥[AMPK--ÅãµÛ¼W¥[ACCÁC»Ä¤Æ(¥¢¬¡)«P¶i CD8 + TIL «ù¤[©Ê©M [¸~½F±±¨î]

----------------------------------------------------------------------------------------------------

CD8 + T ²Ó­M¤¤[AMPKªº¯Ê¥F] ·|³z¹L»¤¾É³J¥ÕÁC»Ä酶¤¶¾Éªº²Ó­M¦º¤`¨Ó[§í¨î]¨ä[§Ü¸~½F]¥\¯à

www.oncotarget.com/article/3501/text/

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/12 ¤U¤È 02:44:39²Ä 3912 ½g¦^À³
2022.2.1-¥H ACC ¬°¼Ð¹vªº NASH ªvÀø·s³~®|

...¦b²³¦h§Ü NASH ¼Ð¹v¤¤¡AACC ³Qµø¬°³Ì¦³«e³~ªº­Ô¿ïÃĪ«¤§¤@¡A¦]¬°®Ú¾Ú FDA ©w¸qªº NASH ÃĪ«¶}¾v«ü«n¡A¨ä§í¨î¾¯¦ü¥G¹F¨ì¤F³Ì°ª²×ÂI¡]§Y¸Ñ¨M¯×ªÕ©Ê¨xª¢©M§ïµ½ÅÖºû¤Æ¡^....

-----------------------------------------------------------------------------------------------

ACC §í¨î¾¯½T¹ê¦³Á{§ÉÀø®Ä¡A¦ý°Æ§@¥Î¹L¤j¤F¨Ç¡C

¥ÌÅS¾JÅãµÛ¼W¥[AMPK->ÅãµÛ¼W¥[ACCÁC»Ä¤Æ(¥¢¥h¬¡©Ê)ªº°Æ§@¥ÎÀ³¸Ó¸û§C¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/12 ¤U¤È 02:15:45²Ä 3911 ½g¦^À³
¥ÌÅS¾J+¤T´â½©¿}¹ïCD8 +ªºÂùºÞ»ô¤U:¤@­Ó¶ÂÁy§í¨î¤@­Ó¥ÕÁy«P¶i!

¤T´â½©¿}(§í¨îCD4+ CD8+ T ²Ó­M¼W´Þ)+ ¥ÌÅS¾JÅãµÛ¼W¥[ACCÁC»Ä¤Æ(¥¢¬¡) «P¶i CD8 + TIL [«ù¤[©Ê©M¸~½F±±¨î]

SNP-6±±¨î±qÀYªº¯×ªÕ(DNL)¥Í¦¨-->These preclinical and phase 2 clinical data demonstrated that SNP-630 and its metabolites can suppress NASH fibrosis through DNL inhibition and inflammation.

----------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/27 ¤U¤È 01:25:35²Ä 3861 ½g¦^À³

¥ÌÅS¾J¥i¯à«ì´_¨ã¦³¦h¥\¯à©Ê©M¸~½F²M°£¯à¤OªºCD8 + T ²Ó­M¾÷¨î???

---------------------------------------------------------------------------------------

1.2024.3.14-ACCªýê¸~½F·LÀô¹Ò¤¤CD8 + T²Ó­M¯×½è§Q¥Î

www.cell.com/cell-metabolism/fulltext/S1550-4131(24)00055-X

§í¨î ACC «P¶i CD8 + TIL «ù¤[©Ê©M¸~½F±±¨î

ACC ±±¨îµÛ±qÀYªº¯×ªÕ¥Í¦¨(DNL)

ACC §í¨î­«·s³s±µ CD8 + T ²Ó­M¥NÁÂ

§Ú­Ìªº¼Æ¾Ú´¦¥Ü¤FACC½Õ¸`ªºLD(¯×ºw)Àx¦s©M²Ö¿n¬O¸~½F¤¤CD8 + T ²Ó­M¥\¯à»ÙꪺÅX°Ê¦]¯À¡C

2.ACC³z¹L¥i°fÁC»Ä¤Æ§Ö³t½Õ¸`¡FÁC»Ä¤Æ¨Ï ACC ¥¢¥h¬¡©Ê¡A¦Ó¥hÁC»Ä¤Æ«h¬¡¤Æ¦¹»Ã¯À

pubmed.ncbi.nlm.nih.gov/7915280/

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/12 ¤W¤È 10:09:29²Ä 3910 ½g¦^À³
www.mdpi.com/2073-4409/10/4/768

§Ú­Ìªº¼Æ¾Úªí©ú¡AD-¥ÌÅS¾JÅãµÛ¼W¥[ AMPK ªºªí¹F©MÁC»Ä¤Æ....ÅãµÛ¼W¥[¤FACCªºÁC»Ä¤Æ©MUCP1ªºªí¹F

-------------------------------------------------------------------------------------------

¥ÌÅS¾JÅãµÛ¼W¥[UCP1-AMPKªí¹F²£¼ö½Õ¸`!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/12 ¤W¤È 09:57:15²Ä 3909 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/11 ¤U¤È 09:45:04²Ä 3906 ½g¦^À³

FDA ©|¥¼§å­ã¥ô¦ó¤@ºØ²£¼ö½Õ¸`¾¯(´îªÎ)!

§¨Ó»P¿Õ©M¿Õ¼w¤£¥i¯à µ´¹ï¤£¥i¯à ¬Ý¤WªvÀøªÎ­Dªº [¥Í¼ö³~®|] ¤¤³Ì¼öªùªº¼Ð¹v???

------------------------------------------------------------------------------------------

§¨Ó¦­´N¬Ý¤WªvÀøªÎ­Dªº[¥Í¼ö³~®|]¼Ð¹v!!( UCP1-AMPKªvÀø¬O¼W¥[²£¼ö´²µo¼ö¶q´N¹³¹B°Ê´îªÎ¡A»PGLP-1§í¨î­¹¼¤§ó°·±d¦w¥þ!)

1.2022.10.12-¨ü¨ì§¨Ó«C·ý¡I»PNimbus ¦X§@¬ãµo¥NÁ¯e¯fªºAMPK ÃĪ«(±ÂÅvª÷4.96»õ¬ü¤¸)

2.2023.4.10--¡nAmplifier Therapeutics ±À¥X­º­ÓAMPK¬¡¤Æ¾¯(§ó°·±dªº´À¥N«~)¨Ó¨ú¥NGLP-1´îªÎÃÄ!

www.genetinfo.com/international-news/item/68226.html

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/11 ¤U¤È 10:16:34²Ä 3908 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/11 ¤U¤È 09:10:30²Ä 3904 ½g¦^À³

2.2009--³o¨Çµ²ªGªí©ú¥ÌÅS¾J¨ã¦³­°§CÅ餺¯×ªÕ¿n²Öªº§@¥Î

www.jstage.jst.go.jp/article/jnsv/55/3/55_3_242/_article/-char/en

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/11 ¤U¤È 09:38:52²Ä 3905 ½g¦^À³

2023.11.17-¤@ºØ·sµo²{ªº¬¡¤Æ UCP1 ªº¤Æ¦Xª«¥i§í¨îªÎ­D¤Î¨ä¬ÛÃö¥NÁ¯¿¶Ãonlinelibrary.wiley.com/doi/10.1002/oby.23948

-------------------------------------------------------------------------------------------------

³o2½g³£¬O¤é¥»¹Î¶¤µoªí(¤£½T©w¦¨­ûÃöÁp©Ê)¡A¦ô­p¬O2009¦~¨SºÆ´îªÎÃÄ¡Aªñ¦~´îªÎÃÄ«¨[°_Ú´]¦A¦¸¬ãµo!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/11 ¤U¤È 09:53:48²Ä 3907 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2023/7/6 ¤W¤È 08:48:51²Ä 3292 ½g¦^À³

¤@ÃÄ´I¡A¤@ÃĽa¡C

杨¨q伟团队¦b¥N谢酶¥Í²z©Ê¥\¯à¬ã¨s¤è­±¨ú±o进®i

¬ã¨s进¤@¨B证实¡ACyp2e1°ò¦]ºV°£¤p¹«¦å²MFGF21ªº¤ô¥­显µÛ¤É°ª...产热°ò¦] [Ucp1µ¥ªºªí达显µÛ¼W°ª]¡C

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2023/5/22 ¤U¤È 09:28:53²Ä 3204 ½g¦^À³

CYP2E1ªí¹F»PUCP1....ªºªí¹F§e­t¬ÛÃö!

1.2023.5.19--UCP1 ¶§©Ê¯×ªÕ²Ó­M¤¤ªºCtnnb1 /£]-³sÀô³J¥Õ¥¢¬¡¼W±j¤F¥Õ¦â¯×ªÕ²Õ´ªº½ÅÅÜ

2.2022-¤ý©ý课题组¦bBiochem Pharmacol发ªí¬ã¨s论¤å¡G细­M¦â¯ÀP450 2E1°ò¦]ºV°£©Î§í¨î³q过调节¯à¶q®ø¯Ó预¨¾°ª¯×饮

­¹诱导ªÎ­D

Cyp2e1¯Ê¥F¥i¥H³q¹L«P¶i¯×ªÕ»Ä¥NÁ©M¼W¥[¯×ªÕ²Ó­Mªº²£¼ö§@¥Î¨Ó¹w¨¾¶¼­¹»¤¾ÉªºªÎ­D¤Î¨ä¬ÛÃöªº¯×ªÕ¨x©M¯Ø®q¯À©è§Ü¡C

----------------------------------------------------------------------------------------------

¥ÌÅS¾J¼W¥[¤FCPT1 ©M UCP1 ªºªí¹F¡C²³©Ò©Pª¾¡ACPT1 ©M UCP1 ·|¼W¥[[²É½uÅ鬡©Ê] ¡A³z¹L[½ÅÅÜ]¼W¥[¯à¶q®ø¯Ó¡A­°§C¯×ªÕ®ø¤Æ²v©MÅé¯×ªÕ²Ö¿n©M¯Ø®q¯À©è§Ü!!!

¤é¥»¹Î¶¤¤@ºØ·sµo²{ªº¬¡¤Æ UCP1 ªº¤Æ¦Xª«???

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/11 ¤U¤È 09:45:04²Ä 3906 ½g¦^À³
FDA ©|¥¼§å­ã¥ô¦ó¤@ºØ²£¼ö½Õ¸`¾¯(´îªÎ)!

§¨Ó»P¿Õ©M¿Õ¼w¤£¥i¯à µ´¹ï¤£¥i¯à ¬Ý¤WªvÀøªÎ­Dªº [¥Í¼ö³~®|] ¤¤³Ì¼öªùªº¼Ð¹v???

----------------------------------------------------------------------------------

2023¦~9¤ë--UCP1 ¬¡¤Æ¡G§Q¥Î¦X¦¨©M¤ÑµM¨Ó·½ªº¤À¤lªvÀøªÎ­Dªº¥Í¼ö³~®|¤¤³Ì¼öªùªº¼Ð¹v

www.sciencedirect.com/science/article/abs/pii/S1359644623002337

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/11 ¤U¤È 09:38:52²Ä 3905 ½g¦^À³
2023.11.17-¤@ºØ·sµo²{ªº¬¡¤Æ UCP1 ªº¤Æ¦Xª«¥i§í¨îªÎ­D¤Î¨ä¬ÛÃö¥NÁ¯¿¶Ãonlinelibrary.wiley.com/doi/10.1002/oby.23948

µ²ªG

§Ú­Ì½T©w¤F¤@ºØ¬¡¤Æ UCP1 ªº­Ô¿ï¤Æ¦Xª«¡C¸Ó¤Æ¦Xª«ªº¨ä¥Lªí¼xªí©ú¡A¥¦¯à»¤¾É¯×ªÕ²Ó­M¤¤ªº²Ó­M²£¼ö¡A¥B²Ó­M¬r©Ê¥i©¿²¤¤£­p¡C¦bÀH«áªº¶¼­¹»¤¾ÉªÎ­D¼Ò«¬¤¤¡A¨Ï¥Î³oºØ¤Æ¦Xª«ªvÀøªº¤p¹«ªí²{¥XÅé­«¼W¥[³t«×¸ûºC¡B¯Ø®q¯À±Ó·P©Ê§ïµ½©M¯à¶q®ø¯Ó¼W¥[¡C¾÷²z¬ã¨sªí©ú¡A¸Ó¤Æ¦Xª«³z¹L´£°ª³Ì¤j©I§l¨Ó¼W¥[²É½uÅé¥Íª«¦X¦¨¡A³o³¡¤À¬O¥Ñ³J¥Õ¿E酶 A (PKA)-p38 µ·µõ­ì¿E¬¡³J¥Õ¿E酶 (MAPK) «H¸¹³q¸ô¤¶¾Éªº¡C...

µ²½×:©ÒŲ©wªº¤Æ¦Xª«¥i§@¬°ªvÀøªÎ­D¤Î¨ä¬ÛÃö¥NÁ¯¿¶Ãªº¼ç¦bªvÀøÃĪ«¡C

------------------------------------------------------------------------------------------------

±N¤é¥»¹Î¶¤ªº¬ã¨s(¤W)

®M¤JÁú°ê¹Î¶¤(¤U)D-¥ÌÅS¾J³z¹L £]3-µÇ¤W¸¢¯À¨üÅé¨Ì¿à©Ê¾÷¨î»¤¾É´Ä¦â¯×ªÕ¼Ëªí«¬

­Ó¤H¦ô­p¤é¥»¹Î¶¤ªº¬ã¨s¤]¬O¥ÌÅS¾J!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/11 ¤U¤È 09:10:30²Ä 3904 ½g¦^À³
¥ÌÅS¾J:³z¹L[½ÅÅÜ]¼W¥[¯à¶q®ø¯Ó¡A­°§C¯×ªÕ®ø¤Æ²v©MÅé¯×ªÕ²Ö¿n!!!

1.2021.1.13--D-¥ÌÅS¾J³z¹L £]3-µÇ¤W¸¢¯À¨üÅé¨Ì¿à©Ê¾÷¨î»¤¾É´Ä¦â¯×ªÕ¼Ëªí«¬

www.mdpi.com/2073-4409/10/4/768

¥ÌÅS¾J»¤¾É¤p¹«¼Ò«¬¤¤¥Õ¦â¯×ªÕ²Ó­M½ÅÅÜ

¦¹¥~¡AD-¥ÌÅS¾JÁÙ¼W¥[¤F­«­n²É½uÅé¼Ð°Oª«ªºªí¹F¡A¨Ò¦p CPT1 ©M UCP1¡C²³©Ò©Pª¾¡ACPT1 ©M UCP1 ·|¼W¥[²É½uÅ鬡©Ê¡A±q¦Ó¼W±j´Ä¦â¯×ªÕ²Ó­M¤¤ªº¯×ªÕ»Ä®ñ¤Æ

2.2009--³o¨Çµ²ªGªí©ú¥ÌÅS¾J¨ã¦³­°§CÅ餺¯×ªÕ¿n²Öªº§@¥Î

www.jstage.jst.go.jp/article/jnsv/55/3/55_3_242/_article/-char/en

---------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤W¤È 11:15:56²Ä 2021 ½g¦^À³

©³¤U1&2ªº½×¤å½T»{CYP2E1 ¯Ê¥F·|¿E¬¡¥Õ¦â¯×ªÕ[½ÅÅÜ]¡C(½ÅÅÜ:¥Õ¦â¯×ªÕ-->½Å¦â¯×ªÕ)

......³Ìªñªº¬ã¨s¶°¤¤¦b½Õ¸`«DŸ§Ý²£¼ö¥HªvÀøªÎ­D¯g...½Õ¸`²£¼ö[¯×ªÕ½ÅÅÜ]¡C³o¶µ¬ã¨sªº¤@­ÓÅå¤Hµo²{¬O CYP2E1 ¯Ê¥F·|¿E¬¡¥Õ¦â¯×ªÕ[½ÅÅÜ]¡A¦ñÀHµÛ®Ö¤ß·Å«×©M¯à¶q®ø¯Óªº¼W¥[

2.2020.10.28 Nature³o½g:www.nature.com/articles/s41586-020-2856-x

...¼Æ¾Úªí©úAldh1a1 / Cyp2e1 +²Ó­Mªí¹F¤@ºØ®Ç¤Àªc¦]¤l¡A¥¦§í¨î´Ä¦â¯×ªÕ²Ó­Mªº²£¼ö¥\¯à¡C

3.´îªÎ·s¤èªk¡I±N¯×ªÕ¡u½ÅÅÜ¡v¥i¼W¿U¯×®Ä²v

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/11 ¤W¤È 06:51:03²Ä 3903 ½g¦^À³
¥ÌÅS¾J§ïµ½Ån©ÊÅÖºû¤Æ¨ä[½T¤Á§@¥Î¾÷Âà©|¤£²M·¡]-->¥ÌÅS¾J¬¡¤ÆmKATP³q¹D???

£]²Ó­M KATP ³q¹Dªº¸²µå¿}½Õ¸`¡G¬O®É­Ô«Ø¥ß·s¼Ò«¬¤F!!!(¿}§¿¯fªvÀø¾÷¨î)

2013.5.17-¯×®ñ¯ÀA₄¤¶¾Éªº[KATP¹[³q¹D¬¡¤Æ]¾É­P[Ån©ÊÅÖºû¤Æ]®ð¹D¤W¥Ö­×´_

journals.physiology.org/doi/full/10.1152/ajplung.00058.2013

----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/17 ¤U¤È 04:33:45²Ä 3829 ½g¦^À³

¤£¬Ý60¦~ªºATP¤å¡C

¬Ý2024.5.17ªº½u¤WµøÀW(5¦ìªÎ­D©M¿}§¿¯f¾ÇªÌ) www.youtube.com/watch?v=Fo0pWsnDgwA

£] ²Ó­M KATP ³q¹Dªº¸²µå¿}½Õ¸`¡G¬O®É­Ô«Ø¥ß·s¼Ò«¬¤F!!!

--------------------------------------------------------------------

·s¼ҫ¬¦³ª§Ä³¡A²`¶ø¤£À´¥¿±`¡C

¸É¥R:¥ÌÅS¾J¬¡¤ÆmKATP³q¹D´£¨Ñ¤ßŦ«OÅ@§@¥Î¡Cwww.mdpi.com/1422-0067/22/5/2395

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/11 ¤W¤È 06:18:18²Ä 3902 ½g¦^À³
¥ÌÅS¾J(§l¤J°ªº¯³zÀ£ÃÄ«~400mg)µ²ºc²³æªº¤p¤À¤l-§ïµ½Ån©ÊÅÖºû¤Æ±wªÌªºªÍ¥\¯à!

1.2005¦~11¤ë7¤é¡A¼Ú·ù©e­û·|±Â¤©·ç¨åStricent AB¥Î©óªvÀøÅn©ÊÅÖºû¤Æªº¥ÌÅS¾Jªº©t¨àÃĺٸ¹¡]EU/3/05/325¡^¡C

¦Û 2012 ¦~ 4 ¤ë 13 ¤é°_¡A¥ÌÅS¾J¦b¼Ú·ù³Q±ÂÅv¬° ¤ä®ðºÞ¾J

¦b 2011 ¦~ 11 ¤ë 8 ¤é¦Ü 9 ¤éªº·|ij¤W¡A©t¨àÃÄ©e­û·|( COMP ) ¼f¬d¤F±N Bronchitol¡]¥ÌÅS¾J¡A¥H«eºÙ¬°¥ÌÅS¿}

¾J¡^§@¬°ªvÀøÅn©ÊÅÖºû¤Æªº©t¨àÃĪº»{©wEU/3/ 05/325 ¡C

www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-05-325

2.2020.5.1-§l¤J¥ÌÅS¾JªvÀøÅn©ÊÅÖºû¤Æ

www.ncbi.nlm.nih.gov/pmc/articles/PMC7195814/

¥ÌÅS¾J¥i¼W¥[ÂH½¤ÅÖ¤ò²M°£²v¡A¦ý¨ä [½T¤Á§@¥Î¾÷Âà©|¤£²M·¡]¡C»P»Ý­n³z¹L¼QÃú¾¹»¼°eªº²{¦³»s¾¯¬Û¤ñ¡A¥ÌÅS¾Jªº°®¯»»s

¾¯¥i¯à§ó¤è«K¥B§ó®e©ö¨Ï¥Î¡C§l¤J°®¯»¥ÌÅS¾JªvÀøÅn©ÊÅÖºû¤Æªº III ´Á¸ÕÅç¤w¸g§¹¦¨¡A²{¤w¦b¿D¬w©M¼Ú¬w¤@¨Ç°ê®a¤W¥«¡C

³o¬O¤§«eµû½×ªº§ó·s¡C

3.2020.11.2-Chiesi «Å¥¬ FDA §å­ã Bronchitol®¡]¥ÌÅS¾J¡^§l¤J¯»¥½

----------------------------------------------------------------------------------------------

µ¥«Ý¤fªA400mg¥ÌÅS¾J+400mg¤T´â½©¿}¦bMASH»P¿}§¿¯f¤j©ñ¥ú©ú!!!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/10 ¤U¤È 07:28:56²Ä 3901 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/2 ¤W¤È 09:36:35²Ä 3870 ½g¦^À³

2024.2.20-­P©Rªº¯×ªÕ¡G¯ØŦ¤º¯×½è¾É­P¯ØŦÀù

¦b©s¼wº¸ÀH¾÷¤Æ©M«e¤©Ê¶¤¦C¬ã¨s¤¤¡A1¯ØŦ¤º¯×ªÕ·|¼W¥[¯ØŦÀùªº­·ÀI¡C³o¬°¯×½è»P¯ØŦÀù¯g¤§¶¡ªº¦]ªGÃö«Y´£¨Ñ¤F¦³»¡ªA¤Oªº¤HÃþÃÒ¾Ú¡A[ÃÒ¹ê¤F¼ï¦·©Ô°²»¡ªº¹w´ú]¡C

---------------------------------------------------------------------------------------------------

¯ØŦ­P©Rªº¯×ªÕ--2«¬¿}§¿¯f»P¡uÀù¤ý¡v¯ØŦÀù

[©s¼wº¸ÀH¾÷¤Æ]³Q»{¬°Ãþ¦ü©ó¡u¦ÛµMªºÀH¾÷¹ï·Ó¸ÕÅç¡v---¦]ªGÃö«Y¬OÅKÃÒ¦p¤sµL¥iÅG»é!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/10 ¤U¤È 07:08:30²Ä 3900 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/10 ¤U¤È 04:31:01²Ä 3898 ½g¦^À³

³z¹L´î¤Ö¯ØŦ¯×ªÕ°fÂà²Ä 2 «¬¿}§¿¯f(¬ã¨s¤H­ûªí©ú¡A³z¹L´îªÎ´î¤Ö¤£¨ì¤@§Jªº¯×ªÕ¥i¥H°fÂà¿}§¿¯f)

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/17 ¤U¤È 05:02:07²Ä 3830 ½g¦^À³

¥ÌÅS¾J+¤T´â½©¿}ªº¾÷¨î???

2024 ¦~ Rolf Luft ¼ú

-------------------------------------------------------------------------------------------------

SNP-6§¹³Æ2¦ì¿}§¿¯fÅv«Â»¡ªº°fÂà¾÷¨î!!!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/10 ¤U¤È 06:54:00²Ä 3899 ½g¦^À³
Professor roy taylor¬O¯Ã¥d´µº¸¤j¾ÇÂå¾Ç©M¥NÁ¾ǺaÅA±Ð±Â ¡A¤]¬O­^°ê¿}§¿¯f°òª÷·|¸ê§Uªº¬ã¨s­û¡C

¦]¨ä¹ï¿}§¿¯f¬ã¨sªº°^Äm¦ÓºaÀòMBE

2023.1.6- www.diabetes.org.uk/about-us/news-and-views/professor-roy-taylor-awarded-mbe-services-diabetes-research

--------------------------------------------------------------------------------------------------

¤@³õ½w¸Ñ­²©R

®õ°Ç±Ð±Â«á¨Óªº¬ã¨s¶i¤@¨B´¦¥Ü¤F 2 «¬¿}§¿¯f¬O¦p¦óµo®iªº¡A¥H¤Î¦p¦óÅý¯ØŦ¦A¦¸¤u§@¥H¨Ï²Ä 2 «¬¿}§¿¯f½w¸Ñ¡C

¦Û 2008 ¦~¥H¨Ó¡A§Ú­Ì¤@ª½¤ä«ù®õ°Ç±Ð±Âªº¶}³Ð©Ê½w¸Ñ¬ã¨s¡C¦ý®õ°Ç±Ð±Âªºµo²{§ï¼g¤F²Ä 2 «¬¿}§¿¯fªº¬G¨Æ¡C

¨ì 2011 ¦~¡A¥Lªº¬ã¨sµ²ªGªí©ú¡A¤@¨Ç 2 «¬¿}§¿¯f±wªÌ¥i¥H³z¹L§C¼ö¶q¶¼­¹Åé­«ºÞ²z­pµe´î»´Åé­«¡A±q¦ÓÀò±o½w¸Ñ¡C¥L¶}µo¤F³Ð·sªº¬ã¨s§Þ³N¡A³o·N¨ýµÛ§Ú­Ì¥i¥H©çÄá¨xŦ©M¯ØŦµ¥¾¹©x¤º³¡©M©P³òªº¯×ªÕ¤ô¥­¹Ï¹³¡C

¥Lªº¥@¬É­º³Ðµ²ªGªí©ú¡A´î¤Ö¨xŦ©M¯ØŦ¤º¦h¾lªº¯×ªÕ¬O½w¸Ñ¯f±¡ªºÃöÁä¡C

¥Lªº¥@¬É­º³Ðµ²ªGªí©ú¡A´î¤Ö¨xŦ©M¯ØŦ¤º¦h¾lªº¯×ªÕ¬O½w¸Ñ¯f±¡ªºÃöÁä¡C

¥Lªº¥@¬É­º³Ðµ²ªGªí©ú¡A´î¤Ö¨xŦ©M¯ØŦ¤º¦h¾lªº¯×ªÕ¬O½w¸Ñ¯f±¡ªºÃöÁä¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/10 ¤U¤È 04:31:01²Ä 3898 ½g¦^À³
www.sinewpharma.com/Upload/download/20240606-video.MP4

40¤À:¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ

-----------------------------------------------------------------------------------------

³z¹L´î¤Ö¯ØŦ¯×ªÕ°fÂà²Ä 2 «¬¿}§¿¯f(¬ã¨s¤H­ûªí©ú¡A³z¹L´îªÎ´î¤Ö¤£¨ì¤@§Jªº¯×ªÕ¥i¥H°fÂà¿}§¿¯f)

www.ncl.ac.uk/press/articles/archive/2015/12/pancreasstudy/

¥@¬É¿}§¿¯f¤j·|¤Wµoªí¡C¬ã¨s­û®õ°Ç±Ð±Â(Professor Roy Taylor)¦b¤j·|¤W»¡¡G¡u²Ä¤G«¬¿}§¿¯f±wªÌ´î­«¤§«á¡A¥i¥H´î¤Ö¯ØŦªº¦h¾l¯×ªÕ¡A«P¨Ï¯ØŦ¥\¯à«ì´_¥¿±`¡C¦]¦¹¡A¦pªG§A°Ý§Ú¡A¯f¤H»Ý­n´î¤Ö´X¤½¤ç¤~¯à§ïµ½¿}§¿¯f¡Aµª®×´N¬O1¤½§J¡C¤£¹L¡A³o1¤½§J¥²¶·¬O¨Ó¦Û¯ØŦªº¯×ªÕ¡C¡v

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/10 ¤U¤È 04:21:46²Ä 3897 ½g¦^À³
SNP-610­°§C29.5 U/L(³o¬O¤HÅéÁ{§É¼Æ¾Ú¡A¤£¬O°Êª«¹êÅç¼Æ¾Ú!)

Type 2 diabetes or pre-diabetes

Present, n=18 Not present, n=17

-----------------------------------------------------------------------------------------

§@ªÌ±o¥Xµ²½×¡A¨xŦ¯×ªÕ°ï¿n¥i¯à¬OÂà¤Æ¬°¿}§¿¯fªºÄ²µo¨Æ¥ó¡C¬°¤F¤ä«ù«á¤@ºØ¥i¯à©Ê¡A¤w¸gµo²{[ALT¤É°ª]¬Oµo¥Í 2 «¬¿}§¿¯fªº¦­´Á¦MÀI¦]¯À¡A»PªÎ­D¡BÅé¯×ªÕ¤À§G¡B¦å¿}¡B¦å¯×¡BAST¡BÁx¬õ¯À¿@«×©M®a±Ú¥vµLÃö....

-----------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/18 ¤U¤È 11:23:36²Ä 3841 ½g¦^À³

www.sinewpharma.com/Upload/202312/news_2023122509345208.pdf

Type 2 diabetes or pre-diabetes

Present, n=18 Not present, n=17

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/10 ¤U¤È 04:12:14²Ä 3896 ½g¦^À³
2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

[oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f???

2«¬¿}§¿¯f©MNAFLD ±wªÌªº[ALT¤U­°]»P [¨xŦ¯×ªÕ´î¤Ö] ¦³Ãö....(SNP-610­°§C29.5 U/L)

2«¬¿}§¿¯f©MNAFLD ±wªÌªº[ALT¤U­°]»P [¨xŦ¯×ªÕ´î¤Ö] ¦³Ãö....(SNP-610­°§C29.5 U/L)

2«¬¿}§¿¯f©MNAFLD ±wªÌªº[ALT¤U­°]»P [¨xŦ¯×ªÕ´î¤Ö] ¦³Ãö....(SNP-610­°§C29.5 U/L)

-----------------------------------------------------------------------------------------------

1. 2024.5.17-[2«¬¿}§¿¯fªºªvÀø¼Ò¦¡¬O®É­ÔÂàÅܤF]

www.mdpi.com/1422-0067/25/10/5488#B55-ijms-25-05488

....³oªí©ú²Ä2«¬¿}§¿¯f¡]¥D­n¡^¬O¥Ñ¨xŦ©M¯ØŦ¤º¹L¦hªº¯×ªÕ¤Þ°_ªº¡C

....¦]¦¹¡A¦­´Á¹w¨¾/´î¤Ö[¨xŦ]©M[¯ØŦ]²§¦ì¯×ªÕ°ï¿n¥i¯à¦¨¬°²Ä¤G«¬¿}§¿¯fºÞ²zªº¥D­nªvÀø¥Ø¼Ð¡C

2.2008.8.26- 2«¬¿}§¿¯fªºµo¯f¾÷Âà¡G°lÂܱqªv¡¨ì¯f¦]ªº¤Ï¦V¸ô®|

link.springer.com/article/10.1007/s00125-008-1116-7

¨xŦ©M¯Ø®q¤¤ªº[²§¦ì¯×ªÕ¨I¿n]¬O¨xŦ¯Ø®q¯À§Ü©Ê©M [£]²Ó­M¥\¯à»Ùê]¬ÛÃö°ÊºA¯Ê³´ªº°ò¦¡C³o¨Ç¯Ê³´¦b§C¯à¶qÁý¾i±ø¥ó¤U¯à°÷ÅãµÛ°fÂà¡A¦b¦­´Á¿}§¿¯f¤¤§¹¥þ°fÂà¡A

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2023/11/23 ¤U¤È 09:34:59²Ä 3543 ½g¦^À³

ALT ­°§C¶W¹L 17 U/L ¤w³QÃÒ©ú»P NASH ±wªÌªº²Õ´¾Ç¤ÏÀ³¬ÛÃö(ÅÖºû¤Æ§ïµ½)!-->SNP-610­°§C29.5 U/L.

www.ncbi.nlm.nih.gov/pmc/articles/PMC6617813/

¶ø¨©Áx»Ä( InterceptªºOCA)¡B elafibranor©M§Q©Ô¾|肽(¿Õ©M¿Õ¼w)ªº¬ã¨s¤wÃÒ©ú¡A¦bNASHªvÀø¬ÛÃö²Õ´¾Ç§ïµ½©Î®ø°hªº±wªÌ¤¤¡AALT ·|¤U­°¡A¦Ó¥B2«¬¿}§¿¯f©MNAFLD ±wªÌªºALT ¤U­°»P¨xŦ¯×ªÕ´î¤Ö¦³Ãö....

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/10 ¤W¤È 10:08:25²Ä 3895 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2022/9/1 ¤U¤È 08:52:35²Ä 2370 ½g¦^À³

SNP-810µLµÇ¬r©Ê³o­ÓÀuÂI¡A¹ï©ó·m§ðNSAIDs¡]«DÃþ©T¾J®øª¢¤îµhÃÄ¡^ªº¥«³õ¥÷ÃB¤j¦³§U¤O!

¤îµhÃį}ÃaµÇŦ«OÅ@¾÷¨î!!!

www.commonhealth.com.tw/article/74087

½Ð·V¥Î¤îµhÃÄ¡IµÇŦ¬ì¦WÂå¨Iµh§i¥Õ

------------------------------------------------------------------------------------------------

2024.7.2-¼³¼ö®§µh¹L¶q¾É­P«æ©Ê[µÇ] ·l¶Ë¦ý[µL¨x¬r©Ê]¡G¯f¨Ò³ø§i

intjem.biomedcentral.com/articles/10.1186/s12245-024-00662-w

µ²½×

Á`¤§¡A¼³¼ö®§µh [µÇ¬r©Ê] ¦Ó [¤£¨x¬r©Ê]¨Ã¤£¨u¨£¡A¥BÀ³ºÊ´ú±wªÌ¶W¹L 48 ¦Ü 72 ¤p®É¡C¾¨ºÞ NAC ¦b¨x¬r©Ê¤è­±ªº§@¥Î²³©Ò©Pª¾¡A¦ý¨ä¦b¹w¨¾µÇ¬r©Ê¤è­±ªº§@¥Î©|¥¼±o¨ìÃÒ¹ê¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/9 ¤U¤È 06:42:02²Ä 3894 ½g¦^À³
www.sinewpharma.com/Upload/download/20240606-video.MP4

40¤À:¤îµhÃÄ(«D³B¤èÃÄ)µ¦²¤©Ê¼Ú¬ü¤À¶}±ÂÅv

--------------------------------------------------------------------------

¬°¦ó¤À¶}±ÂÅv?

¥i¯à»P³o¦³Ãö«Y:2023.7.28www.gao.gov/assets/gao-23-106570.pdf ¬ü°êFDA[«D³B¤èÃÄ]¤¤±Æ¥L©Ê±ø´Ú(¥«³õ¿W¦ûÅv)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/9 ¤U¤È 06:11:11²Ä 3893 ½g¦^À³
1¦~5­¿ªÌ¦p¹L¦¿¤§ÃV¡A5¦~1­¿ªÌ«o¹é­Y¨°¬P!

2024.6.21-½ä¿ùÃä¡I¥x¿n¹q¡u¹H¬ù¥æ³Î2892¸U¡v¡@ºÃ¤Ö¦~ªÑ¯«¤@¤i½ß¥ú

-------------------------------------------------------------------------------

¦~»´¤H²×¨s¬O¦~»´¤H¡A¤Ó½Ä°Ê¤F¡CªÅ¤û®ð¨R¤Ñªº¥xG?

¤£¹L¦~»´¤]¬O¥»¿ú¡A¯d±o«C¤s¦b¤£©È¨S®ã¿N¡A§O§Ñ±Ð°V´N¦n~

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/9 ¤U¤È 05:34:31²Ä 3892 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/5/14 ¤W¤È 08:39:02²Ä 26 ½g¦^À³

....º¡¤j¾÷²v´N¯à¤W¨ì³Ì³»¼h ¡A¦]¦¹(§Ú)Ä~Äò«ù¦³...

--------------------------------------------------------------------------------

...·ç»È¶°¤½¥¬ªº¾ÚÅã¥Ü¡A²b¸ê²£¦b300¸U¨ì3000¸U·s¥x¹ôªº¡u·Ç´I¸Î¼h960¸U¤H¡v¡A¥e¥þ¥x¤H¤f45%¡A±Nªñ¤@¥b...

-------------------------------------------------------------------------------------------------

­Ó¤Hµ²½×:­P´I¤§¹D¡A§Ö´N¬OºC¡AºC´N¬O§Ö¡C(«ùªÑ>12¦~)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/9 ¤U¤È 05:19:47²Ä 3891 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤U¤È 04:48:09²Ä 1550 ½g¦^À³

...¼B³Ó«iµªÂЪí¥Ü....P­È¥Ø«eÁÙ¥¼®³¨ì....©Ò¥HµLªk¤½¥¬¡C

¬O¯uª÷´N¤£©È¤õ·Ò¡A¤p´²¤á¤j©È¬Æ? ©ú¤Ñíöt£x.

------------------------------------------------------------------------------------------------

§Ú¬J¬ÝªÅ´N¤£°µ¦h¤]¤£°µªÅ¡A°O¤£²M¬O¨º¦~¼o¤F¿Ä¸ê¨é¸ê®æ¡C

­P´I¤§¹D¡A§Ö´N¬OºC¡AºC´N¬O§Ö¡A[°í«ù¦Û§Ú§PÂ_]¡A±E±x¦Û¤vªº§ë¸ê¸`«µ!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/9 ¤U¤È 05:06:23²Ä 3890 ½g¦^À³
¡§1¦~5­¿ªÌ¦p¹L¦¿¤§ÃV¡B5¦~1­¿ªÌ«o¹é­Y¨°¬P¡¨(®©¤£¥X? ¦^·Q¤@¤U°ê¹©¿ÄÂ_¤W300.....)

­P´I¤§¹D¡A§Ö´N¬OºC¡AºC´N¬O§Ö¡AµLÄߪi°Ê¡A[°í«ù¦Û§Ú§PÂ_]

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/13 ¤U¤È 05:27:50²Ä 3807 ½g¦^À³

¦p¦ó°í¦u¤º¤ßªº¡§§ë¸ê¸`«µ¡¨¡H

ªÑ»ù¤Wº¦®É¿³¾Ä¡A§Ô¤£¦í·Q­n¥[­Ü¡F¤U¶^®É¤S¼~¼{¡A§Ô¤£¦í¤S»°ºò³Î¦×¡A¸¨³U爲¦w¡A©ó¬O¤@º¦´N¶R¡A¤@¶^´N½æªº¦æ爲µL­­´`Àô!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/7/9 ¤U¤È 04:19:59²Ä 3889 ½g¦^À³
ª½±µ¶}©ñªÑªFÁʶR¸Õ¥Î~~¯Â¯Âªº¤HÅé¸ÕÅç

¬Ý¬O¤£¬O¦p­Jp»¡ªº³o¦n¡A¶R¤F©ñµÛ¤~¦³«H¤ß

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/7/9 ¤W¤È 08:46:01²Ä 3888 ½g¦^À³
º©º©ªø¸ô¤¤¡A¬O©Ô¦^ÁÙ¬O³Ì«á¤W¨®¾÷·|?

Â಴Q3­n¨ì¤F¡A³oÀɯu¬O¿\¥ÉÁÙ¬O¥ÛÀY?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/6 ¤U¤È 11:35:41²Ä 3887 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2021/2/5 ¤W¤È 06:41:22²Ä 694 ½g¦^À³

¥H²{¦bÃĪ«¤W¥«¼f¬d­ì«h¡AAPAP¬O¤£¥i¯à¦b¬ü°ê»P­^°ê¤W¥«¡C

SNP-810µL¨x¬r·s¾¯«¬·sÃÄ¥¿¬O³Ð·s¦w¥þ§ï­²¡A¯àÀò±o¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï­²ªk®×¡n¤°»ò¿EÀy¹ªÀy???????

2020¦~3¤ë27¤é¤t´¶Ã±¸pªº¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï­²ªk®×¡n´N¬O­n¸Ñ¨M³oÃþÃĪ«ªº°ÝÃD¡C

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/1/4 ¤U¤È 05:35:26²Ä 461 ½g¦^À³

1972¦~FDA¥l¶°¤F¤@²ÕÂå¥Í©M¬ì¾Ç®a¨Óµû¦ô¤îµhÃÄ(¥]¬A¹ï¤A酰®ò°ò×ô)..µ²ªGªá¤F48¦~©|¥¼¸Ñ¨M¨x¬r©Ê¡C Orz.

1. 2012¦~1¤ë24¤é

---FDA¤µ¤Ñ¤£·|§å...¹ï¤A酰®ò°ò×ô(APAP)¤]¬O¤@¼Ë¤£·|§å­ã¡]¦b¬ü°ê¡A¹L¶q¨Ï¥Î¬O¾É­P¨x°IºÜªº¥D­n­ì¦]¡^

Analgesics have a spotty history of switching to OTC. According to common wisdom, the FDA would not approve aspirin today much less allow it to go OTC. The same could be said for acetaminophen (overdose of which is the leading cause of liver failure in the US)

---------------------------------------------------------------------------------------------

¥H²{¦bFDAÃĪ«©Ê¨x·l¶Ë¤W¥««eÁ{§É«ü«n¡AAPAP¹L¤£¤F¨x¬r©ÊªùÂe!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/6 ¤U¤È 09:51:18²Ä 3886 ½g¦^À³
·sÃĶ}µoªº®Ú¥»:¨ä¥Hªk¥O¨î«×¬°¸g¡B¹êÃÒ¬ì¾Ç(Á{§É¸ÕÅç)¬°½n¡AÁa¾î¥æ´¦¨¬ì§Þ»Pªk«ß¥æ¬yªºÀ³¥Î¬ì¾Ç¡C

ÃĪ«¨x·l¶Ë«ü«n¤@Åé¾A¥Î!

FDAÃĪ«©Ê¨x·l¶Ë¤W¥««eÁ{§Éµû¦ô¦æ·~«ü«n

www.fda.gov/media/116737/download

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/4 ¤W¤È 07:26:47²Ä 3875 ½g¦^À³

1.2024.4.15-¥[¤J £] ²Ó­M¨ë¿EªvÀø[²Ä1«¬]¿}§¿¯fªº¸ÕÅç

¤@¶µ¸ÕÅ祿¦b©Û¶Ò±w¦³²Ä 1 «¬¿}§¿¯fªº¦¨¦~¤H¨Ó¬ã¨s BMF-219¡A³o¬O¤@

2.2024.6.7-FDA ¹ï Biomea Fusion ªº BMF-219 ¿}§¿¯f¸ÕÅç¶i¦æ¥þ­±Á{§ÉÀÁ¸m

¸Ó¨M©w¬O°ò©ó COVALENT-111 ¸ÕÅ礤µo²{ªº¼ç¦bÃĪ«¤Þ°_ªº[¨x¬r©Ê]¤ô¥­¡C

----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/1 ¤U¤È 01:00:55²Ä 3748 ½g¦^À³

µL¨x¬rSNP-810(12g) VS. ¦³¨x¬rAPAP(4g)ªº[¾î¦V¤ñ¸û]:

4.FDA Drug Hepatotoxicity Steering Committee:

.....(ALT) ≥3 times the upper limit of normal (ULN) and ALT/alkaline phosphatase (ALP) ratio ≥5 times ULN; cholestatic DILI by an ALP ≥2 times ULN and ALT/ALP ratio of ≤2 times ULN; and mixed DILI with ALT ≥3 times ULN, ALP ≥2 times ULN and ALT/ALP ratio <5 but >2 times ULN

¨x·l®`¤@¯ë©w¸q«üALT¶W¹L¥¿±`數­È¤W­­ªº3­¿¥H¤W¡A§Y¶W¹L>3­¿³q±`³Q»{¬°¨ã¦³Á{§É·N¸q¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/5 ¤U¤È 06:40:25²Ä 3885 ½g¦^À³
1.[T1R3©MCaSR]¿}±Ó·P¨üÅé¦b¯ØŦ £] ²Ó­Mªº²Ó­Mªí­±ªí¹F-->¤T´â½©¿}¬OT1R3¿E¬¡¾¯--¥i¯à«P¶i¯Ø¸¢£]²Ó­Mªº·s³¯¥NÁ¡C

2.¤T´â½©¿}[§í¨îCD4+ CD8+ T ²Ó­M¼W´Þ]

­ì¥»§ë¸êªYÄ£ªºÃöª`ÂI¡AÀ£®Ú¨S¬ÝªvÀø¿}§¿¯f³o¶ô¡A¤µ¤Ñ¯u¬O¡m¬ü¦nªº·N¥~¡n¡C

--------------------------------------------------------------------------------------------------

2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

[oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f???

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/5 ¤U¤È 05:46:20²Ä 3884 ½g¦^À³
­^°ê¦P¦æ¥h¦~µoªíªº[¤T´â½©¿}]¾÷¨îÀ°¤FªYÄ£¤j¦£!!!

°ª¿@«×ªº¤T´â½©¿}¥i¯à¾É­PPLC-£^1»P(¬¡¤Æªº¡^T²Ó­M¨üÅ骺ªÅ¶¡¶ZÂ÷§ó¤j¡A±q¦Ó¤¤Â_°T¸¹¶Ç¿é¡A[§í¨îCD4+ CD8+ T ²Ó­M¼W´Þ]

2017.8.1-[1«¬¿}§¿¯f]¤¤ªº¦Û¨­¤ÏÀ³©Ê T ²Ó­M www.jci.org/articles/view/94549

§Ú­Ì¹ï¤HÃþT1Dªº²z¸Ñ¤¤¡A[£]²Ó­M]ªº¯}Ãa¥D­n¬O¥Ñ§K¬Ì¤ÏÀ³ªº¾AÀ³©ÊÁuªº[CD4 +©MCD8 + T²Ó­M] ÅX°Êªº§K¬Ì§ðÀ»¤Þ°_ªº

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/24 ¤U¤È 06:33:18²Ä 3850 ½g¦^À³

¦A¬Ý¤@¦¸¥h¦~ªº[1«¬¿}§¿¯f]ªº¹Ú¦³¦h¤j!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/5 ¤W¤È 08:29:16²Ä 3883 ½g¦^À³
www.sinewpharma.com/Upload/download/20240606-video.MP4

40¤À:¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ

µ²½×:±q¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ¡A8¦¨´N¬O¦³ÅãµÛ¼Æ¾Ú¬°¨Ì¾Ú!

----------------------------------------------------------------------------------------------

2011.6.9--2«¬¿}§¿¯fªº°fÂà¡G£] ²Ó­M¥\¯à¥¿±`¤Æ»P¯ØŦ©M¨xŦ¤T»Ä¥Ìªoà­´î¤Ö¦³Ãö

link.springer.com/article/10.1007/s00125-011-2204-7

¥Ø«eªº¼Æ¾Ú´£¨Ñ¤F©ú½TªºÃÒ¾Ú¡A

Åã¥Ü¯ØŦÁ`¯×ªÕªº´î¤Ö»P[£]²Ó­M¥\¯àªº«ì´_]¦³Ãö¡C

Åã¥Ü¯ØŦÁ`¯×ªÕªº´î¤Ö»P[£]²Ó­M¥\¯àªº«ì´_]¦³Ãö¡C

Åã¥Ü¯ØŦÁ`¯×ªÕªº´î¤Ö»P[£]²Ó­M¥\¯àªº«ì´_]¦³Ãö¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/5 ¤W¤È 07:59:17²Ä 3882 ½g¦^À³
¹ê²{¯u¥¿ªº¿}§¿¯f[ªv¡]¨ú¨M©ó«ì´_¥\¯à©Ê£]²Ó­M½è¶q!!!

¦Ó­«¤¤¤§­«©Î³\¦bT1R3 ¯Ê¥¢-->[Âù¬Û]¯Ø®q¯À¤Àªc¨ü¨ìÅãµÛ§í¨î!!!

------------------------------------------------------------------------------------

2024.1.26--¥\¯à²§½è©Ê£]²Ó­M½Õ¸` [Âù¬Û] [Âù¬Û] [Âù¬Û]¯Ø®q¯À¤Àªc

www.nature.com/articles/s42255-023-00964-y

...§Ú­Ì¶i¤@¨Bªí©ú¡ARR£]s ªº¥\¯à»Ùê¦b¿}§¿¯fªº¶i®i¤¤°_µÛ¦ÜÃö­«­nªº§@¥Î¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/5 ¤W¤È 07:21:51²Ä 3881 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/4 ¤U¤È 09:31:10²Ä 3878 ½g¦^À³

2017.9.17-[¸²µå¿}±Ó·P¨üÅé] ¦b¯Ø®q¯À¤Àªc¤¤ªº§@¥Î

µL½×¦p¦ó

T1R3 ªºªí¹F¦bªÎ­D©M¿}§¿¯f¤¤[­°§C]¡C½T©w¦b¤HÃþªÎ­D©Î¿}§¿¯f¤¤¬O§_Æ[¹î¨ìÃþ¦üªºªí¹FÅܤƱN¬O«Ü¦³½ìªº¡C

---------------------------------------------------------------------------------------------

2005.3.1-«C¤Ö¦~²Ä 2 «¬¿}§¿¯f¡G¯Ø®q¯À§Ü©Ê¡B£] ²Ó­M°IºÜ¡A©Î¨âªÌ­Ý¨ã¡H

diabetesjournals.org/care/article/28/3/638/27718/Youth-Type-2-DiabetesInsulin-resistance-cell

µ²½×

³o¬O²Ä¤@¶µ°w¹ï«C¤Ö¦~ªº¬ã¨s¡AÅã¥Ü»P¬Û¤Ç°tªºªÎ­D¹ï·Ó¨ü¸ÕªÌ¬Û¤ñ¡A±w¦³²Ä 2 «¬¿}§¿¯fªº«C¤Ö¦~ªº¯Ø®q¯À±Ó·P©Ê©M¯Ø®q¯À¤Àªc§¡¨ü·l...¦ý¥O¤H¤£¦wªºÆ[¹îµ²ªG¬O¦b«Ü¤pªº®É­Ô¯Ø®q¯À¤Àªc´NÄY­«¨ü·l¡]FPIS ­°§C¬ù75%¡FSPIS ­°§C¬ù50 %¡^¿}§¿¯f¯fµ{¬Û¹ï¸ûµu¡C³o¨Çµo²{ªº·N¸q¥i¯à¬O¦­´Á»Ý­n¯Ø®q¯À´À¥NÀøªk¨Óºû«ù¦å¿}±±¨î¡C

­Ó¤Hµ²½×:2005¦~¡]FPIS ­°§C¬ù75%¡FSPIS ­°§C¬ù50 %¡^?µª®×À³¸Ó¬O2017¦~£]²Ó­MªºT1R3¯Ê¥¢(FPIS»PSPIS³£¨ü¨ìÅãµÛ§í¨î!!!)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/5 ¤W¤È 06:21:39²Ä 3880 ½g¦^À³
£]²Ó­M·s¥Í¡G¬@±Ï¿}§¿¯fªº[«á°_¤§¨q]<---->SNP-6(¥ÌÅS¾J+¤T´â½©¿})ªºÃIJz¾÷¨î©Î³\¯uªº¤@À»§Y¤¤!?

¦A¬Ý¤@¦¸¦P¦æªº(¤T´â½©¿}T1R3¿E¬¡¾¯)¬ã¨s:

1.2024.5.21-¤G¤Q¦~¬ã¨s¡G²¢¨ý¨üÊ^¼v响¤HÊ^¥N谢¸²µå¿}ªº¤è¦¡

¥L们发现¡A将TAS1R2-TAS1R3¿E动剂(¤T´â½©¿})

2.Nature¥D¥Z¿¯­¹²¢¨ý¾¯[¤T´â½©¿}]¬O T ²Ó­M¤¶¾É¤ÏÀ³ªº­t½Õ¸`¾¯

3.2.¤T´â½©¿}³Q½T©w¬°¯Ø¸¢£]²Ó­M©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯

www.e-enm.org/journal/view.php?doi=10.3803/EnM.2014.29.1.12

4..........

5..........

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/5 ¤W¤È 06:08:02²Ä 3879 ½g¦^À³
SNP-6(¥ÌÅS¾J+¤T´â½©¿})ªºÃIJz¾÷¨î©Î³\¯uªº¤@À»§Y¤¤!?

§ó­«­nªº¬O¡A¦b [T1R3¯Ê¥¢] [T1R3¯Ê¥¢] [T1R3¯Ê¥¢]ªº¯Ø®q¤¤¡A

¯Ø®q¯À¤Àªcªº¨â­Ó¶¥¬q: ²Ä¤@¬Û¯Ø®q¯ÀÄÀ©ñ(FPIS)»P²Ä¤G¬Û¯Ø®q¯ÀÄÀ©ñ(SPIS)³£¨ü¨ì[ÅãµÛ§í¨î]!!!

³Ì¨Î¦å¿}±±¨î»Ý­n²Ä¤@¬Û©M²Ä¤G¬Û¯Ø®q¯ÀÄÀ©ñ¡C

³Ì¨Î¦å¿}±±¨î»Ý­n²Ä¤@¬Û©M²Ä¤G¬Û¯Ø®q¯ÀÄÀ©ñ¡C

³Ì¨Î¦å¿}±±¨î»Ý­n²Ä¤@¬Û©M²Ä¤G¬Û¯Ø®q¯ÀÄÀ©ñ¡C

FPISÄÀ©ñ¹ï©ó¹ï§Ü¤É¿}¯À¹ï¸²µå¿}²£¥Íªº [§Ö³t] ¼vÅT«Ü­«­n¡A¦ÓSPISÄÀ©ñ¹ï©ó [ºû«ù] ³oºØ§í¨î¨Ã¼W¥[¸²µå¿}§Q¥Î²v«Ü

­«­n¡C¯Ê¥FFPISÄÀ©ñ·|¾É­Pµu¼È¡]2¤p®É¡^©M¤¤«×¡]20-30 mg/dl¡^¦å¿}¯Ê³´¡A¦Ó¯Ê¥FSPISÄÀ©ñ·|¾É­Pªø´Á¥B¼@¯P¡]70-100

mg/dl¡^¦å¿}¯Ê³´¡C

------------------------------------------------------------------------------------------------

1.2024.1.26--¥\¯à²§½è©Ê£]²Ó­M½Õ¸` [Âù¬Û] [Âù¬Û] [Âù¬Û]¯Ø®q¯À¤Àªc

www.nature.com/articles/s42255-023-00964-y

µo²{©ö©óÄÀ©ñªº £] ²Ó­M¡]RR£]¡^¬O¹ïÂù¬Û¸²µå¿}¨ë¿Eªº¯Ø®q¯À¤Àªc¦³¤£¦¨¤ñ¨Ò°^Ämªº¨È¸s¡C§Ú­Ì¶i¤@¨Bªí©ú¡ARR£]s ªº¥\¯à»Ùê¦b¿}§¿¯fªº¶i®i¤¤°_µÛ¦ÜÃö­«­nªº§@¥Î¡C

2.2023.2.27-²Ä¤@¬Û¯Ø®q¯À¤Àªc¡G¨äµû¦ô¯à§_«ü¾ÉªvÀø¤èªk¡H

www.sciencedirect.com/science/article/pii/S1043276023000309

...§Ú­Ì®i¥Ü¤F²Ä¤@¬Û¯Ø®q¯À¤Àªc»P¸²µå¿}íºAªº¬ÛÃö©Ê¡A¨Ã¤ÀªR¤F¨ä´î¤Ö¹ïÁ{§Éªí²{¡]¯S§O¬OÀ\«á°ª¦å¿}¡^©M¯e¯fµ²ªGªº

¼vÅT¡C¦b³oºØ±¡ªp¤U¡A«ì´_ £] ²Ó­M¥\¯à¥i¯à·|¦¨¬°¹w¨¾©MªvÀø¿}§¿¯fªº¹CÀ¸³W«h§ïÅܪÌ

¦b³oºØ±¡ªp¤U¡A«ì´_ £] ²Ó­M¥\¯à¥i¯à·|¦¨¬°¹w¨¾©MªvÀø¿}§¿¯fªº¹CÀ¸³W«h§ïÅܪÌ

¦b³oºØ±¡ªp¤U¡A«ì´_ £] ²Ó­M¥\¯à¥i¯à·|¦¨¬°¹w¨¾©MªvÀø¿}§¿¯fªº¹CÀ¸³W«h§ïÅܪ̡A

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/4 ¤U¤È 09:31:10²Ä 3878 ½g¦^À³
2017.9.17-[¸²µå¿}±Ó·P¨üÅé] ¦b¯Ø®q¯À¤Àªc¤¤ªº§@¥Î

dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.13013

³o¨Çµ²ªGªí©ú[T1R3©MCaSR]ªº²§¤G»EÅé¬O [¸²µå¿}±Ó·P¨üÅé]ªº¥D­n¦¨¤À¡C

...

·í´ú¶q±q T1R3 ºV°£¤p¹«Àò±oªº¯Ø®q¤¤ªº¯Ø®q¯À¤Àªc®É¡A»P¥¿±`¤p¹«ªº¯Ø®q¬Û¤ñ¡A¸²µå¿}»¤¾Éªº¯Ø®q¯À¤Àªc³Q§í¨î¬ù 40%¡C§ó­«­nªº¬O¡A¦bT1R3¯Ê¥¢ªº¯Ø®q¤¤¡A¯Ø®q¯À¤Àªcªº²Ä¤@¶¥¬q©M²Ä¤G¶¥¬q³£¨ü¨ìÅãµÛ§í¨î

..µL½×¦p¦ó

T1R3 ªºªí¹F¦bªÎ­D©M¿}§¿¯f¤¤[­°§C]¡C½T©w¦b¤HÃþªÎ­D©Î¿}§¿¯f¤¤¬O§_Æ[¹î¨ìÃþ¦üªºªí¹FÅܤƱN¬O«Ü¦³½ìªº¡C

T1R3 ªºªí¹F¦bªÎ­D©M¿}§¿¯f¤¤[­°§C]¡C½T©w¦b¤HÃþªÎ­D©Î¿}§¿¯f¤¤¬O§_Æ[¹î¨ìÃþ¦üªºªí¹FÅܤƱN¬O«Ü¦³½ìªº¡C

T1R3 ªºªí¹F¦bªÎ­D©M¿}§¿¯f¤¤[­°§C]¡C½T©w¦b¤HÃþªÎ­D©Î¿}§¿¯f¤¤¬O§_Æ[¹î¨ìÃþ¦üªºªí¹FÅܤƱN¬O«Ü¦³½ìªº¡C

-----------------------------------------------------------------------------------------

(¤T´â½©¿}³Q½T©w¬°[¯Ø¸¢£]²Ó­M] ©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯)

2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

À³¸Ó«Ü¦³½ìªº!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/4 ¤U¤È 09:23:01²Ä 3877 ½g¦^À³
SNP-6(¥ÌÅS¾J+¤T´â½©¿})ªºÃIJz¾÷¨î©Î³\¯uªº¤@À»§Y¤¤!?

(¤T´â½©¿}³Q½T©w¬°[¯Ø¸¢£]²Ó­M] ©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯)

1.2024.5.21-¤G¤Q¦~¬ã¨s¡G²¢¨ý¨üÊ^¼v响¤HÊ^¥N谢¸²µå¿}ªº¤è¦¡

m.ebiotrade.com/newsf/2024-5/20240518052435596.htm

¥L们发现¡A将TAS1R2-TAS1R3¿E动剂(¤T´â½©¿}¡A¤@Ïú¹s热¶q²¢¨ý剂)©ÎTAS1R2-TAS1R3«ú§Ü剂(¨Å»Äà­¡A¤@Ïú§í¨î²¢¨ýªº钠盐)ÉO¸²µå¿}²V¦X¡A会¥H¤£¦Pªº¤è¦¡剧¯P§ï变¤HÊ^ªº¸²µå¿}­@¶q¡C

¤@个¤Hªº°·±d状úGÉO¨äTAS1R2-TAS1R3¨üÊ^ªº¬¡©Ê¤§间¬O§_¦s¦b关¨t?该¬ã¨sªº§@ªÌ说¡A¡§¥i¯à¡¨¡A这ªí©ú¨üÊ^¿E¬¡ªºµ{«×对¦å¿}©M¯Ø岛¯À¤ô¥­¤Î¨ä发¯f时间¦³严­«¼v响¡A这对¥N谢°·±d«Ü­«­n¡C

2.2024.5.18-¿}§¿¯f¡A¦Þ¦y¤Wªºªv·U¡C²¢¨ý¨üÊ^¬O关键吗¡H

zh-cn.futuroprossimo.it/2024/05/diabete-la-cura-sulla-punta-della-lingua-la-chiave-e-il-recettore-del-dolce/

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/4 ¤W¤È 09:32:23²Ä 3876 ½g¦^À³
¿}§¿¯f·s[¶t]©À!!!

1.2024.3.20-¿}§¿¯f¤¤±w¯fªº £] ²Ó­M¡G«æ¶E«Ç¤§®Èªº¨£¸Ñ¡G2023 ¦~³Ç¥X¬ì¾Ç¦¨´N¼úÁ¿®y

2.2009¦~-¯ØŦ £] ²Ó­M¤¤ªí¹Fªº²¢¨ý¨üÅé·|¬¡¤Æ¶t©MÀô AMP °T¸¹¨t²Î¨Ã¨ë¿E¯Ø®q¯À¤Àªc

journals.plos.org/plosone/article?id=10.1371/journal.pone.0005106

¤T´â½©¿}¹ï [Ca 2+ ] c©M [cAMP] cªº¼vÅT¡C

-----------------------------------------------------------------------------------

2½g¬ã¨s°Â¦b¤@¶ô¡A·Q¤@¤USNP-6(¥ÌÅS¾J+¤T´â½©¿})ªºÃIJz¾÷¨î???

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/4 ¤W¤È 07:26:47²Ä 3875 ½g¦^À³
1.2024.4.15-¥[¤J £] ²Ó­M¨ë¿EªvÀø[²Ä1«¬]¿}§¿¯fªº¸ÕÅç

¤@¶µ¸ÕÅ祿¦b©Û¶Ò±w¦³²Ä 1 «¬¿}§¿¯fªº¦¨¦~¤H¨Ó¬ã¨s BMF-219¡A³o¬O¤@ºØ¨ë¿E £] ²Ó­M¥Íªøªº·s«¬¤fªAÃĪ«¡C¸ÓÃĪ«¤w¦b

[²Ä2«¬]¿}§¿¯fªvÀø¤¤Åã¥Ü¥X¥i³ßªº®ÄªG¡A¥i§ïµ½½d³ò®É¶¡©M¦å¿}±±¨î¡C

2.2024.6.7-FDA ¹ï Biomea Fusion ªº BMF-219 ¿}§¿¯f¸ÕÅç¶i¦æ¥þ­±Á{§ÉÀÁ¸m

¸Ó¨M©w¬O°ò©ó COVALENT-111 ¸ÕÅ礤µo²{ªº¼ç¦bÃĪ«¤Þ°_ªº[¨x¬r©Ê]¤ô¥­¡C

------------------------------------------------------------------------------------------

¤p¤À¤lÃÄ¥\¯à©Êªv¡1«¬»P2«¬¿}§¿¯fªºÁ{§É¸ÕÅç¡A­º§å2¦W1«¬¿}§¿¯f±wªÌ£]细­M¥\¯à±o¨ì§ïµ½¡A¦³®Ä¦ý¦]¬°[¨x¬r©Ê]À³¸Ó¬O¨SÀ¸¤F!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/4 ¤W¤È 07:10:50²Ä 3874 ½g¦^À³
2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

-------------------------------------------------------------------------------------------------

www.sinewpharma.com/Upload/download/20240606-video.MP4

40¤À:¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ

µ²½×:±q¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ¡A8¦¨´N¬O¦³ÅãµÛ¼Æ¾Ú¬°¨Ì¾Ú!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/4 ¤W¤È 06:57:58²Ä 3873 ½g¦^À³
2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

[oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f???

-----------------------------------------------------------------------------------------------

[oral insulin]¤fªA¯Ø®q¯À--->¿}§¿¯f·s[¶t]©À???

ª`·N¤£¬O²Ó­M»P°Êª«¹êÅç¡A¦Ó¬O¤HÅéÁ{§É¸ÕÅç¼Æ¾Ú!!!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/4 ¤W¤È 06:44:13²Ä 3872 ½g¦^À³
2023.10.13-£]²Ó­M·s¥Í¡G¬@±Ï¿}§¿¯fªº«á°_¤§¨q!!!

www.sciencedirect.com/science/article/pii/S2090123223003120

-----------------------------------------------------------------------------------------

¤T´â½©¿}³Q½T©w¬°[¯Ø¸¢£]²Ó­M] ©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/4 ¤W¤È 06:31:33²Ä 3871 ½g¦^À³
¿}§¿¯f·s[¶t]©À!!!

2024.3.20-¿}§¿¯f¤¤±w¯fªº £] ²Ó­M¡G«æ¶E«Ç¤§®Èªº¨£¸Ñ¡G2023 ¦~³Ç¥X¬ì¾Ç¦¨´N¼úÁ¿®y

diabetesjournals.org/diabetes/article/73/4/545/154111/The-Ailing-Cell-in-Diabetes-Insights-

From-a-Trip

²§±`ªº[£]²Ó­M] [¶t] °T¸¹¶Ç¾É¾É­P T1D µo¯f¾÷¨î.......

¥O¤HÅå³Yªº¬O¡A¶tªº´î¤Ö»PÅãµÛªº¤º½èºôÀ£¤Oªí«¬µLÃö¡A¦Ó¬O¾É­P[¤º½èºô¶t]ªºÅܤơA¾É­P[²É½uÅé¶t]¤ô¥­¤É°ª©M²É½uÅé¥\¯à»Ùê¡A³Ì²×¥[³t¿}§¿¯fªºµo¯f¡C

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/12 ¤U¤È 05:09:10²Ä 3805 ½g¦^À³

2023.7.27-²Ó­M¤º[¶t]°T¸¹¶Ç¾É¡G±`¨£¶ûºÃ¤Hªº·N·Q¤£¨ìªº[·s¨¤¦â]!!!

www.ncbi.nlm.nih.gov/pmc/articles/PMC10413985/

...§ïÅܲӭM¾¹¶¡ Ca 2+³q¶qªº·L§®¥­¿Å¥i¯à¾É­P¦M¤Î¥Í©Rªº¯e¯f¡A¨Ò¦pAD¡BÀù¯g©M·»酶Åé¶J¿n¯g¡A¨Ã¥B¦b¥¼¨Ó¥i¯à·|µo²{§ó¦h¯e¯f...

-------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/2 ¤W¤È 09:22:24²Ä 3751 ½g¦^À³

¥ÌÅS¾J(¶t/Áâ§l¦¬«O¯d)+¤T´â½©¿}(T1R3¿E°Ê¶tÁâ)¡u¤@¥[¤@¤j©ó¤G¡vªº®ÄÀ³!ªºÅܤơC

----------------------------------------------------------------------------------

Nature¥D¥Z(¿¯­¹²¢¨ý¾¯¤T´â½©¿}¬O T ²Ó­M¤¶¾É¤ÏÀ³ªº­t½Õ¸`¾¯--(¤T´â½©¿}´î¤Ö¤FT²Ó­M¤¤TCR¨Ì¿à©Ê¶t³q¶q¡A¦Ó¤£§ïÅܾãÅé²Ó­M¤º¶tÀx¦s)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/2 ¤W¤È 09:36:35²Ä 3870 ½g¦^À³
2024.2.20-­P©Rªº¯×ªÕ¡G¯ØŦ¤º¯×½è¾É­P¯ØŦÀù

www.cell.com/cell-reports-medicine/fulltext/S2666-3791(24)00051-X

¦b©s¼wº¸ÀH¾÷¤Æ©M«e¤©Ê¶¤¦C¬ã¨s¤¤¡A1¯ØŦ¤º¯×ªÕ·|¼W¥[¯ØŦÀùªº­·ÀI¡C³o¬°¯×½è»P¯ØŦÀù¯g¤§¶¡ªº¦]ªGÃö«Y´£¨Ñ¤F¦³»¡ªA¤Oªº¤HÃþÃÒ¾Ú¡A[ÃÒ¹ê¤F¼ï¦·©Ô°²»¡ªº¹w´ú]¡C

[ÃÒ¹ê¤F¼ï¦·©Ô°²»¡ªº¹w´ú]

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/7/2 ¤W¤È 09:22:30²Ä 3869 ½g¦^À³
www.sinewpharma.com/Upload/download/20240606-video.MP4

40¤À:¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ

°ê»Ú3¤j³»¥ZCNS:Cell¡BNature¥H¤ÎScience¡C

¡u¥|¤jÂå¾Ç³»¥Z¡v¡G·s­^®æÄõÂå¾ÇÂø»x(NEJM)¡B¬h¸­¤M(Lancet)¡B¬ü°êÂå¾Ç·|Âø»x(JAMA)¥H¤Î­^°êÂå¾Ç´Á¥Z(BMJ)¡C

1.2023.4.21-¯ØŦªº¯×ªÕÅÜ¡G¯ØŦ¾Çªº¼ï¦·©ÔÅ]²°

www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00064-X/abstract

2.2024.2.7-¤ñ¯×ªÕ¨x§óÄY­«ªº¯×ªÕ¯Ø¡Iwww.edh.tw/article/25090

¯×ªÕ¯Ø¬OÃöÁ䨤¦â

¯Ø®q¯À¬O¥Ñ¯Ø¸¢ªºBeta²Ó­M©Ò¤Àªc¡A¦Ó¯×ªÕ¹ï¯Ø¸¢¬O¦³¬r©Êªº¡C¬ã¨sµo²{¡A¦³¨Ç¤H¦b¯Ø¸¢¯×ªÕ§t¶q¶W¹L5¢Hªº®É­Ô¡A´N±w¦³

¤G«¬¿}§¿¯f¤F¡C [¯×ªÕ¨x] ¥[¤W[¯×ªÕ¯Ø]´N¬O³y¦¨¿}§¿¯fµLªk±±¨îªº¨â¤j­ì¦]¡A¤]ºÙ¬°[Âù´`Àô²z½×¡C]

---------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2023/8/30 ¤U¤È 05:53:57²Ä 3431 ½g¦^À³

1.¸É¤W¤T´â½©¿}Áý¾i¨S±w¤W1«¬¿}§¿¯f¡¨ªºP­È: 35%(P=0.021)¡A50%(P=0.012)¡C(°ª§C¿@«×ªºP<0.05¦³²Î­p¤WÅãµÛ®t²§)

2.§ïµ½¯×ªÕ¯Ø¤Þ°_ªº¯Ø¯fÅÜ¡B[¿}§¿¯f] ©Î¨ä¥L¬ÛÃö¯f¯g¤§²Õ¦Xª«¤Î¤èªk±M§Q (SNP-6ÃĪ«)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/30 ¤U¤È 07:18:40²Ä 3868 ½g¦^À³
·sÃĶ}µoªº®Ú¥»:¨ä¥Hªk¥O¨î«×¬°¸g¡B¹êÃÒ¬ì¾Ç(Á{§É¸ÕÅç)¬°½n¡AÁa¾î¥æ´¦¨¬ì§Þ»Pªk«ß¥æ¬yªºÀ³¥Î¬ì¾Ç¡C

¦h°µÂI¥\½Ò¼W±j²´¥ú¡A³zµø©Ò§ë¸ê¤½¥qªº¸¬Äª¸Ì½æªº¬O¬Æ»òÃÄ?¿ï¾Ü¦³¼ç¤Oªº¤½¥q¡A´N¥i¥H´£°ª³Ó²v!

¤£­nªÈµ²©ó²{¦b¡A®æ§½©ñ¤j¤@ÂI¡A¦A©¹«e¬Ý·Q¹³¤@¦~«á¡B¤­¦~«á¡A¤@¤Á³£·|Åܱo¤£¤@¼Ë¡C

----------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/9/11 ¤W¤È 08:01:05²Ä 2430 ½g¦^À³

¸¨¤«¤U¥Û??? §Ú¦b¹j¤é1/6°ê¹©ªÑ»ù¿ÄÂ_®É¦Ñ¦­Äµ¥Ü!!!(°ê¹©¤G´ÁP­ÈµS¥¼ª¾?)

¡u¤½µL´çªe¡A¤½³º´çªe¡C¼Zªe¦Ó¦º¡A·í©`¤½¦ó¡I¡v

----------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 07:50:51²Ä 1878 ½g¦^À³

...¤µ¤Ñ±q¸Ñª¼¼Æ¾Ú¨Ó¬Ý [¥h¦~ªº¥[¦¬­«¯gªÌ] ´N¬O[»´¤¤¯g¦³®Ä©Ê«Ü¤£©úÅã¡A©Ò¥H¥[¤J­«¯g±wªÌÁ{§É]

---------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/12/29 ¤U¤È 01:47:04²Ä 1534 ½g¦^À³

...°ê¹©:DMC«Øij¼W¥[¦¬ªv»Ý­n®ñ®ð¤ä«ù¤§­«¯g¦í°|¯f±w¡C

³o®É¦³2ºØ¥i¯à©Ê:¤@¬O¦³®Ä©Ò¥H¥[¤J­«¯g±wªÌ¡A¤G¬O¥i¯à»´¤¤¯g¦³®Ä©Ê¤£©úÅã¡A©Ò¥H¥[¤J­«¯g±wªÌÁ{§É¬Ý¬Ý¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/30 ¤U¤È 06:58:03²Ä 3867 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2021/2/3 ¤W¤È 10:56:59²Ä 662 ½g¦^À³

J&J»PGSKªº°ª¼h¬OÄø³J?¥H«e¹C»¡°ê·|ij­ûªý¼¸FDA¡A²{¦b¤£ª¾¹D¤Ï¹L¨Ó§Q¥Î³o±ø¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï­²ªk®×¡n???¬°½T«OOTCÃÄ«~ªº[¦w¥þ©Ê]¡A FDA¥u»Ý¤@¯È¦æ¬F©R¥O...

-------------------------------------------------------------------------------------------------

2023.7.28www.gao.gov/assets/gao-23-106570.pdf

¬ü°êFDA[«D³B¤èÃÄ]¤¤±Æ¥L©Ê±ø´Ú(¥«³õ¿W¦ûÅv)

...2018 ¦~1 ¤ë¼gµ¹°ê·|»â¾É¤Hªº¤@«Ê«H¤¤¡A¤@­Ó¥Nªí®ø¶OªÌ§Q¯qªº²Õ´¤½¶}´£¥X¤F³o¼Ëªº¾á¼~¡G«D³B¤èÃĤ½¥q¥i¯à·|­­¨î¸û¦Ñ¦ý¦P¼Ë¦³®Äªº«D³B¤èÃĪº¨ÑÀ³¡A±q¦Ó­¢¨Ï®ø¶OªÌÁʶR¸û·s¡B¸û¶Q¥BÀò±o[¿W®a¸gÀçÅv]ªºÃĪ«

­Ó¤Hµ²½×:¤jÃļt©ñ±ó[¿W®a¸gÀçÅv]? ©ñ±ó±q®ø¶OªÌ¤f³U±Ç§ó¦h¿ú?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/30 ¤W¤È 09:21:00²Ä 3866 ½g¦^À³
ªYÄ£ªº¥Ø¼Ð¬O´Â¦V¥H°ª¨x¦w¥þ©Êªº¤AñQÓi×ô¡u¨ú¥N¡v²{¦³¤AñQÓi×ôªº¥«³õ¡C

¤jÃļt·|«ç¼Ëª¾ªkª±ªk¡A¥HOTC±M½×­q³æ½Ð¨D¦J÷ÅýFDAµo¥¬¦æ¬F©R¥O.....???? ³o¬OµL¨x¬rSNP-810ªºOTC«D³B¤èÃÄ»ù­È¡I

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/30 ¤W¤È 08:53:22²Ä 3865 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 07:05:38²Ä 3781 ½g¦^À³

...§ï­²ªk®×¤º¤å¦³¹ªÀy«D³B¤èÃÄ[¦w¥þ³Ð·s]!

--------------------------------------------------------------------------------------------------

ªYÄ£ªº¥Ø¼Ð¬O´Â¦V¥H°ª¨x¦w¥þ©Êªº¤AñQÓi×ô¡u¨ú¥N¡v²{¦³¤AñQÓi×ôªº¥«³õ¡C

Ãļt¥i¥H­n¨DFDA§ó§ï¨Ï¥Î±ø¥ó©Î¦¨¤À.....µ¥--->´£¥æ(OTC±M½×­q³æ½Ð¨DOMOR¡^

sbiaevents.com/files2024/OMUFA-Webinar-June-2024-Slides.pdf

¹ï©ó·s¼W©Î¥[±j¥H¤U [¦w¥þ¬ÛÃö] «D³B¤èÃıMµÛÅܧó¡AµL½×µ¥¯Å¬°¦ó¡AOMOR §¡¤£¦¬¨ú¥ô¦ó¶O¥Î(¨ä¾lÅܧó­n¦¬¿ú)¡G

¸T§Ò¯g¡Bĵ§i©Î¹w¨¾±¹¬I

Ãö©ó¨Ï¥Î©ÎÀݥάÛÃöªº­·ÀIªºÁn©ú

¦³Ãö¾¯¶q©Mµ¹ÃĪº»¡©ú¡A¦®¦b´£°ª«D³B¤èÃıMµÛÃĪ«ªº¦w¥þ¨Ï¥Î

­Ó¤Hµ²½×:´Á«Ý¹Ú¹Ò¦¨¯u¡A¥@¬É¦]¹Ú¦Ó§ïÅÜ!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/30 ¤W¤È 08:35:24²Ä 3864 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/25 ¤U¤È 10:58:33²Ä 3854 ½g¦^À³

...Ãļt§ä¥Á¥N¬IÀ£FDA-[¥P©é¥P]À¸½Xµ²§ô!

2024.6.14-¬ü°ê­×§ï«áªº«D³B¤èÃıMµÛ­p¹ºÅܧó±q¹ï¤AñQ®ò°ò×ô¥Ö½§¤ÏÀ³Äµ§i¶}©l

¤µ¤Ñ¡AFDA µo¥¬¤F¤@¶µÀÀijªº[¦æ¬F©R¥O]....

--------------------------------------------------------------------------------------------------

Ãļt¥i¥H­n¨DFDA§ó§ï¨Ï¥Î±ø¥ó©Î¦¨¤À.....µ¥--->´£¥æ(OTC±M½×­q³æ½Ð¨DOMOR¡^

FDA­n¨DÃļt¥[µùĵ§i»y.....µ¥--->¥Îªº¬O(¦æ¬F©R¥O)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/30 ¤W¤È 08:21:31²Ä 3863 ½g¦^À³
www.sinewpharma.com/Upload/download/20240606-video.MP4

39¤À30¬í:¤À§O¦V¨äFDA»PEMA±N¨ä¾Ö¦³¨x¬r©Ê......²¾¥X¥«³õ....

­Ó¤Hµ²½×:¤jÃļtªºª¾ªkª±ªk¡A§ó¥i©È!!!

----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 08:31:15²Ä 3782 ½g¦^À³

ªYÄ£±N¥Ó½Ð¦w¥þ·sÃij\¥iÃÒ(¥«³õ±MÀçÅv?)¨Ã´£¨Ñµ¹°ê»Ú¤jÃļt(°ê»Ú¤jÃļt¤£¥Î­«·s°µÁ{§É¥Ó½ÐÃÄÃÒ)

3.[FDA...¦æ¬F©R¥O±Â¤©[¥«³õ±MÀçÅv][¥«³õ±MÀçÅv][¥«³õ±MÀçÅv]

...OTCÃÄ«~§ï­² (SNP-810¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¡C¥i­×§ï©Î§R°£FDA¨x¬rĵ»y)

1.³Ì²×¦æ¬F©R¥Oµo¥¬«á¡AFDA ¥i¥H§ó§ï¶Ü¡H

¦³¤@¶µ±ø´Ú¤¹³\ FDA ¦b¦³·sÃÒ¾Úªí©ú¯S©wÃĪ«©Î¬YÃþÃĪ«ºc¦¨[¤£¨}¨Æ¥ó]ªº[¤£¦X²z­·]ÀI¨Ã»Ý­n¼ÐÅҩΨä¥LÃþ«¬ªº§ó§ï

®É¡A¤¹³\FDA ¹ï¥ô¦ó³Ì²×¦æ¬F©R¥O¶i¦æ§ó§ï¡C

2.»s³y°Ó¦p¦ó½Ð¨D§ó§ï±M½×¡H

»s³y°Ó¥i¥H­n¨D§ó§ï¨Ï¥Î±ø¥ó©Î¦¨¤À¡A¨Ò¦p³z¹L´£¥æ OTC ±M½×­q³æ½Ð¨D¡]¡uOMOR¡v¡^¡C

3.¦b·sªº«D³B​​¤èÃĺʺޮج[¤U¡A§Úªº«D³B¤èÃĦ³¸ê®æÀò±o¯S³\¸gÀçÅv¶Ü¡H

¦pªG·sªº¤HÅé¬ã¨s¹ïµo¥¬³Ì²×¦æ¬F©R¥O¦ÜÃö­«­n¡A¨º»òFDA ¥i¥H¦bµo¥¬¥Ñ¥Ó¿ìªÌµo°_ªº°w¹ï·s«D³B¤èÃĬ¡©Ê¦¨¤À¡]¤§«e¥¼

¦C¤J¦U½×©Î©R¥O¡^ªº³Ì²×¦æ¬F©R¥O©Î°w¹ï¤£¦P¨Ï¥Î±ø¥óªº¦æ¬F©R¥O«á±Â¤©¥«³õ±MÀçÅv¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/29 ¤U¤È 03:27:16²Ä 3862 ½g¦^À³
2024.6.6-ªk»¡·|¼v­µÀÉ httpd://www.sinewpharma.com/Upload/download/20240606-video.MP4

¯u¹ê.°È¹ê.¥­¹ê

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/27 ¤U¤È 01:25:35²Ä 3861 ½g¦^À³
¥ÌÅS¾J¥i¯à«ì´_¨ã¦³¦h¥\¯à©Ê©M¸~½F²M°£¯à¤OªºCD8 + T ²Ó­M¾÷¨î???

°ªº¯³zÀ£[¥ÌÅS¾J]«á¦å¼ß[¹[¿@«×]¤É°ª¬O¥Ñ©ó[K+¹[]±q²Ó­M [²¾¥X] ¶i¤J²Ó­M¥~²G...

--------------------------------------------------------------------------------------

1.2016.9.14(Nature¥D¥Z)¸~½F·LÀô¹Ò¤¤ªºÂ÷¤l§K¬Ì§í¨î­­¨î¤F T ²Ó­M®ÄÀ³¥\¯à

www.nature.com/articles/nature19364

¸~½F¤ºT²Ó­Mªº±þÀù¬¡©Ê©¹©¹·|¨ü¨ì¼vÅT¡A¾É­P¯e¯f¶i®i¡C§Ú­Ì¥ý«eµo²{¡A¸~½F¤º²Ó­M [¥~] K+ ªº¤É°ª»P¥¿¦b¶i¦æªº²Ó­M¦º¤`¦³Ãö¡A³o­­¨î¤F CD8+ T ²Ó­Mªº Akt-mTOR °T¸¹¶Ç¾É©M®ÄÀ³¥\¯à¡C¬°¤F½w¸Ñ K+ ¤¶¾Éªº T ²Ó­M§í¨î¡A§Ú­Ì³z¹L°ò¦]¤â¬q¨Ó­°§C²Ó­M[¤º]K+¡C

2.2019.3.29-¸~½F¤¤ªºT²Ó­M·F©Ê©M¥\¯à»Ùê¬O¥Ñ¦@¦P¾÷¨îIJµoªº

www.science.org/doi/full/10.1126/science.aau0135

§Ú­Ìµo²{¸~½F·LÀô¹Ò¤¤¹L¶qªº [¹[]¬O³oºØ [¤G¤Àªk] ªº°ò¦¡A¦b«O«ù·F©Êªº¦P®ÉIJµo T ²Ó­M®ÄÀ³¥\¯àªº§í¨î¡C°ª¤ô¥­ªº²Ó­M [¥~] ¹[³z¹L­­¨îÀç¾i§l¦¬¨Ó­­¨îT ²Ó­M®ÄÀ³µ{§Ç¡A±q¦Ó»¤¾É¦Û¾½§@¥Î¨Ã´î¤Ö®ÄÀ³¾¹©M¯ÓºÜ¦ìÂIªº²Õ³J¥Õ¤AñQ¤Æ¡A

¶i¦Ó²£¥Í¨ã¦³§ïµ½ªºÅ餺«ù¤[©Ê¡B¦h¯à©Ê©M¸~½F²M°£¯à¤OªºCD8 + T ²Ó­M¡C

¶i¦Ó²£¥Í¨ã¦³§ïµ½ªºÅ餺«ù¤[©Ê¡B¦h¯à©Ê©M¸~½F²M°£¯à¤OªºCD8 + T ²Ó­M¡C

³oºØ¾÷¨îª¾ÃѼW¶i¤F§Ú­Ì¹ï T ²Ó­M¥\¯à»Ùꪺ²z¸Ñ¡A¨Ã¥i¯à±a¨Ó·sªº¤èªk¡A±q¦Ó¯à°÷¶}¾v¥Î©óÀù¯g§K¬ÌªvÀøªº¼W±j T ²Ó­Mµ¦²¤¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/27 ¤W¤È 11:52:21²Ä 3860 ½g¦^À³
¥ÌÅS¾J(º¯³zÀ£½Õ±±NFAT5ªº¬¡¤Æ¥[¼@¸~½F®û¼íCD8+T²Ó­Mªº¯ÓºÜ?)+¤T´â½©¿}(§í¨îCD4+ CD8+ T ²Ó­M¼W´Þ)ªº¨ó¦P®ÄÀ³!!!

1.2023.10.9-¡m¦ÛµM§K¬Ì¾Ç¡n¡G¬¥®á¤j¾Ç¹Î¶¤µo²{±Mªù½Õ¸`¸~½F¤¤T²Ó­M¯ÓºÜªº¯S®í³J¥Õ¡I

www.nature.com/articles/s41590-023-01614-x

¬ã¨s´¦¥Ü¡ANFAT5ªº°ªªí²{¯à°÷¥[¼@¸~½F®û¼íCD8+T²Ó­Mªº¯ÓºÜ¡A©Î¥i§@¬°¼ç¦bªº§K¬ÌªvÀø¹vÂI¡A³z¹L¤¶¤JNFAT5ªº[ªí¹F©Î

¬¡©Ê]¨Ó´£°ªCD8+T²Ó­M¹ï¸~½Fªº¤ÏÀ³¡A±q¦Ó§ïµ½Àù¯gªvÀøªº®ÄªG¡C

NFAT5ªº¬¡¤Æ¨ü²Ó­M¥~ [º¯³zÀ£½Õ±±]

NFAT5ªº¬¡¤Æ¨ü²Ó­M¥~ [º¯³zÀ£½Õ±±]

NFAT5ªº¬¡¤Æ¨ü²Ó­M¥~ [º¯³zÀ£½Õ±±]

......NFAT5¹ï©ó¨ä¥¦¨ë¿E±ø¥ó¡A¦p®ñ¤ÆÀ£¤O¡B¯Ê®ñ¡B²Ó­M¿E¯À¡B¨ë¿E¤£±Ó·P¡C

2.2013.7.19-¬¡©Ê®ñ½Õ¸` NFAT5 ¼Ð¹v°ò¦]ªºÀô¹Ò¨Ì¿à©Ê§í¨î www.nature.com/articles/emm201361

[°ªº¯³zÀ£] ¥ÌÅS¾J]¾¯¶q¨Ì¿à©Ê»¤¾É NFAT5 ¬¡©Ê¡A¦ý´î¤Ö LPS »¤¾Éªº IL-6 ²£¥Í¡C

3.2016.7.28-¾AÀ³©Ê§K¬Ì¨t²Î¦b¨x·l¶Ë©M¨x²Ó­MÀùµo®i¤¤ªºÂù­«§@¥Î

www.cell.com/cancer-cell/fulltext/S1535-6108(16)30269-0?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1535610816302690%3Fshowall%3Dtrue

CD8 +²Ó­Mªº¬¡¤ÆÅãµÛ«P¶i¨xÀùªºµo¥Í¡C CD8 +²Ó­M¯ÓºÜªº¤p¹«ÀH«á§¡¥¼¥X²{¨x¸~½F

§Ú­Ìªº¼Æ¾Ú½T©w CD8 + T ²Ó­M¬Oµoª¢¬ÛÃö¨xÀùµo¥ÍªºÃöÁä²Ó­M¦¨¤À¡C

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/24 ¤U¤È 05:31:04²Ä 3847 ½g¦^À³

1. 2023.3.15-Nature¥D¥Z-¿¯­¹²¢¨ý¾¯[¤T´â½©¿}]¬O[T²Ó­M]¤¶¾É¤ÏÀ³ªº­t½Õ¸`¾¯

¤T´â½©¿}Åã²{§í¨îCD4+ CD8+ T ²Ó­M¼W´Þªº¾¯¶q¨Ì¿à©Ê¯à¤O

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/27 ¤W¤È 09:40:22²Ä 3859 ½g¦^À³
2023/08/17 10:24

¡e°OªÌ·¨°ê¤å¡þ¥x¥_³ø¾É¡f³Ò°Ê³¡³Ò°Ê°òª÷¹B¥Î§½°ê¤º§ë¸ê²Õ«e²Õªø´å°i¤å¡A³Q±±©ó¥ô¤º»P®É¥ôÄ_¨Î¶°¹Î°õ¦æªø­ð·¡¯Pµ¥¤H¦X§@¡A¾Þ±±³Ò°Ê°òª÷¡A°ª»ù©Ó±µÄ_¨Î¶°¹Î¡u­Ë³f¡v¥X²æªº18¸U±i»·ªF¦Ê³fªÑ²¼¡A¨ÏÄ_¨ÎÀò§Q¬ù4.5»õ¤¸¡A¤@¼f¨Ì¶¡±µ¾ÞÁaªÑ»ù¸o­«§P´å°i¤å9¦~¡B­ð·¡¯P8¦~....

-------------------------------------------------------------------------------------------------

¬ÝµÛ­·ÀY»¡¸Ü¡A¤jªÑªF¤£§C½Õ? ¨S±ÂÅv«e·Q¦³¬ßÀY¡A¬Ýú³°Ó·Q³y¶Õ§_?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/27 ¤W¤È 09:30:17²Ä 3858 ½g¦^À³
¥xÆW°·«O¸p¤½§G ¥h¦~2023¥xÆW¤Hªº°·«O¥ÎÃıƦæ:

[¨Ï¥Î¤H¼Æ³Ì¦h]ªºÃĪ«¬O¦¨¤À¬°¤AñQ®ò×ôªº¤îµhÃÄ¡A¨Ï¥Î¤H¼Æ¹F898¸U¤H¡A±Æ¦W²Ä¤@

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/6/27 ¤W¤È 09:12:14²Ä 3857 ½g¦^À³
¦Aµ¹¥D¤O¤@¦¸¥X³fªº¾÷·|¡A¥þ¥x¬y·P¡B¤­º~ªÍª¢¤S¨Ó¤F¡C¤îµhÃħ½¨Ó¬Ý¬Ý
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/26 ¤W¤È 07:48:54²Ä 3856 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/4/19 ¤W¤È 08:18:34²Ä 3698 ½g¦^À³

2017.9.14-¬ü°ê°ê·|¼f¬d«D³B¤èÃÄ ¨âÄҥߪk¯ó®×±N¹ý©³§ï­² FDA ¹ï«D³B¤è²£«~ªººÊºÞ¤è¦¡(¦]¬°¤¾ªøªk³Wµ{§Ç¡AFDA ªá¤F¤C¦~®É¶¡¤~­n¨D¹ï¤AñQÓi×ôµo¥X¨xŦ¬r©Êĵ§i)

----------------------------------------------------------------------------------------------

¤T¶¥¬q³W«h¨î©w¬yµ{¡]ANPR¡BTFM ©M FM¡^¤¾ªøªk³Wµ{§Ç-->FDA ªá¤F¤C¦~®É¶¡¤~­n¨D¹ï¤AñQÓi×ôµo¥X¨xŦ¬r©Êĵ§i)

2024¦~6¤ë14¤é¤@¯È[¦æ¬F©R¥O]--->[«D³B¤èÃÄ]±MµÛ­p¹ºÅܧó±q¹ï¤AñQ®ò°ò×ô [¥Ö½§¤ÏÀ³]ĵ§i¶}©l¡C

§ñÃö¦w¥þ©Êªº¨x¬r¦p¦ó¸Ñ??????

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/26 ¤W¤È 07:36:27²Ä 3855 ½g¦^À³
1.2017.09.13-«eFDA¥N²z§½ªøJanet Woodcock¦b²³Ä³°|³Æ¸ß¸ê®Æ:

We could start with the skin reactions to acetaminophen.

(§Ú­Ì¥i¥H±q¹ï¤AñQ®ò°ò×ôªº¥Ö½§¤ÏÀ³¶}©l)

2.2020.3.27-¤t´¶Ã±¸p¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï­²ªk®×¡n¥´³qFDA¥ô·þ¤G¯ß!!!

¤T¶¥¬q³W«h¨î©w¬yµ{¡]ANPR¡BTFM ©M FM¡^±N³Q¦æ¬F©R¥O¬yµ{¨ú¥N¡C

3.2024.6.14-¬ü°ê­×§ï«áªº[«D³B¤èÃÄ]±MµÛ­p¹ºÅܧó±q¹ï¤AñQ®ò°ò×ô [¥Ö½§¤ÏÀ³]ĵ§i¶}©l

-------------------------------------------------------------------------------------------------

µL¨x¬r¹ï¤AñQ®ò°ò×ô²Å¦X¤Þ¥Î3.³o±øªk³W???

3.¦b [·sªº«D³B​​¤èÃÄ] ºÊºÞ®Ø¬[¤U¡A§Úªº«D³B¤èÃĦ³¸ê®æÀò±o¯S³\¸gÀçÅv¶Ü¡H

¦pªG [·sªº¤HÅé¬ã¨s] ¹ïµo¥¬ [³Ì²×¦æ¬F©R¥O] ¦ÜÃö­«­n¡A¨º»òFDA ¥i¥H¦bµo¥¬¥Ñ¥Ó¿ìªÌµo°_ªº°w¹ï·s«D³B¤èÃĬ¡©Ê¦¨¤À¡]¤§«e¥¼¦C¤J¦U½×©Î©R¥O¡^ªº³Ì²×¦æ¬F©R¥O©Î°w¹ï¤£¦P¨Ï¥Î±ø¥óªº¦æ¬F©R¥O«á±Â¤© [¥«³õ±MÀçÅv]¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/25 ¤U¤È 10:58:33²Ä 3854 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2021/1/31 ¤W¤È 09:39:52²Ä 646 ½g¦^À³

Ãļt¸òFDA [¥P©é¥P]À¸½Xµ²§ô!

2017.09.13 ²{¥N¤ÆFDAªk³W«D³B¤èÃĪ« FDAÃĪ«µû¦ô»P¬ã¨s¤¤¤ß¡]CDER ¡^¥D¥ôJanet Woodcock¦b²³Ä³°|³Æ¸ß¸ê®Æ

www.govinfo.gov/content/pkg/CHRG-115hhrg27228/html/CHRG-115hhrg27228.htm

...Dr. Woodcock. OK. Well, we could start with the skin reactions to acetaminophen.

-------------------------------------------------------------------------------------------------

Ãļt§ä¥Á¥N¬IÀ£FDA-[¥P©é¥P]À¸½Xµ²§ô!

2024.6.14-¬ü°ê­×§ï«áªº«D³B¤èÃıMµÛ­p¹ºÅܧó±q¹ï¤AñQ®ò°ò×ô¥Ö½§¤ÏÀ³Äµ§i¶}©l

www.fda.gov/drugs/drug-safety-and-availability/fda-issues-agency-initiated-proposed-order-regarding-otc-monograph-drugs-containing-acetaminophen

¤µ¤Ñ¡AFDA µo¥¬¤F¤@¶µÀÀijªº[¦æ¬F©R¥O]¡A¥H¸Ñ¨M»P§t¦³¹ï¤AñQ®ò°ò×ôªº«D³B¤è (OTC) ±MµÛÃÄ«~¬ÛÃöªº¦w¥þ°ÝÃD¡C

...FDA ÃĪ«µû¦ô»P¬ã¨s¤¤¤ß«D³B¤èÃĿ줽«Ç¥D¥ô Theresa Michele Âå¾Ç³Õ¤hªí¥Ü¡G¡§¤µ¤Ñªº¦æ°Ê¥Nªí¤F FDA ¹ê¬I°ê·|·s±ÂÅv¡]§@¬° OTC ±M½×§ï­²ªº¤@³¡¤À¡^ªº­«­n¨½µ{¸O¡C¡¨ ¡§¤µ¤Ñ´£¥Xªº©R¥O¦³§U©ó½T«O§Ú­Ì¥«³õ¤W«D³B¤èÃĪº¦w¥þ©Ê©M¦³®Ä©Ê¡C¡¨

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/25 ¤W¤È 07:25:44²Ä 3853 ½g¦^À³
2024.4.2--³o³U²Ó­M¥i¥H¦b¤HÅ餺ªø¥X·sªº¨xŦ(IIa´Á¸ÕÅç²×¥½´Á¨x¯f(ESLD)

---------------------------------------------------------------------------------------------

¹L¥hªº¤Q¦~......¥L­Ìªº¤èªk¦b¦Ñ¹«¡B½Þ©Mª¯¨­¤W°ö¨|·sªº°g§A¨xŦ-->8¦¨¾÷²v¦b¤HÅ餺ªø¥X·sªº°g§A¨xŦ!

±µ¨ü¨x²Ó­M²¾´ÓªÌ²×¥Í»Ý­nªA¥Î§K¬Ì§í¨î¾¯(´N¹³±µ¨ü²¾´Ó¾¹©xªÌªA¥Î§Ü±Æ¥¸ÃĪ«¤@¼Ë)-->³oÂI·¥¤j­­¨î¤F¾A¥Î±wªÌ!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/25 ¤W¤È 06:59:39²Ä 3852 ½g¦^À³
¦PºØ²§Åé²Ó­MÀøªk!

±N°·±dªº¨ÑÅé¨x²Ó­M²¾´Ó¨ì¨x°IºÜ±wªÌªº²O¤Úµ²¤¤¡C¨xŦ¨ã¦³Åå¤Hªº¦A¥Í¯à¤O¡A¦pªG¦³®Ä¥i¯à·|¹ý©³§ïÅܨx¯fªºªvÀø¤èªk¡C

1.¨xŦ

2024.4.2--³o³U²Ó­M¥i¥H¦b¤HÅ餺ªø¥X·sªº¨xŦ(IIa´Á¸ÕÅç²×¥½´Á¨x¯f(ESLD)

www.wired.com/story/cells-grow-liver-inside-patient/

¬ì¾Ç®a­º¦¸¹Á¸Õ¦b¤HÅ餺°ö¨|·sªº·L«¬¨xŦ....

(2023.4.12--LyGenesis ©M Imagine Pharma ¦X§@¶}µo[1«¬¿}§¿¯f]Àøªk (¨S³zº|ª÷ÃB)

--------------------------------------------------------------------------------------------------

2.¯ØŦ:

Lantidra¬O±N¨Ó¦Û[¦º¤`®½ÃتÌ] ªº¯Ø®q[£] cell]´£¨ú¥X«á¡Aª`®g¦Ü±wªÌ--->¥h¦~§å­ã¤W¥«!

VX-880[²§Åé·F²Ó­M]¾DFDA¼È°±!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/24 ¤U¤È 07:13:08²Ä 3851 ½g¦^À³
¥h¦~1«¬¿}§¿¯fªº¹Ú¨º»ò¤j!

³o½g

The dietary sweetener [sucralose]is a negative modulator of T cell-mediated responses

¤Sµn¤WNATURE¥D¥Z

¸U¤@

¦pªGSNP-6¤p¹«¹êÅç½T©w[¦A²{©Ê]¥BÀu©ó³æ¤è¤T´â½©¿}¡A¤jÃļt¤K­·§j¤£°Ê???

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/24 ¤U¤È 06:33:18²Ä 3850 ½g¦^À³
¦A¬Ý¤@¦¸¥h¦~ªº[1«¬¿}§¿¯f]ªº¹Ú¦³¦h¤j!

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2023/9/14 ¤U¤È 08:32:08²Ä 3445 ½g¦^À³

¤µ¦~¤j«¬»sÃĤ½¥q¹ï[1«¬¿}§¿¯f]ÃĪ««Ü·P¿³½ì!!!

1.2023.3.13--Áɿյ᥸¸ê [29 »õ¬ü¤¸] ¦¬ÁÊ Provention Bio¡A¶i­x[1«¬¿}§¿¯f]»â°ì

...Áɿյ᭺®u°õ¦æ©x Paul Hudson ¤W­Ó¤ëªí¥Ü¡A¤½¥q¬Ý¨ì¤F[1«¬¿}§¿¯f]ÃĪ«¶}µoªº¥¨¤j«e´º¡A¨Ã­«¥Ó¤F¥L±N[¤£¦A]­P¤O©ó[2«¬¿}§¿¯f]©MªÎ­D¯gªº¶i¤@¨B¬ã¨s¡C

2. 2023.4.12--LyGenesis ©M Imagine Pharma ¦X§@¶}µo[1«¬¿}§¿¯f]Àøªk (¨S³zº|ª÷ÃB)

3.2023.6.12--AZÄâ¤âQuellªñ [21»õ¬ü¤¸] Treg²Ó­MÀøªk§ð[²Ä1«¬¿}§¿¯f]»PIBD

news.gbimonthly.com/tw/article/show.php?num=59502

4. 2023.6.29-§¨Ó±N¦¬ÁÊSigilon©Ò¦³³Ñ¾lªÑ¥÷ ¥HÂX¤j¨ä¿}§¿¯fªvÀø²£«~(1«¬¿}§¿¯f)

Sigilion ªºªÑ»ù¦b½L«e¥æ©ö¤¤ öt¤É[¶W¹L 8 ­¿]¦Ü 34.48 ¬ü¤¸¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/24 ¤U¤È 06:25:05²Ä 3849 ½g¦^À³
2023.3.15-Nature¥D¥Z-¿¯­¹²¢¨ý¾¯[¤T´â½©¿}]¬O[T²Ó­M]¤¶¾É¤ÏÀ³ªº­t½Õ¸`¾¯

¡§¥Î´¶³q¤ôÁý¾iªº¤p¹«100% ±w¦³1«¬¿}§¿¯f¡A¤T´â½©¿}Áý¾i¨S±w¤W1«¬¿}§¿¯f¡¨ªºP­È: 35%(§C¿@«×P=0.021)¡A50%(°ª¿@«× P=0.012)

------------------------------------------------------------------------------------------

ªYÄ£·|¤£ª¾³o½gNature¥D¥Zªº¤p¹«¹êÅç¡AÅçÃÒSNP-6ªvÀø1«¬¿}§¿¯f¦A²{©Ê¦p¦ó?(²z½×¤W¡A¥ÌÅS¾J»P¤T´â½©¿}¦³¨ó¦P®ÄÀ³¡AÀ³¸ÓÀu©ó³æ¥Î¤T´â½©¿}ªº®ÄªG)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/24 ¤U¤È 05:40:57²Ä 3848 ½g¦^À³
¡§¥Î´¶³q¤ôÁý¾iªº¤p¹«100% ±w¦³1«¬¿}§¿¯f¡A¤T´â½©¿}Áý¾i¨S±w¤W1«¬¿}§¿¯f¡¨ªºP­È: 35%(P=0.021)¡A50%(P=0.012)¡C(°ª§C¿@«×ªºP<0.05¦³²Î­p¤WÅãµÛ®t²§)
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/24 ¤U¤È 05:31:04²Ä 3847 ½g¦^À³
1. 2023.3.15-Nature¥D¥Z-¿¯­¹²¢¨ý¾¯[¤T´â½©¿}]¬O[T²Ó­M]¤¶¾É¤ÏÀ³ªº­t½Õ¸`¾¯

¤T´â½©¿}Áý¾i¨S±w¤W1«¬¿}§¿¯f¡¨ªºP­È: 35%(P=0.021)¡A50%(P=0.012)¡C(°ª§C¿@«×ªºP<0.05¦³²Î­p¤WÅãµÛ®t²§)

¤T´â½©¿}Åã²{§í¨îCD4+ CD8+ T ²Ó­M¼W´Þªº¾¯¶q¨Ì¿à©Ê¯à¤O

2.¤T´â½©¿}³Q½T©w¬°¯Ø¸¢£]²Ó­M©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯

www.e-enm.org/journal/view.php?doi=10.3803/EnM.2014.29.1.12

3.2017¦~-T ²Ó­M¤¶¾Éªº £] ²Ó­M¯}Ãa¡G1 «¬¿}§¿¯f­I´º¤Uªº¦ÛÅé§K¬Ì©M¦PºØ§K¬Ì

www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2017.00343/full

1«¬¿}§¿¯f¬O§K¬Ì¨t²Î T ²Ó­M¯}Ãa¯ØŦ £] ²Ó­Mªºµ²ªG...­º¥ý¡A§Ú­Ì´y­z¤F¥Ø«e¹ï £] ²Ó­M¦ÛÅé§K¬Ì¯}Ãaªº²z¸Ñ¡A¥]¬A CD4

©M CD8 T ²Ó­Mªº§@¥Î¥H¤Î§Ü­ì¯S²§©Ê­@¨ü»¤¾Éªº´XºØ¥i¯à©Ê¡C

£]²Ó­M¦A¥Íªº«e´£¬O¡A¦pªG¦ÛÅé¤ÏÀ³©ÊT²Ó­M³Q²¾°£©Î§í¨î¡A²{¦³ªº£]²Ó­M¥i¥H¼W´Þ...

---------------------------------------------------------------------------------------

1+2+3=¦nÄÀ³s³s!!!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/24 ¤U¤È 01:49:09²Ä 3846 ½g¦^À³
2024.1.9--Vertex[²Ä¤@«¬¿}§¿¯f]²Ó­MÀøªkÁ{§É¶Ç2¦º¡B¼È°±¸ÕÅç!

....VX-880¬O¤@ºØ[²§Åé·F²Ó­M]¨Ó·½¡B§¹¥þ¤À¤Æ¡B²£¥Í¯Ø®q¯Àªº[£] cell]Àøªk....

------------------------------------------------------------------------------------------

Lantidra¬O±N¨Ó¦Û[¦º¤`®½ÃتÌ] ªº¯Ø®q[£] cell]´£¨ú¥X«á¡Aª`®g¦Ü±wªÌ--->¥h¦~§å­ã¤W¥«!

VX-880[²§Åé·F²Ó­M]¾DFDA¼È°±!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/24 ¤U¤È 01:36:42²Ä 3845 ½g¦^À³
¹ê²{¯u¥¿ªº¿}§¿¯f[ªv¡]¨ú¨M©ó«ì´_¥\¯à©Ê£]²Ó­M½è¶q¡A¦A¥Í¤ñ²¾´Ó¨ã¦³Àu¶Õ¡A¦ý¤´Ãø¥H¹ê²{¡C

--------------------------------------------------------------------------------------

1.2024.4.21-§Q¥Î £] ²Ó­M¦A¥Í¥Íª«¾ÇªvÀø¿}§¿¯f

www.sciencedirect.com/science/article/pii/S1043276024000821

2.2023.6.28-­º´Ú²Ä¤@«¬¿}§¿¯f²Ó­MÀøªkÀòFDA§å­ã

news.gbimonthly.com/tw/article/show.php?num=60226

Lantidra¬O±N¨Ó¦Û[¦º¤`®½ÃتÌ] ªº¯Ø®q[£] cell]´£¨ú¥X«á¡Aª`®g¦Ü±wªÌ....

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/20 ¤W¤È 09:59:24²Ä 3844 ½g¦^À³
«ì´_£]²Ó­Mªº¼Æ¶q©M¥\¯à¥i¯à¬O§ïµ½¬Æ¦Üªv¡¿}§¿¯fªº¦³®Ä¤â¬q!!!

¤@ºØ¦³§l¤Þ¤Oªºµ¦²¤¬Oª½±µ¦b¯ØŦ¤º¦A¥Í £] ²Ó­M¡CµM¦Ó¡AÁöµM¹L¥h¤w¸g´£¥X¤F´XºØ£]²Ó­M¦A¥Í¤èªk¡A¦ýÁ{§ÉÂà¤Æ³QÃÒ©ú¨ã¦³¬D¾Ô©Ê...

2023.8.1-°fÂà¯ØŦ £] ²Ó­M¥h¤À¤ÆªvÀø²Ä 2 «¬¿}§¿¯fwww.nature.com/articles/s12276-023-01043-8

--------------------------------------------------------------------------------------

¤T´â½©¿}³Q½T©w¬°¯Ø¸¢£]²Ó­M©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯

www.e-enm.org/journal/view.php?doi=10.3803/EnM.2014.29.1.12

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/20 ¤W¤È 09:20:29²Ä 3843 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2023/8/30 ¤U¤È 05:53:57²Ä 3431 ½g¦^À³

1.¸É¤W¤T´â½©¿}Áý¾i¨S±w¤W1«¬¿}§¿¯f¡¨ªºP­È: 35%(P=0.021)¡A50%(P=0.012)¡C(°ª§C¿@«×ªºP<0.05¦³²Î­p¤WÅãµÛ®t²§)

2.§ïµ½¯×ªÕ¯Ø¤Þ°_ªº¯Ø¯fÅÜ¡B[¿}§¿¯f] ©Î¨ä¥L¬ÛÃö¯f¯g¤§²Õ¦Xª«¤Î¤èªk±M§Q (SNP-6ÃĪ«)

patentimages.storage.googleapis.com/53/7b/9d/922137f38251d0/TW201720461A.pdf

---------------------------------------------------------------------------------------------------

±q±M§Q»PP2¨Ó±ÀÂ_:¦¶¸³9/24¦b²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

[oral insulin]´N¬OSNP-6µL»~!!!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/19 ¤W¤È 09:13:56²Ä 3842 ½g¦^À³
¥ÌÅS¾J(¶t/Áâ§l¦¬«O¯d)+¤T´â½©¿}(T1R3¿E°Ê¶tÁâ)¡u¤@¥[¤@¤j©ó¤G¡vªº®ÄÀ³!

¥ÌÅS¾J¬¡¤ÆmKATP³q¹D(²É½uÅéATP¹[³q¹D)

ATP¬O²Ó­Mªº¥D­n¯à¶q¨Ó·½¡A¥²¶·»P[ÁâÂ÷¤l]µ²¦X¤~¯à¨ã¦³¥Íª«¬¡©Ê¡C©Ò¿×ªº ATP ¹ê»Ú¤W³q±`¬O[Mg-ATP]¡C

----------------------------------------------------------------------------------------

2024¦~Rolf Luft¼ú:Professor Frances Ashcroft

Frances Ashcroft (Oxford) 2: ATP-sensitive potassium channels & neonatal diabetes

www.youtube.com/watch?v=AVG4V9ur39c

MgATP

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/18 ¤U¤È 11:23:36²Ä 3841 ½g¦^À³
www.sinewpharma.com/Upload/202312/news_2023122509345208.pdf

Type 2 diabetes or pre-diabetes

Present, n=18

Not present, n=17

-------------------------------------------

¦³ÁôÂꩼƾڦb9/24ªi¤h¹y¤fÀY³ø§i???

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/18 ¤U¤È 11:10:06²Ä 3840 ½g¦^À³
¦pªG[oral insulin]=SNP-610¡A¥i¯à·|¦³¡m¬ü¦nªº·N¥~¡n???

Ä´¦p½÷·çÃļtªº¬ã¨s¤H­û¬O·N¥~µo²{«Â¦Ó¿û¯àªv¶§·õ»Ùê¡A­ì¥ý»sÃĪº¥Ø¼Ð¬O¥Î¨ÓªvÀø¤ßµ±µh¡C

²É½uÅé¿}§¿¯f¬O¥Ñ©ó[ATP]²£¥Í¨ü¨ì§í»s¦Ó¾É­P¯Ø®q¯À¤Àªc¥\¯à»Ùê¦Ó¤Þ°_ªº²Ä¤G«¬¿}§¿¯f¡C

2023.8.21--II«¬¿}§¿¯f¤Î¨ä¨Öµo¯gªº [·sªvÀø¤è¦V]¡G²É½uÅé°Ê¤O¾Ç

www.ncbi.nlm.nih.gov/pmc/articles/PMC10475949/

(Ãø©Ç2024¦~Rolf Luft¼ú¹{µ¹Professor Frances Ashcroft)

--------------------------------------------------------------------------------------------------

¦¶¸³9/24¦b²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

[oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f???

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2023/8/26 ¤U¤È 07:56:54²Ä 3426 ½g¦^À³

..²z½×¤W¡ASNP-6ÃĪ«¥iªvÀø[1«¬]¿}§¿¯f»P [2«¬]¿}§¿¯f¡A´N¬Ý¤p¹«¹êÅçµ²ªGÂà¤Æ¦b¤H¨­¤W¦³¦h°ª???

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/6/18 ¤U¤È 03:25:40²Ä 3839 ½g¦^À³
r¤j«È®ð¤F

¬Û¸û¨Ó¬Ý¡A¤½¥q¤~¬O¯È¤W½Í§L¡A¦nÅ¥¬O¾Ç³N¬£¡C¤£¦n´N¬O¤£¾ÇµL¼Æ

­nµ¹¥L³½¦ººô¯}¡AÃC¦â¬Ý¬Ý

=============

«¥®a´N·|¯È¤W½Í§L¡A¨º¬O¤Uµ¦¡A¦³ÂI³½¦ººô¯}¤§¨ý~

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/18 ¤W¤È 11:15:11²Ä 3838 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/17 ¤U¤È 04:33:45²Ä 3829 ½g¦^À³

...¬Ý2024.5.17ªº½u¤WµøÀW(5¦ìªÎ­D©M¿}§¿¯f¾ÇªÌ) www.youtube.com/watch?v=Fo0pWsnDgwA

......(¥ÌÅS¾J+¤T´â½©¿})¾÷¨î¡ASNP-610¦³À¸¨SÀ¸µ¥Á{§É´¦¾å?

-------------------------------------------------------------------------------

²Ä¤K©¡ªi¤h¹yMASH ÃĪ«¶}µo°ª®p·| September 24-26, 2024 | Boston, MA

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

[oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f???

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/18 ¤W¤È 11:00:02²Ä 3837 ½g¦^À³
9¦~«eªº­¹¦w¨Æ¥ó¡A¨ý¥þªº¡u·À³»­·¼É¡v³ô¥i­ÉÃè¡C
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/18 ¤W¤È 10:53:50²Ä 3836 ½g¦^À³
«¥®a´N·|¯È¤W½Í§L¡A¨º¬O¤Uµ¦¡A¦³ÂI³½¦ººô¯}¤§¨ý~
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GJames10139245  µoªí®É¶¡:2024/6/18 ¤W¤È 10:39:08²Ä 3835 ½g¦^À³
R¤jªº¾Þ½L°ª©ú¡AÀ³¸Ó¨Ó¥X¥ôÁ`¸g²z¡C¤½¥qªº©R¯ß¬O·~°È²{ª÷¬y¡A¬ãµo§Þ³N¨ä¦¸
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/18 ¤W¤È 10:18:04²Ä 3834 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/9 ¤W¤È 09:16:38²Ä 3790 ½g¦^À³

¤jÃļt¡u¤U¤£¤F¥x¡v§óÁ}Ãø¦a¤@¤Ñ¡AÅý¶D³^«ß®v¾ß¨ìºj¡A¯à´Á«Ý¤£µo¥Í¤j¨Æ???

¶D³^«ß®v/®ø¶OªÌ/¾ÇªÌ/µû½×®a/ªk©x¦b½æ³õ¬[¤W¬Ý¨£SAFETYNADOL(µL¨x¬r)¡A¹j¾ÀªºTylenol(¦³¨x¬r)

-------------------------------------------------------------------------------------------

§Ú¾Þ½L«h¥ý±ÂÅv¤@®a23½u¼t¡A­É¤O¶D³^«ß®v/®ø¶OªÌ/¾ÇªÌ/µû½×®aµ¥µ¥ÁÖ½×À£¤O¡AÅý¤jÃļt³QÅF¦¨¸ÁºÛ......

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/18 ¤W¤È 10:08:54²Ä 3833 ½g¦^À³
²Ä¤K©¡ªi¤h¹yMASH ÃĪ«¶}µo°ª®p·| September 24-26, 2024 | Boston, MA

11:30 am Workshop D: Exploring Non-Invasive Tests & Biomarkers for MASH in Action

Kai-Min Chu

Chief Executive, Sinew

Miriam Kidron

Chief Scientific Officer, Oramed

Synopsis

Delving into promising results for SNP-6 Series in treating MASH with multi-functional effects and a POC Quantitative Non-Invasive Test for MASH: Insights from animal and clinical trials. Showing clinically significant improvements in biomarkers of liver injury, inflammation, and fibrosis in a Phase 2 study in patients with MASH. Also exploring a case study of this in a phase 2 oral insulin versus placebo study

------------------------------------------------------------------------------------------------

©ñ¨ì²Ä¤T©uªi¤h¹y³o­Ó¤fÀY³ø§i¡A²´¤U°£¤F±ÂÅv¥~³£¤£°÷«G!

Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/6/18 ¤W¤È 08:49:19²Ä 3832 ½g¦^À³
¹ï¤£°_¦U¦ì(¦ý§Ú·Q¦³²¼ªº¤H¤]«Ü¤Ö¤F)¡A¦aº»­Ë¾`°­¡A§Æ±æ§âÃa¹B¥Î¥ú

¦A¨£60«O½Ã¾Ô

==========================

§¹¤F¡A§Ú¤â½â¨Ó¶R¤F~©ñ¨ì²Ä¤T©u

ªGµM¤S±Y¤F

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/17 ¤U¤È 05:12:17²Ä 3831 ½g¦^À³
¤T´â½©¿}³Q½T©w¬°¯Ø¸¢£]²Ó­M©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯-->§Ö³tÅãµÛ¼W¥[²Ó­M¤ºATP¤ô¥­

¥ÌÅS¾J¬¡¤ÆmKATP³q¹D(²É½uÅéATP¹[³q¹D)

¥ÌÅS¾J(¶t/Áâ§l¦¬«O¯d)+¤T´â½©¿}(T1R3¿E°Ê¶tÁâ)¡u¤@¥[¤@¤j©ó¤G¡vªº®ÄÀ³!ªºÅܤơC

«Ü²M·¡Åo!

-------------------------------------------------------------------------------------------------

2024 ¦~ Rolf Luft ¼ú

[£]²Ó­M] [KATP]³q¹D¡A³z¹L¸²µå¿}¥NÁ¬°[ATP]¨ÓÃö³¬¸Ó³q¹D....

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/17 ¤U¤È 05:02:07²Ä 3830 ½g¦^À³
¥ÌÅS¾J+¤T´â½©¿}ªº¾÷¨î???

2024 ¦~ Rolf Luft ¼ú

ki.se/en/mmk/research/rolf-luft-award/professor-frances-ashcroft-receives-the-rolf-luft-award-2024

Frances Ashcroft µo²{¤F¦b[ £]²Ó­M]¤¤ªí¹Fªº[KATP]³q¹D¡A¥¦¬OÅTÀ³¦å¿}¤É°ª¦Ó¨ë¿E¯Ø®q¯À¤Àªcªº«H¸¹³q¸ôªºÃöÁä²Õ¦¨³¡¤À¡C¦oµo²{¡A³z¹L¸²µå¿}¥NÁ¬°[ ATP ]¨ÓÃö³¬¸Ó³q¹D¦b¯Ø®q¯ÀÄÀ©ñ¤¤°_µÛ¦ÜÃö­«­nªº§@¥Î¡C

------------------------------------------------------------------------------------------------

Rolf Luft ¼ú:¥Ñ·ç¨åµÛ¦WÂå¬ì¤j¾Ç¥dùªL´µ¥d¾Ç°|¹{µo¡A¤]¬O¿Õ¨©º¸¤j·|ªº©Ò¦b¦a¡A¨C¦~³£·|ªí¹ü¥þ²y¤@¦ì¹ï¤º¤Àªc¾Ç©M¿}§¿¯f¬ã¨s°µ¥X³Ç¥X°^Ämªº¬ì¾Ç®a¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/17 ¤U¤È 04:33:45²Ä 3829 ½g¦^À³
¤£¬Ý60¦~ªºATP¤å¡C

¬Ý2024.5.17ªº½u¤WµøÀW(5¦ìªÎ­D©M¿}§¿¯f¾ÇªÌ) www.youtube.com/watch?v=Fo0pWsnDgwA

£] ²Ó­M KATP ³q¹Dªº¸²µå¿}½Õ¸`¡G¬O®É­Ô«Ø¥ß·s¼Ò«¬¤F!!!

£] ²Ó­M KATP ³q¹Dªº¸²µå¿}½Õ¸`¡G¬O§_»Ý­n·s¼Ò«¬???

-------------------------------------------------------------------------

·s¼ҫ¬¦³ª§Ä³¡A²`¶ø¤£À´¥¿±`¡C

¥u®ø§âµøÀWªºÃöÁä¦r:£]-Cell/KATP /ATP /Caicium...¡A¤Þ¤J§Ú¶K¹Lªº(¥ÌÅS¾J+¤T´â½©¿})¾÷¨î¡ASNP-610¦³À¸¨SÀ¸µ¥Á{§É´¦¾å?

¸É¥R:¥ÌÅS¾J¬¡¤ÆmKATP³q¹D´£¨Ñ¤ßŦ«OÅ@§@¥Î¡Cwww.mdpi.com/1422-0067/22/5/2395

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/16 ¤W¤È 11:48:21²Ä 3828 ½g¦^À³
60¦~«eªºNature¥D¥Z¤åÄm¡Aª`®g¤TÁC»Ä¸¢苷(ATP¡^²G¼W¥[¨xŦATP§t¶q¡A¥i¥H¹w¨¾ø¥¾¦Ãþ°Êª«¯×ªÕ¨xªºµo®i¡C

¦¹¥~«D°sºë©Ê¯×ªÕ©Ê¨xª¢±wªÌ¦bµu¼È¯ÓºÉ«á¸É¥R¨xŦ ATP Àx³Æªº¯à¤OÅãµÛ¨ü·l¡C

1964.12.1-¤TÁC»Ä¸¢苷ATP¹w¨¾¯×ªÕ¨x

www.nature.com/articles/2041196a0

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/15 ¤U¤È 08:41:22²Ä 3827 ½g¦^À³
¨x²Ó­M²£¥Í§¿»Äªº³t²v¬O²Ó­M ATP íºA¨ü·lªº±Ó·P«ü¼Ð

www.journal-of-hepatology.eu/article/S0168-8278(24)00145-4/fulltext

-----------------------------------------------------------------------------------------

¦pªGSNP-810(APAP+¥ÌÅS¾J+¤T´â½©¿})--->¯à¸Ñ¨MAPAPªº¨x¬r©Ê

¨ºSNP-610(¥ÌÅS¾J+¤T´â½©¿})--->¥i¯àªvÀøMASH(NASH)ªº·§²v???

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/15 ¤U¤È 08:33:35²Ä 3826 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/10 ¤U¤È 04:05:55²Ä 3793 ½g¦^À³

§A¾á¤ßªº¨Æ90% ¤£·|µo¥Í¡I

¥ÌÅS¾J+¤T´â½©¿}ªºAPAP¥h¬r¨¾¬r¾÷¨î¬O....§Ö³tÅãµÛ¼W¥[²Ó­M¤ºATP¤ô¥­)->³o¾÷¨î¦bªvÀøMASH(NASH)¤]«Ü­«­n!

-----------------------------------------------------------------------------------------------------

¨x²Ó­M²£¥Íªº[§¿»Ä]¬O [ATP®ø¯Ó]ªº¤@­Ó«D±`±Ó·Pªº«ü¼Ð!!!

¤åÄm¸ê®Æ:

1.2016¦~¦å²M§¿»Ä»P¤¤°êªÎ­D¦¨¤H«D°sºë©Ê¯×ªÕ¨xªº[­·ÀI¿W¥ß]¥B[½u©Ê¬ÛÃö]

www.nature.com/articles/srep38605

2.2024.3.5-¨à¬ì MASLD(¥NÁÂ¥\¯à»Ùê¬ÛÃöªº¯×ªÕ©Ê¨x¯f) ©w¸q¤¤ªº§¿»Ä¡G¬O®É­Ô¹ê¬I¶EÂ_¼Ð·Ç¤F¶Ü¡H

www.journal-of-hepatology.eu/article/S0168-8278(24)00145-4/fulltext

3.2023.6.20-³z¹L¨ü±±°I´î°Ñ¼ÆÀË´ú¬ü°ê¤H¸s¦å²M§¿»Ä»P¨x¯×ªÕÅܩʪºÃöÁp

www.ncbi.nlm.nih.gov/pmc/articles/PMC10280954/

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/15 ¤U¤È 08:06:29²Ä 3825 ½g¦^À³
¥h¦~Nature¤l¥Z2023.11.24- «D³W½d BIM ½Õ¸`ªº¯à¶q¥NÁ¨M©wÃĪ«¤Þ°_ªº¨xŦÃa¦º(BIMªº®ø¯Ó¥i¨¾¤îAPAP»¤µoªº¨xÃa¦º)

www.nature.com/articles/s41418-023-01245-7

BIM ¯Ê¥F¼W±j¤FÁ` ATP ªº²£¥Í¡A¨Ã±N¥Íª«¯àÃÐÂà¦V¿}¸Ñ¡A±q¦Ó«ù¤[«OÅ@§K¨ü APAP »¤¾Éªº¨x·l¶Ë¡C

­ä¤`²É½uÅé¥~½¤³z¤Æ·|¾É­PAPAP»¤¾Éªº²É½uÅ駹¾ã©Ê³à¥¢¡A±q¦Ó¥[¼@ ATP ®ø¯Ó©M ROS §Î¦¨

APAP¤Þ°_ªº¨xÃa¦º¥D­nµo¥Í¦b¨xŦ¤¤¥¡ÀR¯ß©P³ò¡C³o¥i¥H³z¹L§½³¡CYP2E1 °ªªí¹F¡]±NAPAP Âà´«¬°NAPQI¡^¨Ó¸ÑÄÀ

...¤F¸Ñ APAP ¤¤¬r»¤¾Éªº¥Ù¬Þ²Ó­M¦º¤`¨Æ¥ó¹ï©ó·sªºªvÀø¤èªk¦ÜÃö­«­n¡C

§Ú­Ì¦b³o¸Ì´¦¥Ü¤F¤@­Ó¤@¯ë³W«h¡A§Y¨x²Ó­Mªº¥Íª«¯à¯S¼x¨M©w¤F AILI ªºµ²ªG¡A

¥D­n¨Ì¿à²É½uÅé ATP ¥Í¦¨ªº²Ó­M¹ï APAP ¬r©Ê±Ó·P¡C

¥D­n¨Ì¿à²É½uÅé ATP ¥Í¦¨ªº²Ó­M¹ï APAP ¬r©Ê±Ó·P¡C

¥D­n¨Ì¿à²É½uÅé ATP ¥Í¦¨ªº²Ó­M¹ï APAP ¬r©Ê±Ó·P¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/15 ¤U¤È 07:34:34²Ä 3824 ½g¦^À³
[³æ²Ó­MªÅ¶¡Âà¿ý²Õ¤ÀªR]-2020¦~¤J¿ï[Nature]´Á¥Z³Ì¨Î§Þ³N¡A¬Oªñ¤Q¦~¨Ó¥Íª«Âå¾Ç»â°ì³Ì¨üÆf¥Øªº§Þ³N¤§¤@ ¡C

2021.5.12-¨Ï¥Î[³æ²Ó­MRNA©w§Ç]¹ï¤AñQ®ò°ò×ô¹L¶q«á¦­´Á¨xŦÂà¿ý²Õ´ºÆ[¶i¦æªÅ¶¡­««Ø

academic.oup.com/toxsci/article/182/2/327/6275242

...¦¹¦X¦¨ ATP ¯à¤Oªº¼W±j¬O¦³§Qªº¡A¨Ã¥B¥i¯à¬° PP(ªùÀR¯ß©P³ò)²Ó­M´£¨ÑÃB¥~ªº«OÅ@¤â¬q¡C¦b³o¤è­±¡AAPAP-PC¨x²Ó­Mªí²{¥X»P¯à¶q²£¥Í¬ÛÃöªº°ò¦]ªº±j¯P»¤¾É¡A¥i¯à¬O¬°¤F¼W¥[ATPªº²£¥Í¡A¥Hº¡¨¬APAP¤ÏÀ³¤Þ°_ªº¼sªx¥NÁ»ݨD¡C»Pµ¥¼¯º¸¾¯¶qªº NAC ¬Û¤ñ¡AAPAP ¼ÉÅS«á¬I¥Î GSH ¥i¥H§ó¤jµ{«×¦a´î¤Ö¨x·l¶Ë¡A³¡¤À­ì¦]¬O GSH §ó¦³®Ä¦a¼W¥[¤F§J¹p¥¬´µ´`Àô¤¤ªº¤¤¶¡²£ª«¡A¥i¯à·|¼W¥[ ATP¡C PC(¤¤¥¡©P³ò)¨x²Ó­M¼W¥[¯à¶q²£¥Í©M¦X¦¨¥Íª«¯à¬ÛÃö³J¥Õ½èªº ATP ®ø¯Ó©Ò»ÝªºÃB¥~®É¶¡¹ï³o¨Ç²Ó­M¦³®`....

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/10 ¤U¤È 04:05:55²Ä 3793 ½g¦^À³

§A¾á¤ßªº¨Æ90% ¤£·|µo¥Í¡I

¥ÌÅS¾J+¤T´â½©¿}ªºAPAP¥h¬r¨¾¬r¾÷¨î¬O?°£¤F§í¨îcyp2e1¥~¡AÃöÁä¥i¯à¦b¥¨¾½²Ó­M[¦­´Á¥B¥i¯àª½±µ]ªº§ó¦n«OÅ@¾÷¨î:§Ö³t ÅãµÛ¼W¥[²Ó­M¤ºATP¤ô¥­)->³o¾÷¨î¦bªvÀøMASH(NASH)¤]«Ü­«­n!

1.2009.12.23--GSH»PNAC«OÅ@¤p¹«§K¨ü¹ï¤AñQ®ò°ò×ô¨x¬r©Êªº·s¾÷¨î

...»P GSH ¬Û¤ñ¡ANAC ³B²z¦b«ì´_ ATP ©M²É½uÅé GSH ¤ô¥­¤è­±®ÄªG¸û®t....

2.2013.2.5--¹ï²Ó­M[¥~]ATPªº¤ÏÀ³©Ê§ïÅÜ·|¼W±j¹ï¤AñQÓi×ôªº¨x¬r©Ê

APAP¤Þ°_ªº¨x·l¶Ë¨Ì¿à²Ó­M¥~ATP°T¸¹¶Ç¾É

...·í²Ó­M¥~ATP§@¥Î¨ü¨ì§í¨î®É¡AªA¥Î¹L¶q¹ï¤AñQ®ò°ò×ôªº¤p¹«ªº¨x·l¶Ë©úÅã´î¤Ö¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/15 ¤U¤È 12:25:30²Ä 3823 ½g¦^À³
½aÁ|ªk±À½×¤@¤U:

Q1: GSK¥i¯à¤£¥i¯à±À¥X(OTC«D³B¤è¤fªA)Advil:¤AñQ®ò°ò×ô¡]1000mg¡^+¥¬¬¥ªâ¡]300mg¡^???

Q2: SNP-810¯àÅýGSK¥Ï¶}Advil Âù®Ä¤ù¾¯ OTC[¥é»sÃÄ]???

-------------------------------------------------------------------------------------------

A1:µS¥¼¥iª¾?

A2:SNP-810¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/15 ¤U¤È 12:08:02²Ä 3822 ½g¦^À³
1.2011¦~-¸¯Äõ¯À¥v§J²£¥ÍªºÁ{§É¼Æ¾Ú¤ä«ù 1,000 ²@§J¹ï¤AñQ®ò°ò×ô¤ñ 500 ²@§J©M 650 ²@§J¾¯¶q¨ã¦³§ó¦nªº¤îµh¥\®Ä¡A

´°«PFDA ºû«ù°ª¾¯¶qªº OTC ª¬ºA¡C´°«P FDA ºû«ù°ª¾¯¶qªº OTC ª¬ºA¡C

pink.citeline.com/PS104947/Glaxo-Acetaminophen-Efficacy-Studies-Fill-FDAs-1000MG-Dose-Data-Gaps

¥Ø«e¬ü°êOTCªºAPAP¾¯¶q500mg¬°¥D¡A¤Ö¼Æ650mg¡C

---------------------------------------------------------------------------------------------------

2. 2020.3.2-FDA§å­ãGSK(OTC«D³B¤è¤fªA)Advil:¤AñQ®ò°ò×ô¡]500mg¡^+¥¬¬¥ªâ¡]250mg¡^

----------------------------------------------------------------------------------------------

3.2023.10.18- FDA§å­ã(³B¤èª`®g¾¯)Maxigesic IV¹ï¤AñQ®ò°ò×ô1000mg +¥¬¬¥ªâ300mg¡A¥Î©óªvÀø³N«á¯kµh¡C

-----------------------------------------------------------------------------------------------

4.2023.7.17- ¬ü°ê FDA §å­ã¸¯Äõ¯À¥v§J Advil Âù®Ä¤ù¾¯ªºÁû²É[¥é»sÃÄ]

www.thehindu.com/business/us-fda-gives-nod-for-granules-copy-of-glaxosmithklines-advil-

dual-action-tablets/article67080704.ece

---------------------------------------------------------------------------------------------

½aÁ|ªk±À½×¤@¤U:

Q1: GSK¥i¯à¤£¥i¯à±À¥X(OTC«D³B¤è¤fªA)Advil:¤AñQ®ò°ò×ô¡]1000mg¡^+¥¬¬¥ªâ¡]300mg¡^???

Q2: SNP-810¯àÅýGSK¥Ï¶}Advil Âù®Ä¤ù¾¯ OTC[¥é»sÃÄ]???

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/15 ¤W¤È 10:58:11²Ä 3821 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/14 ¤W¤È 05:56:18²Ä 3814 ½g¦^À³

¥þ²y³ÌüL医药­Ë爷现¥@¡A³Q¡§³Î¡¨ªº¥u¦³ùÚ·ç吗¡Hxueqiu.com/5666183627/274295175

¦n®ø®§¬O¡AAiolos Bio°_码没¦b¥æ©ö¥»¨­骗ùÚ·ç¡F§¥®ø®§¬O¡A结ªG¤ñ³Q¥¦骗¤F还难¨ü

------------------------------------------------------------------------------------------------

²´¥ú¬r»¶ªº­Ë·Ý¬Ýªº¬O:¦P¾÷¨îªºÃĪ«¡A§O¤H1­Ó¤ë1°w¡A«í·ç6­Ó¤ë1°w¡C

SNP-810µL¨x¬r¡AOTC¥«³õ°ª¾¯¶q¦b²Î­p¾Ç¤WÀu©ó¸û§C¾¯¶q¡A»ù®æ¨S¦³¸û¶Q¡A¨S¦³Ävª§Àu¶Õ?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/15 ¤W¤È 10:16:06²Ä 3820 ½g¦^À³
2020.10.28-°ê®a¬rª«¤¤¤ß©IÆ~·ç¤h¤j¾¯¶q¹ï¤AñQ®ò°ò×ô¡]¼³¼ö®§µh¡^¤ù¾¯¤W¥««e»P¤W¥««á¹ï¤ñ

www.ncbi.nlm.nih.gov/pmc/articles/PMC7593813/

µ²½×©M¬ÛÃö©Ê

³o¶µ¬ã¨sµo²{¡A¦Û2003 ¦~§å­ã1000 ²@§J¤ù¾¯«á¡A·ç¤hªº¹ï¤AñQ®ò°ò×ô°tÃÄ©M»P¹ï¤AñQ®ò°ò×ô¬ÛÃöªº¤¤¬r¨Æ¥ó[ÅãµÛ¼W¥[]¡C

----------------------------------------------------------------------------------------------------

ªvÀø«æ©Ê»´«×¦Ü¤¤«×¯kµh¡A°ª¾¯¶q(1000mg)¦b²Î­p¾Ç¤WÀu©ó¸û§C¾¯¶qªº(500mg)¡C

¦³¨x¬rªºAPAP´N¬O³½»Pºµ´x¤£¥i­Ý±o¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/15 ¤W¤È 10:09:26²Ä 3819 ½g¦^À³
OTC«D³B¤èAPAPªº¤îµh®ÄªG¬O§_¦s¦b[¾¯¶q¨Ì¿à©Ê] Âíµh§@¥Î???

2018.9.28-«D³B¤è¼³¼ö®§µhªº¾¯¶q¦³§U©ó¦³®Ä½w¸Ñ«æ©Ê»´«×¦Ü¤¤«×¯kµh

openpainjournal.com/VOLUME/11/PAGE/12/FULLTEXT/

µ²½×

¸û°ª¾¯¶qªº³tÄÀ¹ï¤AñQ®ò°ò×ô¡]1000 ²@§J¡^¡Aµu®É¶¡¡]4-5 ¤Ñ¡^¨Ï¥Î¨Ã¿í´`¼ÐÅÒ¤¤°w¹ï¦MÀI¤H¸sªº«Øij¡A¹ï©ó±w¦³»´«×¦Ü¤¤«×ªº¦¨¤H¨Ó»¡¡A¤ñ§C¾¯¶q´£¨Ñ¦w¥þ¡B§ó¦³®Äªº¤îµh®ÄªG«æ©Ê¯kµh¡C

2006 ¦~µoªíªº¤@¶µ¹ïª½±µ¤ñ¸û¤£¦P¾¯¶qªº¼³¼ö®§µhªvÀø«æ©Ê»´«×¦Ü¤¤«×¯kµhªºÀH¾÷¡BÂùª¼¸ÕÅ窺¤j«¬¨t²Îµû»ùµo²{¡A¸û°ª¾¯¶qªº¼³¼ö®§µh(1000mg) ¦b²Î­p¾Ç¤WÀu©ó¸û§C¾¯¶qªº¼³¼ö®§µh(500mg)¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2024/6/14 ¤W¤È 10:53:33²Ä 3818 ½g¦^À³
§¹¤F¡A§Ú¤â½â¨Ó¶R¤F~©ñ¨ì²Ä¤T©u

ªGµM¤S±Y¤F

===================================================

·|­û¡G´MÄ_10151381 µoªí®É¶¡:2024/6/13 ¤U¤È 02:17:17²Ä 3806 ½g¦^À³

ªÑ²¼ªº»ù®æ¬O­nÅý¥«³õ¦³·Q¹³ªÅ¶¡¡A¤£­n»¡ÃĦ³¤°»ò½ÆÂøªº¾÷Âà¡AÃø¹DÄvª§¹ï¤â¨S¦³¡H

ªYÄ£¦bªÑªF·|¤W³£¤wÄÀ¥X¦p¦¹ªº¤j§Q¦h¡Aµ²ªG....

¤§«eªº¥«³õ¥D¤O¨é°Ó¡G´I¨¹-¢æ·R¡A´¿¸g«ù¦³¹O2000±i¥H¤W¡A§¡»ù±µªñ80¤¸¡A¥i±¤©ê¤W¤S©ê¤U¡A

ªñ´Á¤w¶}©l¥X²æ¡A¬Ý¨Ó¬O·Ç³Æ±ó¦u¤F¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2024/6/14 ¤W¤È 07:15:28²Ä 3817 ½g¦^À³
¤£¥i¯à¥i¯à!?

ºÖº¸¼¯´µ:¡§±Æ°£¤@¤Á¤£¥i¯àªº¡A³Ñ¤Uªº§Y¨Ï¦A¤£¥i¯à¡A¨º¤]¬O¯u¬Û¡¨--³oºØ[¤£¥i¯àªº¥ô°È]´N¥Ñ´ö©i¡P§J¾|´µ¸Ñ¨M¡C

¤Z¤H¤@­Ó¡A§Ú´N·|¼É¤O¯}¸Ñªk(½aÁ|ªk)¡A³v¤@¦C¥X©Ò¦³¥i¯à±¡ªp(¾÷¨î)¡AÂk¯Ç±À²z¥Xµ²½×!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
12345678910¤U¤@­¶¤U¤Q­¶

         

¡@

§Ú¡@¡@­n¡@¡@¦^¡@¡@À³¡@¡@¥»¡@¡@¸Ü¡@¡@ÃD

·| ¡@­û¡G

  

§@ ªÌ ¡G

 

¬ÛÃöªÑ²¼¤½¥q¦WºÙ ¡G

ªYÄ£¥ÍÂå

¤º¡@ ®e¡G

¡@
½Ð¥ýµn¤J ­Y±z©|µL·|­û¨­¤À¡A½Ð¥ý¥Ó½Ð±b¸¹ ¡@
¡@

°Q½×°Ï¬ÛÃö³W©w¡G
    1.­Y±b¸¹¶¢¸m¹L¤[¨t²Î·|¦Û°Êµn¥X¡A«Øij¦b¼g¦n¤å³¹¨Ã¥B©|¥¼µo°e¤§«e¥ý¦æ½Æ»s¡A¥H§Kµo°e¥¢±Ñ«á¾É­P¤º¤å®ø¥¢¡I
    2.½Ð¤Å°Q½×ªÑ²¼¶R½æ©Î´£¤Î¦¨¥æ»ù¦ìµ¥¨Æ©y¡A¤Z¬O¯d¤U¬ÛÃö¥æ©ö°T®§¡A¥»ºô±N¦Û°Ê§R°£¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
    3.ÄY¸T¯d¤UÁpµ¸¤è¦¡¡A½Ñ¦pLINE¡BFB¡BE-mail¡B¹q¸Ü..µ¥¡A©Î¥H¥ô¦ó©ú¥Ü¡B·t¥Üµ¥¤âªk¶i¦æÁpµ¸¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
    4.¬°ÁקK®ö¶Oºô¸ô¸ê·½¡A½Ð¤Å±N¬Û¦P¤º®e³sÄòµo¦b¦h­Ó¤£¦P¥DÃD¤º¡A©ÎªÌ³sÄòµo°e¦h­Ó·s¥DÃD¡A­Y¦³¦¹Ãþ¬~ª©¤§¦æ¬°±NµLªkÄ~Äò°Ñ»P°Q½×¡I
    5.ÄY¸T·N¹ÏÂǥΥ»ºô¥­¥x¤½µM´²¥¬¤å¦r©ó²³¡A¦Ó«üÂÖ¡B«V°d©Î¶Ç­z¨¬¥H·´·l¥L¤H¦WÅA¤§¨ÆªÌ¡A­Y¦]¦Ó¯A¤Îªk«ß°ÝÃD¡A·§»P¥»¤½¥qµLÃö¡A·q½Ð¿í¦u¡C

·q½Ð´L­«¥»ºô¤§¸gÀç²z©À¨Ã¿í¦uª©³W¡AÁÂÁ¡C


¼s§i¦X§@ ¥¼¤W¥«ÂdªÑ²¼¬d¸ß ¥¼¤W¥«ºô¯¸¾ÉÄý ¥¼¤W¥«ÂdªÑ²¼±MÃD ¿³ÂdªÑ²¼±MÃD ¥¼¤W¥«ªÑ²¼-¶°¹Î¤ÀÃþ ²§·~Âà§ë¸ê¥Í§Þ·~ ¤U³æ±Ð¾Ç
¥¼¤W¥«|¥¼¤W¥«ªÑ²¼|³Ì±M·~ªº  ¥xÆW¥¼¤W¥«ªÑ²¼  °]¸gºô¯¸-Copyright©2022¡£¥²´Iºô¡¤ §K¥I¶OªA°È±M½u:0800-035-178   ªA°È«H½c:postmaster@berich.com.tw
¥»ºô¯¸¬° ¥¼¤W¥«ÂdªÑ²¼¬d¸ß,¥¼¤W¥«ªÑ²¼§Y®É·s»D,¥¼¤W¥«¤½¥q¤½§i,¿³ÂdªÑ²¼¶R½æ,·Ç¤W¥«ªÑ²¼,¤¤ÅҪѠ ¬ÛÃö¸ê°T¤À¨É¥æ¬yªÀ¸sºô¯¸,¸ê®Æ¶È¨Ñ°Ñ¦Ò,¨Ï¥ÎªÌ½Ð¦Û¦æ·r°u!
¥»ºô¯¸¤£¤¶¤J·|­û¶¡¤§¥¼¤W¥«ªÑ²¼¶R½æ,³æ¯Â´£¨Ñ  ¥¼¤W¥«ªÑ²¼¦æ±¡,«ùªÑÂàÅý,¥¼¤W¥«ªÑ²¼¹L¤á¿Ô¸ß  ¶È´£¨Ñ¥¼¤W¥«ªÑ²¼¥æ©ö¥­¥xµ¹·|­û¨Ï¥Î,¨Ì¥»¸ê®Æ¥æ©ö«á¬ÕÁ«¦Û­t!